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Abstract 
The spread of cancer to distant sites, metastasis, is responsible for the majority of cancer 
related deaths.  Metastasis is a complex process comprising a number of steps and 
mechanisms which take place over time.  Due to the temporal and extemperaneous nature 
of metastasis it has proved difficult to study.  Current models are limited in their application 
and there is a need to develop new models which provide a better and more meaningful 
biological context for the study of metastasis. 
Taking a tissue engineering approach, this project has sought to develop a set of in vitro 
models for the exploration of cancer metastasis in three dimensions.  Two collagen based 
assays were developed to allow the exploration of metastasis in a three dimensional (3D) 
environment.   A simple collagen based assay was developed to create multiple regions of 
interest, allowing the study of cell migration, invasion and colonization in two dimensions, 
three dimensions and at border zones.  Compression of collagen was used to construct a 
stiffer more elastic 3D in vitro context and this assay was developed to provide multiple 
regions of interest for the study of metastasis in a more structured and biologically relevant 
environment. 
The chick chorioallantoic membrane (CAM) assay was explored as an in vivo model for the 
study of metastasis however this allowed only a short time period for study.  However, the 
decellularization of CAM tissue provided a novel and useful 3D context which could be used 
for the study of metastatic mechanisms in direct comparison to the in vivo model but over 
longer time periods.   
vi 
 
Decellularized CAM was successfully used in conjunction with the other two assays to 
explore the differential expression of intermediate fillaments across different 3D 
environments, confirming the need to use different assays and approaches when 
investigating metastatic mechanisms. 
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1 
 
1. Introduction 
1.1. Cancer 
Cancer is one of the leading causes of death worldwide, with 14 million new cases and 8.2 
million cancer related deaths reported in 2012 (IARC 2014).  In the same year it was 
estimated that 2.5 million people in the UK were living with cancer and that this was 
projected to rise to around 4 million by 2030 (Maddams et al. 2012). 
Cancer is in fact a set of diseases, each cancer being unique to the person, arising as it does 
from changes within individual cells leading to aberrant cell behaviour, unregulated tissue 
function and ultimately to organ failure.  Hanahan and Weinberg have defined a framework 
for the development and spread of cancers based  on common characteristics and 
mechanisms found through research in the field (Hanahan and Weinberg 2011).  Six 
hallmarks and a further two emerging hallmarks have been described along with two 
enabling characteristics and these are illustrated in Figure 1.1  and summarised in  
Table 1.1.   
Figure 1.1,  The hallmarks of cancer (Hanahan and Weinberg 2011). 
2 
 
Table 1. 1 Hallmarks and characteristics of cancer, based on Hanahan and Weinberg, 2000 
and 2011. 
Hallmark Description Evidence 
Sustained 
proliferative 
signalling 
Cell cycle progression is tightly controlled in 
normal cells to maintain tissue homeostasis.  
Deregulated signalling sustained over time leads to 
uncontrolled growth and tissue destabilization. 
These are key features of tumorigenesis. 
(Keller et al. 2014, 
Kerkhoff and Rapp 
1998, Medema and 
Macůrek 2011, Nik-
Zainal et al. 2012, 
Pylayeva-Gupta et al. 
2011, Youssef et al. 
2012) 
Resisting cell 
death 
Programmed cell death as a means of eliminating 
damaged or malfunctioning cells is important in 
tissue homeostasis.  Aberrant cells avoiding 
apoptosis can contribute to increasing tumour 
mass.  
(Kim  et al. 2012, 
Mehlen and Puisieux 
2006, Ouyang et al. 
2012, Stewart and 
Abrams 2008) 
Evading 
growth 
suppressors 
To develop successfully a tumour must also avoid 
negative regulators which suppress aberrant 
growth during normal tissue homeostasis. RB and 
TP53 are key tumour suppressor proteins which 
act as gatekeepers at cell cycle checkpoints which 
are frequently defective in cancers. 
(Kim Mi Ra et al. 2012, 
Song et al. 2012, 
Stewart and Abrams 
2008) 
Activation of 
invasion and 
metastasis 
Metastasis has been described as a complex multi-
step process involving: invasion, intravasation, 
transit and escape, culminating in colonization of 
suitable niches where micrometastases, may 
develop into secondary tumours.   
(Bravo-Cordero et al. 
2012, Canel et al. 2013, 
Nguyen et al. 2009, 
Sanz-Moreno et al. 
2008, Scheel et al. 
2007) 
Enabling 
replicative 
immortality 
Cells are normally limited in the number of 
divisions they make via mechanisms such as fixed 
length telomeres.  Cells able to divide indefinitely 
run the risk of incorporating and perpetuating 
errors which combined with genomic instability 
and apoptosis resistance lead to continuous 
replication of aberrant cells. 
(Shay and Wright 2011, 
Stewart  et al. 2002) 
Angiogenesis 
induction 
Tumour mass is limited without a method of 
transport of nutrients and waste products.  
Angiogenesis is triggered in many cancers allowing 
further development.  Hypoxia is a key contributor 
to the up-regulation of growth factor secretion, 
along with other changes in cell signalling.  
(Ghosh et al. 2008, 
Lorusso and Ruegg 
2008, Lu 2006, Orimo 
and Weinberg 2006, 
Wang Zongwei et al. 
2015, Weis and Cheresh 
2011) 
Deregulation 
of cell 
energetics 
Altered metabolism in cancer lesions may further 
enable growth and cell proliferation by utilizing 
aerobic glycolysis and up-regulating associated 
receptors to provide the necessary glucose 
required. Links between oncogene expression, 
mutations in tumour suppressor genes and 
glycolytic switching have been observed. 
(Cairns et al. 2011, 
Martinez-Outschoorn 
et al. 2011, Räsänen 
and Vaheri 2010, 
Sebastián et al. 2012) 
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Hallmark Description Evidence 
Avoidance of 
immune 
destruction 
Immune surveillance usually provides a mechanism 
to eliminate unwanted bodies.  
Immunocompromised patients suffer greater 
cancer incidence which suggests the importance of 
a healthy immune system in cancer development. 
(Dadi et al. , Malladi et 
al. 2016, Stewart and 
Abrams 2008) 
Enabling characteristic 
Genomic 
mutation/ 
instability 
A genotype allowing aberrant cell behaviour is 
believed to be important in the development of 
cancer at the cellular level. 
(Medema and Macůrek 
2011, Nguyen Don X. 
and Massagué 2007) 
Tumour-
promoting 
inflammation 
The presence of immune cells and the similarity 
between cancerous lesions and wound healing 
have led to the belief that chronic inflammation is 
important in some cancers. 
(Candido and 
Hagemann 2012, 
Mantovani et al. 2008, 
Räsänen and Vaheri 
2010, Spaeth et al. 
2008) 
 
Regardless of the initial trigger, it is generally the accumulation of a number of errant traits 
at a cellular level which render normal tissue homeostasis and error correction mechanisms 
ineffective, allowing the outward spread of cancer via invasion and metastasis to occur.   
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1.2. Metastasis 
Metastasis is the main cause of cancer related death (WHO 2015).  It is a complex multi-step 
process in which cells move away from a primary tumour, establishing themselves elsewhere 
in the body where they may form new tumorous growths known as metastases.  One of the 
eight hallmarks of cancer, metastasis is enabled by:  changes in character of the escaping 
cell, compliance and flexibility of the surrounding environment and the assistance of non-
tumour cells that reside within (Hanahan and Weinberg 2011, Lorusso and Ruegg 2008).  
Non-cancerous tumour related cells may be recruited by and associate with the tumour itself 
or be part of the environment through which the escaping cell passes (Hanahan and 
Coussens 2012, Joyce and Pollard 2008, Karnoub et al. 2007, Wyckoff et al. 2007). The initial 
steps of invasion and metastasis are therefore dependent on changes which allow tumour 
cells to escape, these changes arising within the tumour cells themselves or as a result of the 
properties of the surrounding tumour microenvironment (Alexander and Friedl 2012, 
Radisky et al. 2005).  A number of different models of metastasis have been proposed which 
are summarised in Table 1.2.  Each of these models suggests a complex pathway in which 
cancer progression is dependent on cellular change over time. For metastasis to occur, cells 
must escape from the primary tumour, invade into the surrounding tissue and migrate or 
transit away to take up residence at a new site, successful colonization at the distant site 
being the final stage of the metastatic process as a secondary growth or metastasis forms 
(Figure 1.2).  Metastasis is therefore a progressive and complex process involving multiple 
stages (Valastyan and Weinberg 2011).  Most cancers occur in epithelial or endothelial tissue 
in which cells are bound together via cell-cell junctions in either single or multiple layers 
(McCaffrey and Macara 2011, Radisky 2005, Radisky et al. 2005).   A number of different 
types of junction connect the cells:  tight junctions, channel-forming gap junctions and signal 
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relay junctions (Balda and Matter 2008, Bissell and Radisky 2001, Lecuit and Yap 2015).  In 
addition, cells are anchored to the basement membrane, a specialized extra-cellular layer 
comprising a combination of proteins secreted by the epithelial or endothelial cells which 
attach to one side and the stromal fibroblasts of the extra cellular matrix (ECM) on the other 
side (McCaffrey and Macara 2011, Rowe and Weiss 2008).  Cells must detach from the 
basement membrane as well as each other if they are to migrate (Kelley et al. 2014, Rowe 
and Weiss 2008).  An unanchored cell would normally undergo anoikis, that is cell death due 
to loss of anchorage, but a key feature of cellular transformation in cancer is the gaining of 
anchorage-independence allowing a tumour cell to commence its journey to a new site 
(Hanahan and Weinberg 2011, Hernandez-Caballero 2013, Mehlen and Puisieux 2006).  This 
type of cell transition is similar to the tightly regulated epithelial-mesenchymal transition 
(EMT) which takes place during embryogenesis (Thiery et al. 2009, Zoltan-Jones et al. 2003) a 
process believed to originate from early in the evolution of multicellular organisms (Larue 
and Bellacosa 2005).   
Figure 1.2, The metastatic process.  Metastasis is a staged process, cells interacting with and 
transiting through a number of different environments before reaching and colonizing at a 
new site. Based on Valastyan and Weinberg 2011. 
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Table 1.2, Models of metastasis 
Model Description Proponents Reference 
Linear 
Progression 
Step-wise progression of cancer. Primary 
tumour matures before metastasis 
commences. 
Leslie Foulds (Foulds 
1958) 
Parallel 
Progression 
Metastatic cells disseminate early in 
primary tumour development and 
development of tumorous tissue occurs in 
parallel. Proposed due to size and 
occurrence of secondary growths which 
could not be explained by time course of 
linear progression model. 
Collins, 
Loeffler and 
Tivey 
(Collins et 
al. 1956) 
Dissemination 
to first pass 
organ 
Metastasizing cells move and develop into 
secondary growths at new sites 
dependent on the circulatory pathways of 
the body, e.g. breast cancer metastasizing 
to the lungs. 
James Ewing (Ewing 
1928) 
Metastatic 
Cascade 
Theory 
The step-wise progression of metastasis: 
escape, invasion into surrounding tissue, 
intravasation of the circulatory system, 
extravasation, invasion, colonization at a 
distal site and development of secondary 
growths.  
Bross, Viadana 
and Pickren 
(Bross et 
al. 1975) 
Seed and Soil 
Hypothesis 
Successful metastasis is based on both the 
dissemination of malignant cells and the 
ability of a cell to grow in the secondary 
tumour microenvironment, the ‘pre-
metastatic niche’. 
Stephen Paget  (Paget 
1989) 
Cancer Stem 
Cell 
Hypothesis 
A small pool of multipotent cells with self-
renewing capability provide a pool of cells 
available for the production of tumour 
cells with metastatic capability.   
Reya, 
Morrison, 
Clarke and 
Weissman 
(Reya et 
al. 2001) 
Clonal 
Selection and 
Expansion 
Genetic and epigenetic changes cause a 
series of mutations to arise in cells 
resulting in the development of cancer, 
either via the loss of tumour suppressor 
function or by a gene gaining ‘oncogenic’ 
capacity.  
Fidler and 
Kripke, 
expanded by 
Vogelstein, 
Fearon and 
Hamilton 
(Fidler and 
Kripke 
1977, 
Vogelstein 
et al. 
1988) 
Epithelial-
Mesenchymal-
Transition 
(EMT) 
Metastatic 
progression 
Model 
Cells escaping from a primary tumour in 
solid cancers undergo a phenotypic 
change allowing them to adopt 
mesenchymal cell characteristics involving 
the down-regulation of proteins including 
those binding the cell within its tissue. 
Boyer and 
Thiery 
(Boyer 
and Thiery 
1993) 
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1.3. Epithelial-Mesenchymal Transition (EMT) 
EMT is a highly regulated process in healthy tissue and involves several steps summarised in 
Table 1.3 below.  In EMT, epithelial cells detach from a tissue mass and take on the cell 
characteristics of a de-differentiated mesenchymal cell, allowing their migration to a new 
location (Radisky 2005, Rowe and Weiss 2008).   Mesenchymal cells are  anchorage-
independent stromal cells able to migrate, synthesize and organize ECM components and 
secrete proteases (including matrix metalloproteases - MMPs) and growth factors (Larue and 
Bellacosa 2005, Radisky 2005).   EMT is induced by a range of both genetic and 
environmental factors including hyaluronan expression, MMP exposure, Reactive Oxygen 
Species (ROS), TGFβ/SMAD signalling pathway (Radisky 2005, Radisky et al. 2005, Zoltan-
Jones et al. 2003).   
An EMT like process has been observed during cancer progression, triggered by the tumour 
and its surrounding environment, but in contrast to the highly organised and programmed 
step-wise EMT, this takes place in an un-regulated fashion (Kalluri and Weinberg 2009, Tsai  
and Yang 2013).  E-cadherin expression is an important characteristic of epithelial cells 
organised into layered tissue, the cadherin-adheren tight junction assembly allowing cells to 
maintain polarity and cell position within tissue and thus acting as a  tumour suppressor 
(Larue and Bellacosa 2005, McCaffrey and Macara 2011).  The breaking of tight junctions is 
therefore a vital step in the EMT process (Bissell and Radisky 2001, Onder et al. 2008).   
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Table 1.3, Epithelial-Mesenchymal Transition (EMT) in cancer progression 
Mechanism Processes involved Result Evidence 
Loss of cell-cell 
adhesion at tight 
junctions.   
Loss of cell polarity 
 
 E-cadherin down-regulated 
(sequestered into vesicles) and 
replaced by N-cadherin 
 Up-regulation of vimentin 
(AKT1 target) and fibronectin 
may occur 
 Beta-catenin released and may 
activate canonical Wnt 
pathway leading to 
transcription factor activation 
 Delta-catenin released which 
may activate GTPases. 
 Increased cellular hyaluronan 
Cell morphology 
changes to 
elongated 
mesenchymal 
type and 
individual cells 
are free to 
migrate 
 
(Larue and 
Bellacosa 
2005, Schafer 
et al. 2014) 
(Evanko et al. 
2007, Mani 
et al. 2008, 
Onder et al. 
2008, Zhu et 
al. 2011) 
Loss of cell-ECM 
adhesion 
 Integrins giving a cell polarity 
and binding it to basement 
membrane are lost 
Induction of  
pro-invasive cell 
signalling pathways 
 TGFβ activates RhoA GTPase 
 PI3K/AKT 
 Increased hyaluronan in many 
cancers believed to influence 
key cell signalling pathways 
Activation of cell 
migration 
associated 
signalling 
pathways 
 
(Madsen et 
al. 2015, 
Sahai and 
Marshall 
2003, Sanz-
Moreno et al. 
2008, Zoltan-
Jones et al. 
2003) 
Matrix degradation  Secretion of Matrix 
Metalloproteases (MMPs), 
serine proteases, cathepsins 
 Membrane bound matrix 
metalloproteases may also 
degrade pericellular tissue 
 MMP3 and MMP9 linked to 
Rac1b induction 
Degraded tissue 
gives cells space 
to move into. 
 
Rac1b signalling 
known to drive 
cell migration in 
some cancers 
(Radisky et 
al. 2005, Rolli 
et al. 2003, 
Zijlstra et al. 
2004) 
Transcription 
factors induced: 
SNAIL, SLUG, 
TWIST 
 ROS triggers SNAIL which 
triggers EMT 
 TWIST linked to early EMT 
steps 
Inhibition of 
apoptosis 
and block cell 
differentiation 
favouring cell 
migration 
(Onder et al. 
2008, Scheel 
et al. 2011, 
Sleeman and 
Thiery 2011) 
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Mechanism Processes involved Result Evidence 
Acquisition of stem 
cell type 
characteristics: 
 Self-
renewal 
capability 
 Phenotypic 
plasticity 
 Possible that cells undergoing 
de-differentiation during EMT 
like process also gain other 
properties of stem cells such 
as self-renewal allowing them 
to persist until a suitable 
environment for growth is 
available. 
 Ability to remain de-
differentiated or to 
differentiate according 
conditions encountered in a 
new environment. 
Cancer Stem 
Cells which can 
seed themselves 
at distant sites 
and initiate the 
growth of a new 
tumour. 
(Hanahan 
and 
Weinberg 
2011, Mani 
et al. 2008, 
Schwitalla et 
al. 2013) 
In mesenchymal cells, N-cadherin expression is up-regulated allowing cells to function 
independently and facilitating migration (Larue and Bellacosa 2005, Onder et al. 2008).  The 
PI3K/AKT signalling pathway is also known to be involved in EMT, driving the process and 
interacting with other important cell signalling pathways (Larue and Bellacosa 2005).  When 
the PI3K/AKT pathway is triggered, phosphorylated activated AKT leads to the expression of 
transcription factors Slug and Snail which act to repress E-cadherin expression at cell-cell 
junctions, enabling a cell to detach from its host tissue.  Vimentin and fibronectin expression 
are also increased as is the expression of matrix metalloproteases allowing basement matrix 
degradation to take place (Xu et al. 2015).  Mesenchymal-epithelial transition (MET), the 
reverse process of EMT, is believed to facilitate the seeding of tumour cells at distant sites 
where with the right environmental conditions they may develop into metastases (Scheel et 
al. 2007, Tsai  and Yang 2013). Once cells have detached from tissue either individually or as 
a group, they may adopt a variety of mechanisms to enable movement either over or 
through tissue (Friedl and Gilmour 2009, Friedl and Wolf 2003). 
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1.4. Cell migration 
Cell migration is a process driven by the biophysical properties of the cell substrate as well as 
by the characteristics of the moving cell itself (Discher et al. 2005, Friedl Peter and Wolf 
2003a, Lämmermann and Sixt 2009).  A number of different modes of migration have been 
observed with cells adopting a range of morphologies when moving across or through tissue 
(Fackler and Grosse 2008, Friedl Peter and Wolf 2003a, Wolf et al. 2003).   Cells have been 
seen to move either individually or as a group under different experimental conditions both 
in vivo and in vitro (Doyle et al. 2012, Friedl and Alexander 2011, Hegerfeldt et al. 2002, 
Petrie et al. 2009).  Plasticity in both morphology and mechanism have also been observed.  
Friedl and Wolf describe this in their ‘tuning model’ suggesting that plasticity lies on a 
continuum in which cells may change their strategy from one form and mechanism to 
another based on environmental cues (Arciero et al. 2011, Friedl and Gilmour 2009, Friedl 
and Wolf 2009a).  The modes of cell migration and associated characteristics are 
summarised in Table 1.4.  
In order to move forward, a cell must translocate itself mechanically using  either a pushing 
or pulling mechanism (Petrie and Yamada 2012).  In a two dimensional environment (2D) 
cells have been observed to crawl across a surface employing the mechanisms of protrusion, 
attachment, contraction, and detachment (Bergert et al. 2012, Ridley 2011).     
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Table 1.4,   Modes of cell migration and associated characteristics  
Migration 
mode 
Characteristics Morphology Evidence 
Amoeboid - 
blebbing 
Expansion and retraction of 
rounded membrane protrusions 
at the plasma membrane. 
Low or no adhesion; no visible 
polarity 
 
(Charras et al. 
2008, Paluch et al. 
2006, Sahai and 
Marshall 2003)  
Mixed 
amoeboid/ 
mesenchymal  
Cells rounded or elongated cells 
with blunt ended tube like 
extensions – lobopodia.  Cells 
may have lateral blebs.  Weak 
adhesion.  Cell polarity may be 
present. 
 
 
 
 
(Friedl and Wolf 
2009b, Petrie et al. 
2012) 
 
Mesenchymal Elongated individual cells with 
extensions: filopodia / 
lamellipodia. Leading and 
trailing edge; polarized and 
directed migration. 
 (Lämmermann and 
Sixt 2009, 
Mannherz et al. 
2007, Petrie et al. 
2012, Yamaguchi 
and Condeelis 
2007) 
Cell streaming 
– multiple 
cells 
Cells may form a chain with 
loose contacts. 
Cells move in a stream along 
tracks or tunnels which may be 
forged by the leading cell or 
pre-exist. 
 (Alexander and 
Friedl 2012, Friedl 
and Wolf 2008, 
Gaggioli et al. 2007, 
Wolf et al. 2003) 
Collective 
movement 
Sheet like invasive movement. 
Cells may move as a group or 
sheet with some adhesive 
connections broken on the 
outside of the group to allow 
this.  (Primordial cells move 
collectively in response to 
chemical gradients.) 
 
(Arciero et al. 2011, 
Friedl and Gilmour 
2009, Hidalgo-
Carcedo et al. 2011, 
Weijer 2009)  
In 3D a cell has the opportunity to interact with its environment on all of its surfaces (Doyle 
et al. 2013).  A variety of propulsive mechanisms has been identified including: filopodia, 
lobopodia, invadopodia and membrane blebs (Le Clainche and Carlier 2008a, Petrie et al. 
2012, Ridley 2011, Sahai and Marshall 2003). 
  
Lamellipodium 
Migration 
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Table 1.5, Cell protrusions and migration mode 
Type of Cell 
Protrusion  
Dimension 
(D) 
Cell 
Morphology 
Mechanism of Motility 
Adhesion Type 
Evidence 
Membrane 
Ruffling 
2D Flattened and 
spread 
Actin polymerization at the 
leading edge, retrograde 
transport and depolymerisation 
at the trailing edge. 
(Le Clainche 
and Carlier 
2008, Wehrle-
Haller and 
Imhof 2003) 
Lamellipodia 2D Flattened and 
spread 
Aggregated focal adhesions 
provide adhesion comprising 
proteins including: 
Vinculin, paxillin, talin, alpha-
actinin, zyxin, VASP, FAK p130Cas.  
At the leading edge, cofiln severs 
actin filaments and free barbed 
ends act as sites for actin 
polymerization, Arp2/3 providing 
nucleation sites where WAVE acts 
in conjunction with Rac1 and 
formins to enable extension of 
actin filaments. 
(Fraley et al. 
2010, Ridley 
2011, Sanz-
Moreno et al. 
2008, Wehrle-
Haller 2012)  
Filopodia 3D Various IRSp53 bends the membrane and 
recruits Cdc42 and mDia2 
WASP/N-WASP which stimulate 
actin polymerization at the 
leading edge to form narrow 
finger-like protrusions.  Profilin 
provides actin monomers for 
polymerization. 
(Le Clainche 
and Carlier 
2008, Ridley 
2011) 
Lobopodia 3D  Collagen 
  Matrigel 
In fibroblasts similar signalling 
process to lamellipodia but with 
high RhoA at leading edge in a 3D 
matrix with linear elasticity 
lobopodia form instead. 
(Petrie et al. 
2012, Petrie 
and Yamada 
2012, Sixt 
2012) 
Blebs – 
rounded and 
elongated 
1D 
2D 
3D 
 Rounded 
 Spread 
with blebs 
at leading 
edges 
 Elbowing 
and 
chimneying 
Initiation, development and 
retraction of a bleb are driven by 
internal pressure and acto-
myosin cortex contractility – 
occurs when Rho/ROCK levels are 
high but Rac signalling is absent. 
(Lorentzen et 
al. 2011, Otto 
et al. 2011, 
Sahai and 
Marshall 2003, 
Wolf et al. 
2003)  
Invadopodia  2D, 3D Various Protrusive extensions: 
lamellipodia and filopodia 
combine with proteolysis of the 
surroundings allowing cells to 
invade and move through tissue. 
(Magalhaes et 
al. 2011, Oser 
et al. 2009, 
Ridley 2011) 
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Whether motility is facilitated by pushing or pulling, it is vital for a cell to anchor itself to its 
substrate so that it can proceed.   Anchorage via adhesion proteins is one option and this is 
employed extensively in lamellipodia and filopodia in a 2D environment where small focal 
adhesions comprising groups of proteins linked to the cytoskeletal stress fibres anchor the 
cell to the 2D surface.  On a two dimensional surface, cells adopt a flattened morphology 
advancing via broad veil-like lamellipodia or finger-like filopodia with focal adhesion 
complexes providing a means of substrate attachment (Ridley 2011, Yamaguchi and 
Condeelis 2007).  Whilst the character of focal adhesions in 3D has yet to be fully 
characterized, Fraley and colleagues have found that where present, adhesion proteins are 
diversely spread across the cell surface rather than forming focussed focal adhesions (Fraley 
et al. 2010).  It seems too that focal adhesion composition varies with the deformability of 
the substrate of attachment (Plotnikov et al. 2012) and that the matrix constituents play a 
role in the types and sizes of adhesions (Doyle et al. 2015).  Cell migration speed has also 
been linked to the  shape and size of focal adhesions (Kim and Wirtz 2013).  
As an alternative to adhesion, membrane blebbing in 3D migration may involve the cell 
levering itself forward as it inserts blebs into pores and gaps in the surrounding matrix or 
uses a chimneying action where actomyosin contractility is the main force responsible for 
forwards movement (Charras et al. 2008, Doyle et al. 2012, Doyle et al. 2009, Lämmermann 
and Sixt 2009, Lorentzen et al. 2011) 
At the molecular level, cell migration is co-ordinated by Rho GTPases a group of small cell 
signalling molecules which act as molecular switches as they cycle between the active bound 
GTP state and inactive non-bound GDP (Sahai and Marshall 2003a).    In mesenchymal 
movement, actin polymerization at the leading edge must be co-ordinated with 
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depolymerisation at the rear as well as attachment/detachment of focal adhesion complexes 
and the release of proteases for matrix degradation in invasive migration (Friedl and Wolf 
2009; Wolf et al. 2006).  Cell signalling pathways control and regulate this process.  
Specifically, activated Rac, RhoA and Cdc42 GTPases control the formation of protrusions at 
the leading edge and RhoA, ERK, phosphatase and proteins for proteolysis of adhesion 
components are involved in cell retraction (Ridley 2011, Vicente-Manzanares et al. 2005).  A 
simplified schematic of these pathways is shown at Figure 1.3 and specific details  for 
different modes of migration are summarised in Table 1.5.  Rho, Rock and Rac have been 
identified as important factors in the ability of cells to switch between mesenchymal and 
amoeboid migration modes (Sanz-Moreno et al. 2008).   Proteins NEDD9 and DOCK3 
complex to drive WAVE2 complex via RAC1 to reduce actomyosin contractility resulting in 
mesenchymal morphology, whereas Rho via Rock increase actomyosin contractility blocking 
Rac1 via ARHGAP22 resulting in amoeboid morphology (Sanz-Moreno et al. 2008).  Invasive 
cell migration may also involve proteolysis of the surrounding matrix where cells adopting 
mesenchymal style migration either secrete or use membrane-anchored proteins to degrade 
the surrounding matrix as they move through (Bravo-Cordero et al. 2012, Ridley 2011, Sahai 
and Marshall 2003a). 
It seems that cell migration in 3D varies according to a number of different properties of the 
surrounding matrix such as elasticity, density, porosity, pH, matrix composition and the 
bundling of collagen fibres within it (Doyle et al. 2015, Fraley et al. 2010, Sapudom et al. 
2015, Zaman et al. 2006).  The context for a migrating cell is clearly an important 
consideration when investigating metastasis, a metastasizing cell moving through a range of 
different contexts and environments during its escape, transit and arrival at a new site.  
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Figure 1.3, Cell signalling pathways in cell migration in 2D: A leading edge, B retracting 
edge, C diagram showing signalling in cell migrating in 2D using lamellipodia (Schweitzer et 
al. 2011, Vicente-Manzanares et al. 2005, Wehrle-Haller and Inhof 2003). 
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1.5. Metastasis in context 
A tumour grows and develops in a tissue context.  Metastasizing tumour cells migrating 
away, move through and interact with the surrounding tissue environment and eventually 
arrive at and interact in a new tissue context where, if successful, a secondary growth may 
develop. 
1.5.1. The Tumour Microenvironment (TME) 
The similarities between the activated tissue surrounding a tumour and those of a healing 
wound were identified by Dvorak when he likened the tumour microenvironment (TME) to 
‘a wound that does not heal’ (Dvorak 1986).  Since then the active role of tissue resident 
stromal cells has been identified in both facilitating invasion through the creation of a 
permissive environment and via the paracrine activation of the tumour cells themselves  
(Bremnes et al. 2011, Rønnov-Jessen and Bissell 2009).  Signalling between cancer associated 
fibroblasts (CAF) and tumour cells has been shown to activate cell migration and the role of 
macrophages in activation, invasion, migration and intravasation has also been described 
(Condeelis and Pollard 2006, Gaggioli et al. 2007, Madar et al. 2013, Räsänen and Vaheri 
2010).  The TME therefore is not only a permissive environment but its composition and 
stromal interactions can actually drive tumour invasion and metastasis (Bravo-Cordero et al. 
2012). Figure 1.4 shows a simplified diagram of the major components and interactions of 
the TME based on some of the recent research findings.  The main elements of the TME are: 
structural components such as collagen and fibronectin; resident stromal cells including 
fibroblasts and macrophages; circulating factors including growth factors, cytokines, 
exosomes and microvesicles; recruited cells such as immune cells and bone marrow derived 
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cells (Bremnes et al. 2011, McAllister and Weinberg 2014, Quail and Joyce 2013, Räsänen 
and Vaheri 2010).   
Growth factors and cytokines released within the TME and by the tumour cells themselves 
serve to activate the remodelling as well as to recruit cells outside the environment.  The 
cytokine Interleukin 6, (Il-6) has been found to play a role at the leading edge of tumour cell 
invasion within the tumour environment as well as in preparing the premetastatic niche 
(Chang et al. 2013).  TGFβ has also been identified as an important regulator within the TME, 
supressing immune cell function and promoting invasion, however it can also have an anti -
tumorigenic role and so more research is needed to understand the targets and mechanisms 
of this important cytokine in the progression or containment of cancer (Massagué 2008, 
Padua and Massagué 2009).  
Figure 1.4, Changes in the tumour microenvironment leading to tumour progression, 
invasion and metastasis. (Based on (Hanahan and Weinberg 2011, Lorusso and Ruegg 2008, 
Lu H. 2006, Räsänen and Vaheri 2010)). 
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Inflammation has been identified as an important part of the activation state within the 
TME, with the associated cell signalling driving the recruitment of external resources in an 
effort to return correct function to the tissue as part of a wound healing like process 
(McAllister and Weinberg 2014).  This is a similar state to the permanent activation of a 
chronic wound in which the persistently inflamed and activated state leads to a shift in 
dynamics with different stromal cell phenotypes emerging (Martin and Nunan 2015).  
Changes in gene expression have been identified for all cell types within the TME and an 
over representation of genes associated with TME remodelling (Allinen et al. 2004, Bremnes 
et al. 2011, Casey et al. 2009).  Remodelling of the environment surrounding the tumour has 
been identified in providing escape routes for tumour cells via matrix stiffening and the 
alignment of collagen fibres of the extracellular matrix (Bravo-Cordero et al. 2012, 
Gligorijevic et al. 2012).  The structure of the extracellular matrix plays an important role in 
the normal regulation and homeostasis of tissue and therefore disruption and remodelling of 
this dynamic element surrounding tissue can assist cancer progression (Joyce and Pollard 
2009).  
1.5.2. The Extracellular Matrix (ECM) 
Extracellular matrix surrounds, supports and provides homeostasis for all tissues in the body, 
providing a biomechanical and biochemical scaffold for tissues and the cells within, 
comprising fibrous proteins, proteoglycans and water (Frantz et al. 2010).  The ECM for each 
tissue differs in structure and its specific components.  It is a dynamic environment which is 
constantly modelled and remodelled around the tissue it serves, according to the tissue 
needs and cues generated via interactive signalling between the tissue and stromal cells that 
reside within.  Fibroblasts are responsible for both secreting and remodelling the structural 
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components, mainly collagen and elastin which provide tensile strength to the matrix.  Cells 
within the tissue are able to bind to ECM via adhesion proteins and the state of the ECM can 
dictate whether cell adhesion is migratory. Cells respond to elasticity and rigidity within 
tissue so the correct contextual properties are important if tissue homeostasis is to be 
maintained (Discher et al. 2005, Engler et al. 2006).  Interaction with the ECM via a number 
of different binding sites provided by the matrix can also determine patterns of gene 
expression, driving phenotypic changes in TME cells (Frantz et al. 2010, Hynes 2009, Nelson 
and Bissell 2006).  The ECM is normally a highly controlled and tightly regulated 
environment, however its dynamic nature means it can become dysregulated in response to 
disease cues such as in the presence of a tumour (Brizzi et al. 2012, Lu et al. 2012).   As part 
of both the tumour microenvironment and also as a potential site of metastatic colonization, 
the ECM can be programmed and reprogrammed to provide support and structure to meet 
the specific requirements of the neoplastic cells. 
1.5.3. The premetastatic niche 
The seeding and colonization of metastatic cells at a distant site may be assisted by invasive 
mechanisms within the metastasizing cell and by the preparation of the distant site in 
advance (Sleeman 2012).  There is evidence that both of these may occur.  Circulating 
tumour cells may aggregate with platelets, hijacking the clot formation process and then be 
assisted in leaving blood vessels and entering a premetastatic niche at an area of endothelial 
damage.  Endothelial exposure of collagen to trigger thrombus formation and platelet 
accumulation may be caused deliberately so that tumour cells can enter at such a site 
(Kaplan et al. 2005, Quail and Joyce 2013).  The preparation of a premetastatic niche has 
been observed where factors expressed and disseminated from the tumour and surrounding 
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microenvironment have been found to home to particular sites at which cells are then able 
to seed.  Bone Marrow derived cells (BMDCs) expressing VEGFR1 are known to be recruited 
and contribute to the vascularization of the tumour microenvironment, were also found to 
home to and play a role in the upregulation of fibronectin at premetastatic sites via the VLA4 
integrin they express (Kaplan et al. 2005). There is also evidence that tumour hypoxia driven 
expression of lysyl oxidase (LOX) may play a role in the recruitment of cells for premetastatic 
niche preparation (Cox et al. 2016, Erler et al. 2006).  Here again is evidence that the 
extracellular matrix structure plays an important role in the context of metastasis.   
When attempting to investigate and model metastasis, the context for study is therefore 
important, however much of the initial work into invasion and migration has been 
conducted on 2D surfaces or in overly simplistic environments which do not represent the 
complexity of the niche environment of a cell in tissue.  The aim for modelling metastasis is 
therefore to create a biologically relevant environment for investigation. 
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1.6. Modelling cell migration and metastasis 
Studying metastasis in the live environment is not possible mainly because by the time a 
patient is diagnosed with metastatic cancer, the events to be studied have already taken 
place.  In addition, the accumulation of the necessary traits and enabling factors typically 
takes place over a number of years going unnoticed and if they were to be discovered 
intervention would be the priority for ethical reasons.  Observation and histological 
examination of tumour samples is possible retrospectively where samples are provided and 
live imaging and monitoring of tumorous growths in patients undergoing treatments can 
provide some insight.  However, in order to understand the metastatic process at a 
molecular level, modelling metastasis using research tools allows detailed research to take 
place in a controlled environment.  A range of models from mammalian in vivo, ex vivo, in 
vitro and in silico models has and is being used to elucidate the multiple stages of metastasis 
with the aim of providing further insight as a basis for the development of better 
treatments. 
Whilst mammalian models may seem the most representative, their inherent complexity 
means that they are difficult to work with.  Invasion and metastasis are spontaneous and 
therefore unpredictable so even where tumour explants are introduced into a mammalian 
host such as a mouse or rat, creating a suitable and biologically relevant tumour 
microenvironment in which to observe metastatic invasion is a challenge.  Animal models 
are usually immunocompromised in order to accept exogenous tumour cells and therefore 
lack some of the component cells which play a critical role within the tumour 
microenvironment.  Where tumours are grown orthotopically, the environment is less than 
ideal because most primary tumours develop within a host tissue, surrounded by the stroma 
rather than sitting on top of it.  Cells have been injected into the circulation within in vivo 
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models such as mouse, rat and chick embryo so that extravasation and seeding at metastatic 
sites can be studied, however the cells introduced are typically a suspension of cells from a 
cancer cell line, these having been cultured outside the live environment and so their protein 
expression profiles, mechanisms and behaviours may be quite different to cells that have 
metastasized and invaded spontaneously within their natural host.  Despite these issues, 
much has been learnt about the steps and mechanisms of metastasis from animal models in 
recent years, especially with the concurrent development in technology allowing 
visualization of events in deep tissue to be recorded and analysed.  The escape and invasion 
of metastasizing cells has been modelled in immunocompromised mice with detailed 
mechanisms being determined for the invasion of tumour cells with partner macrophages 
(Condeelis and Pollard 2006).  The mechanisms of invasion during the spread of mammary 
tumours to the lungs has also been elucidated in the mouse model using the specialized 
microscopy techniques of intravital multiphoton imaging, in combination with either the skin 
flap technique which provides a window into a tumour for several hours at a time or by 
placing the animal in a stereotactic box which allows images to be taken regularly over a 
period of 7 days (Gligorijevic and Condeelis 2009, Gligorijevic et al. 2012, Kedrin et al. 2008).  
In order to specifically identify introduced cells, activated fluorophores have been used so 
that their mechanisms and interactions with host tissue can be observed and recorded.  
Spinning disc confocal microscopy has also been used to visualise cell behaviour in vivo but is 
limited in the depth of field and therefore tissue depth it can penetrate and the resolution 
and therefore clarity with which it can capture events in context (Jonkman and Brown 2015).  
Second and third harmonic generation imaging have been employed in combination with 
intravital multiphoton microscopy to provide images of the matrix structure without the 
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need for fluorophores to define it (Friedl et al. 2007, Gligorijevic and Condeelis 2009, Wang 
et al. 2005).   
The chick embryo model has also been used for the investigation of angiogenesis and 
metastasis and is a useful model due to its fast development time, easy manipulation and 
highly vascularized extracellular matrix layer which develops just beneath the shell.  Cells or 
tumours have been grafted onto the chorioallantoic membrane surface, a window having 
been made in the egg to allow access to this ECM like tissue.  Alternatively cancer cells have 
been injected into the vasculature of the CAM and tracking of cells within both CAM and 
chick have been carried out to determine the extent of spread to distant sites (Deryugina 
and Quigley 2008b, Shioda et al. 1997, Zijlstra et al 2002).  
Other notable models include the zebra fish, which whilst not mammalian, has several 
advantages as a genetic model including: fast development, ease of genetic manipulation, 
transparency and good access for experimental observation due to its small size and low 
tissue depth (Woodhouse and Kelly 2011).  Recently, the initial events in metastasis have 
been observed and recorded using this model along with reporter cell lines expressing 
fluorescent proteins to track both tumour cell and macrophage behaviour, allowing the 
capture of a precipitous chance event to be recorded (Tulotta et al. 2016).  The drosophila 
model has also been used to model the genetic mechanisms involved in metastasis for 
example to explore the loss of cell polarity during metastasis and the mechanism of action of 
tumour suppressors in cancer progression (Woodhouse and Kelly 2011). 
Following in vivo work, the opportunity for the analysis of live events in excised tissue is an 
option, providing the right support systems can be set up, for example the excision of 
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tumour and associated stroma from a euthanized mammalian model and further monitoring 
of live events within the tissue (Gligorijevic et al. 2012). 
Much of the work to discover mechanisms in early metastasis such as migration and invasion 
has initially been conducted on 2D surfaces.  Frequently coated with ECM components, 
these flat surfaces have provided access to visualize cells moving over and interacting with 
each other and the surface beneath.    High resolution microscopy and techniques such as 
total internal reflectance imaging (TIRF) have enabled the elucidation of mechanisms such as 
focal adhesion turnover as cells have traversed a coated 2D plate (Berginski et al. 2011, 
Pasapera et al. 2015).  However as the 2D models lacked the complexity and biological 
relevance, simple 3D models emerged in which soft gels such as agarose were used to 
encapsulate cells.  ECM components such as collagen, fibronectin and laminin have also 
provided soft gel like contexts for the encapsulation of cells or for cells to be seeded onto 
and allowed to invade.  However as the elasticity and tension of a tissue has been found to 
affect cellular responses such as adhesion and migration, more relevant biological matrices 
have been sought for the investigation of metastasis.  Artificial matrices have been used 
along with tissue culture plastic, such as the Boyden chamber, in which cells are encouraged 
to translocate through a hanging 3D filter towards an attractant such as a growth factor of 
interest (Boyden 1962, Chen 2005).  Imaging the extent of invasion could then be conducted 
via confocal microscopy once cells had been fixed and stained with appropriate 
fluorophores.  Recently more complex artificial matrices have been designed for the use of 
3D cell culture, such as Alvetex (Reinnervate), a polystyrene based porous cell scaffold which 
can be sterilized and used as a biocompatible tissue culture scaffold, either cut to a specific 
shape and size or as a tissue culture well insert (Davies et al. 2015, Smith et al. 2015).   
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One of the advantages of a 3D culture environment is that it can be set up and manipulated 
according to a specific experimental design and cells cultured over a longer period than cells 
on 2D surfaces.  Recording and observation of events can therefore be conducted over 
longer periods than in 2D or in vivo experiments and therefore 3D culture is potentially more 
useful in establishing a timeline of events.  However, as with in vivo models, where 3D 
matrices are used for the study of metastatic mechanisms, accessing and visualizing cell 
behaviours and interactions is impeded by properties of the matrix and the density of cells 
contained within, especially where matrices are opaque, autofluorescent or have high 
reflectance.   
The construction of a biologically relevant 3D matrix which is sufficiently representative of 
the tissue to be studied, but one that can be manipulated and controlled for experimental 
purposes, is the ideal for studying metastasis.  Tissue engineering techniques offer useful 
tools with which to create relevant biological niche environments in which to study 
processes such as metastasis.  A number of these techniques are beginning to emerge as 
possibilities including the use of decellularized tissue as a scaffold for cell population and 3D 
bio-printing as a means to recreate a specific organ shape and structure (Guyette et al. 2016, 
Lu et al. 2014, Murphy and Atala 2014). 
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1.7. Project aims  
Given that context is important, the ability to model cancer metastasis in a biologically 
relevant environment is crucial.  It is also important to be able to create, manipulate and 
then observe and record the emerging behaviours within any model used. As any 
experimental model used will have both advantages and limitations, the use of a number of 
models with different attributes permits investigation from different perspectives. 
The overall aim of this PhD Project was to develop a set of in vitro assays which would allow 
an integrated approach to the investigation of the metastatic mechanisms involved in 
escape and invasion and colonization at a metastatic site.  The requirement for models 
developed was that they could be created and assembled using easily available and every 
day laboratory items so that they would be cheap and easy to replicate.  Capturing and 
quantification of events should be carried out with standard technologies which are widely 
available.  Innovation would be sought from tissue engineering practices in creating a range 
of environments which were biologically relevant and could be used to create a suitably 
representative model of the metastatic niche for metastatic escape and invasion from a 
primary tumour and for the metastatic niche at which colonization could then be studied.  
Using the suite of assays it should be possible to select the appropriate experimental models 
in order to compare and contrast cell behaviours under different conditions.  It should be 
possible to move between the models to enable the manipulation and further investigation 
of specific behaviours observed.    
Hypothesis: Cell behaviour will vary according to the structural and biophysical properties of 
the experimental model into which they are introduced.  
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2. Materials and Methods 
This chapter includes general materials and methods.  Specific details relating to materials 
and methods employed are located within each results chapter. 
Materials were obtained from Sigma Aldrich unless otherwise stated. 
2.1. Cell culture 
Three cell lines were selected for culture and testing of the models developed: HT1080 
fibrosarcoma cells, MDA-MB-231 adenocarconoma cells and MCF-7 adenocarcinoma cells.  
Both HT1080 and MDA-MB-231 cells are highly migratory and cells are able to display  
morphologies ranging from rounded/amoeboid to mesenchymal in different contexts.  
HT1080 cells originate from a primary site and selecting this cell line provided cells which 
had not yet adapted to a distant metastatic site.  In contrast, MDA-MB-231 cells originate 
from a metastatic site and will have adapted to inhabit the new niche from which they were 
collected.  MCF-7 cells are also metastatic in origin but characteristically invade as a sheet 
and do not typically migrate individually as do the HT1080 and MDA-MB-231 cells.  MCF-7 
cells were used as a control cell-line for cell migration characteristics.  The individual details 
for each cell line are given in the following sections. 
2.1.1. HT1080 human fibrosarcoma cells 
HT1080 human fibrosarcoma cells were obtained from The Health Protection Agency (HPA), 
European Collection of Cell Cultures.  The original source for the cell line was the American 
Type Culture Collection (ATCC), USA, the cell sample having been taken from a fibrosarcoma 
located close to the acetabulum of the hip joint in connective tissue of a 35year old male 
Caucasian in 1972.  The HT1080 cells were cultured and routinely passaged in either 25cm2 
or 75cm2 culture flasks (Greiner bio-one) in Dulbeco’s Modified Eagles Media (DMEM)  
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(containing 1mM Sodium Pyruvate, 3.97mM Glutamine, 5.56mM D-Glucose, full list of 
contents at Appendix A1) supplemented with 1% Penicillin/Streptomycin and 10% Fetal 
Bovine Serum (FBS) (Gibco, Thermo Fisher Scientific).  Cells were placed in a humidified 
incubator at 37oC, 5% CO2 where they were allowed to settle, adhere and grow. Cells were 
passaged whilst in the log growth phase typically at around 60-80% confluence. Overlying 
growth medium was aspirated and cells washed with 5ml sterile Phosphate-buffered Saline 
solution (PBS, Gibco).  Washed cells were trypsinized using 0.05% Trypsin-EDTA (Gibco) to 
detach them from the surface of the flask.  Cells were re-suspended in pre-warmed 
supplemented DMEM and transferred to either culture flasks or plates with additional pre-
warmed medium used to make up the appropriate volume according to the flask or well size.  
The cell dilution used was adjusted according to the cell density required and time available 
for growth. 
2.1.2. MDA-MB-231 human adenocarcinoma cells 
MDA-MB-231 adenocarcinoma cells were also obtained from the HPA European Cell 
Collection of Cell Cultures.  The source for the cell line was the American Type Culture 
Collection, USA, the original sample having been obtained from an adenocarcinoma, pleural 
effusion metastatic site in a 51 year old female Caucasian suffering from breast cancer.   
MDA-MB-231 cells were cultured in a similar way to that described for HT1080 cells using 
DMEM containing the same supplements in the same proportions.  Cells were passaged 
during the log growth phase and plated at a density sufficient to allow good adherence and 
growth, typically a 1:4 – 1:6 split from cells growing at 60-80% confluence. 
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2.1.3. MCF7 human adenocarcinoma cells 
MCF7 adenocarcinoma cells were obtained from the HPA European Cell Collection.  These 
cells were categorized as epithelial and originated from a metastatic invasion of the lung in a 
69 year old Caucasian female and were collected via a pleural effusion.   
The cells were cultured and passaged in a similar way to MDA-MB-231 cells using DMEM 
supplemented with 10% FBS and Penicillin/Streptomycin.  Cells were passaged during the log 
growth phase and plated at a density sufficient to allow good adherence and growth, 
typically a 1:4 – 1:8 split from cells growing at 60-80% confluence. 
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2.2. Cell culture materials  
2.2.1. Matrigel preparation 
Matrigel (BD Biosciences) defrosted and kept on ice, was diluted with DMEM (no Pen/Strep 
or FBS added) or cells re-suspended in DMEM (no additives).  Diluted Matrigel was added to 
wells of 6 or 12-well tissue culture plates (Cellstar, Greiner Bio-one) or 35mm microscope 
dishes (Ibitreat-Ibidi, Thistle Scientific Ltd.) using a chilled 200μl pipette tip and left to 
polymerise for 20-30 minutes in an incubator at 37oC, 5% CO2.  Supplemented growth 
medium was then added gently. 
2.2.2. Collagen preparation 
Rat Tail Type 1 Collagen was obtained from either BD Biosciences or Merck Millipore at 2.3-
5mg/ml (concentration varied by batch).  This was stored at 4oC and kept on ice during 
preparation.  To obtain the desired collagen concentration, collagen was added to 10X 
DMEM (Gibco, Thermo Fisher Scientific) and the pH adjusted with 0.5 M sodium hydroxide 
solution to give pH 7-8.  The required volume was made up with cells re-suspended in 
DMEM or with DMEM only for a cell-free matrix.  Collagen solution with or without cells was 
added to tissue culture plates (6-well or 12-well - Cellstar, Greiner Bio-one) or 35mm 
microscopy dish (Ibitreat-Ibidi, Thistle Scientific Ltd.). 
2.2.3. Fibronectin preparation 
Human fibronectin was obtained (R&D Systems) and a stock solution of 150µg/ml made in 
sterile PBS which was aliquoted and stored at -20oC. Aliquots were defrosted as required and 
used either as a collagen additive or added to PBS to make a coating. 
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2.3. Development of permanently expressing Green Fluorescent Protein (GFP+) 
cell lines 
2.3.1. Myristoylated GFP+ cell lines 
MDA-MB-231 and HT1080 cells were permanently transfected to overexpress a membrane 
tagged Green Fluorescent Protein (GFP) using a PB CAG myr GFP transposon (Figure 2.1 A) 
and PB HYPBASE transposase (Figure 2.1 B) - kindly gifted by Dr Mike McGrew of The Roslin 
Institute.   
The transfection protocol was first optimized using three different ratios of transposon to 
transposase: 1:1, 1:3 and 2:3.  The optimal ratio of 1:1 was then used to transfect cells which 
had been grown to 60% confluence in a 12-well plate (Greiner Bio-one) using 4μg each of 
transposon and transposase, 12μl Fugene 6 (Promega) and 372μl DMEM (no additives).  
Cells were left for 48 hours then GFP+/puromycin resistant cells were selected (Puromycin 
from Fisher Scientific).  Media containing puromycin was changed every 2-3 days and cells 
monitored until only fluorescent cells remained.  These were then expanded for 
experimental use.  Initialy, selective pressure with puromycin was in the range of 0.5 - 
1μg/ml and ongoing selective pressure was 0.3μg/ml for MDA-MB-231 CAG Myr GFP+ cells 
and 0.5μg/ml for HT1080 CAG Myr GFP+ cells (although MDA-MB-231 GFP+ cells were also 
stable without puromycin).  Transfection success was verified using epifluorescence 
microscopy.   
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Figure 2.1.  Vector maps for plasmids used to create GFP positive stably transfected cell 
lines: A PB CAG Myr GFP plasmid with puromycin resistance gene; B PB HYPBASE 
transposase plasmid. 
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2.3.2. Lentiviral GFP+ cell lines 
2.3.2.1. Plasmid preparation 
A lentiviral vector for enhanced Green Fluorescent Protein was assembled from three 
plasmids: 
– pMD2.G  envelope plasmid; 
– pCMV-dR8.74 packaging plasmid; 
– pHR.sin.cPPT.SFFV.eGFP.WPRE plasmid containing eGFP gene to be 
expressed. 
Plasmid stocks were expanded as follows:  Excell Gold 10 Escherichia coli cells (Agilent) were 
transformed with each of the three plasmids and grown on LB agar/ampicillin 100µg/ml 
overnight.  A colony was selected for each plasmid, transferred and cultured overnight in LB 
broth/ampicillin (100µg/ml).  A mini-prep kit (Qiagen – details at Appendix A2) was used to 
extract and purify the plasmids and glycerol stocks were made.  A restriction digest was 
conducted (restriction maps shown at Figure 2.2) to check the size of each plasmid and the 
resultant linearized fragments were run out on a 1% agarose gel with ethidium bromide 
(1µl/ml) used to enable visualisation (Figure 2.3).  
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Figure 2.2, Restriction maps and cutting sites for lentiviral plasmids. Cutting sites selected 
for each enzyme are indicated with green arrows for each plasmid and fragment sizes in 
bases are listed to the right.  A, pMD2G;   B, pCMV-dR8.74;  C, HR.sin.cPPT.SFFV.eGFP.WPRE.  
Plasmid maps were generated using SnapGene Viewer 3.1.4.  
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Figure 2.3, Images for agarose gels run for plasmid selection from the mini-prep.   
A  plasmids pMD2.G (Sample H2/2 in Lane 3 was selected) and 
pHR.sin.cPPT.SFFV.eGFP.WPRE (sample P1 shown in Lanes 5 and 8 was selected);  
B Plasmid pCMV-dR8.74 (sample H1/1 in Lane 2 was selected). Units = Kb (Kilobases). 
2.3.2.2. Lentivirus production 
HEK 293T cells were obtained and cultured in 175cm2 flasks (T175) in DMEM with 10% FBS 
and 1% Penicillin/Streptomycin.  Cells were transduced using a protocol based on Salmon 
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and Trono, (Salmon and Trono, 2007):  2 hours before transduction, the growth medium was 
aspirated and replaced with DMEM / 2% FBS.   
The plasmid mix was prepared in a tube containing the following: Packaging plasmid 
pCMV.R8.7.4, 18.96µg, Envelope plasmid pMD2.VSV.G, 8.17µg, Transfer plasmid (with eGFP 
gene) 29.17µg.  Serum free DMEM was added to plasmid mix to make 1/3 of final volume. 
Polyethylenimine (PEI – Sigma) was added to make up the final volume, mixed well and 
incubated for 15 minutes.  Transduction mix was added to 20ml of reduced serum medium 
over cells in each T175 flask at 75µl/cm2 flask surface area.  After 16 hours the medium was 
replaced with DMEM/ 2% FBS. 
Lentivirus was harvested from cells both two and three days after transduction.  Growth 
medium was first aspirated and replaced with DMEM/ 2% FBS.   The aspirated medium was 
centrifuged at 1230g for 10 minutes at room temperature and the supernatant was then 
passed through a 0.22µm Nalgene filter (Fisher Scientific).  The filtered supernatant was 
transferred to ultracentrifuge tubes and centrifuged at 50,000g for 2 hours at 4oC to retrieve 
the lentivirus.  The supernatant was discarded and the pellet air dried by inverting the spin 
tube.  The lentivirus was recovered by re-suspending the pellet in PBS which was then left on 
ice for an hour.  Lentivirus/PBS was mixed then transferred to 1.5ml eppendorf tubes for 
centrifugation at 1500g   at room temperature for 10 minutes to remove any debris.  The 
supernatant was transferred to a new tube where the suspension was adjusted to 10mM 
magnesium chloride and 5 units/ml DNASE added, followed by 30 minutes incubation at 
37oC.  The Lentivirus product was aliquoted, frozen and stored at -80oC. 
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2.3.2.3. Titration of lentivirus using HeLa cells 
HeLa cells were cultured in DMEM (High glucose @ 4.5g/L, L-glutamine, Pyruvate) + 10% 
FBS, 1% PenStrep, then seeded at 50,000 per well in a 6 well plate (Greiner Bio-one).  After 
24 hours, GFP+ lentivirus was added in 3 dilutions: 7µl, 14µl and 21µl per well.  The lentivirus 
was added in the presence of polybrene (Sigma) at a final concentration of 16µg/ml to assist 
transduction.  After 16-24 hours the growth medium was replaced.  Cells were harvested 
after a further 2 days and re-suspended in 1% PFA/PBS for analysis via flow cytometry.  
Control cells were also prepared: negative control, HeLa cells with no virus added (GFP-) and 
for a positive control: MDA-MB-231 Myr GFP+ cells (GFP+).  Flow cytometry samples were 
run on a BD Accuri C6 Flow Cytometer, two samples for each condition.   FlowJo software 
was used to format and analyse data and then an MOI (multiplicity of infection ratio) was 
calculated.  Figure 2.4 shows the flow cytometry run for control cells to define the 
paramaters for selection. 
Figure 2.4, Flow cytometry controls for determining the best cell transduction of lentivirus 
in HeLa cells.  Red peak shows the unstained HeLa cell population.  Blue peaks show MDA-
MB-231 GFP+ cells used as a positive control.  The blue peak is mainly shifted to the right 
compared to the red peak for unstained cells.  This signature location for the blue peak is 
used to locate GFP+ cells on experimental runs. 
Y axis shows cell count, X axis shows fluorescence.
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Figure 2.5, Flow cytometry graphs for optimisation of GFP+ lentivirus transduction 
quantities. The shifted blue peak in A, C, E shows the number of GFP+ cells after lentivirus 
transduction and the red peak shows non GFP+ cells (unsuccesful transduction).  The GFP+ 
population is quantified as a % (CFSE+ value shown in the polygon) for each sample: B, D, F.  
Thus the addition of 21µl (E) of lentivirus results in 28.4% transduction in a 6 well plate for 
HeLa cells (F). 
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2.4. Fixing and staining cells  
Cells and or tissues were fixed in pre-warmed 4% paraformaldehyde/PBS then washed three 
times with PBS.  Where cells were contained in or seeded onto collagen they were then 
washed for ten minutes three times in PBS.  Cells were permeabilized with 0.2% Triton X-
100/PBS (TritonX-100 from Sigma) for ten minutes then washed a further three times with 
PBS.  Blocking was carried out for 4-6 hours or overnight at 4oC using either 10% goat 
serum/PBS (Fisher Scientific) in 0.1% TritonX100/PBS or the specific block solution specified 
for an antibody.  Primary antibodies diluted into the appropriate block solution were added 
to the cells which were then incubated overnight at 4oC (12-16 hours).  Cells were washed 
with 0.1% TritonX100/PBS three times then blocked for ½ -1 hour at room temperature 
using 2% Goat Serum diluted into 0.1% Triton X-100/PBS.  The secondary antibody was 
added to blocking solution at the appropriate concentration then added to cells for at least 1 
hour in the dark at room temperature or for at least 2 hours at 4oC.  Cells were washed three 
times with 0.1% TritonX100/PBS then three times with PBS and mounted using Vectashield 
containing DAPI (4′,6-Diamidino-2-phenylindole dihydrochloride, Vector Laboratories) 
alternatively DAPI was added at 10µg/ml to the penultimate PBS wash (Sigma) and 
Vectashield H-1000 fluorescence mounting medium (Vectorlabs) was used.  All washes were 
conducted for 10 minutes each at room temperature.  Where phalloidin stain was used 
alone, this was added after cell permeabilization in 0.1% TritonX100/PBS and left overnight 
at 4oC or for 2 hours at room temperature.  Where phalloidin was part of immuno-staining it 
was added with the secondary antibody.  Samples were mounted onto Superfrost slides 
(Thermo Scientific – Menzel Gläser) unless otherwise stated.  Menzel Gläser No 1 coverslips 
(Thermo Scientific), 22 x 22mm for small samples.  Samples were mounted using Vectashield 
mounting medium either with or without DAPI unless otherwise stated. 
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Details of antibodies and stains used are as follows: 
Stains: 
4',6-Diamidino-2-phenylindole (DAPI) was used at 10µg/ml.  
Phalloidin - either Invitrogen (546) or phalloidin-atto 565 (Sigma), both used 1:250. 
Primary antibodies: 
GFP – anti-rabbit Sigma A11122, 1:100, 0.1% TritonX-100/PBS 10% goat serum (Fisher 
Scientific); 
Keratin – anti-mouse, Abcam ab118817, 1:200, 0.1% TritonX-100, 0.1% BSA (Fisher 
Scientific), 10% goat serum; 
Ki67 – anti-rabbit, abcam16667, 1:500, blocking solution 1% BSA in 0.1% TritonX-100/PBS 
Vimentin – anti-mouse, abcam ab8978, 1:250, blocking solution 1% BSA in 0.1% TritonX-
100/PBS 
Secondary antibodies: 
Anti-rabbit 488, AlexaFluor from Fisher Scientific 
Anti-mouse 488, AlexaFluor from Fisher Scientific  
Anti-rabbit 647, AlexaFluor from Fisher Scientific 
Anti-mouse 647, AlexaFluor from Fisher Scientific 
These were all used at either 1:100 for 1 hour at room temperature or 1:200 for 2 hours at 
room temperature for better binding and a cleaner result and diluted into 2% goat serum / 
0.1% TritonX-100/PBS.  (Samples were blocked first in the same solution for at least half an 
hour before adding the secondary antibody.) 
41 
 
2.4.1. Embedding and sectioning samples 
Some dense collagen or tissue based samples were embedded and sectioned to enable 
further and more detailed microscopic analysis.  Samples were fixed using 4% PFA/PBS as 
required then washed three times in PBS to remove the PFA.  Staining was carried out if 
required although some samples were stained after sectioning. 
Samples to be embedded were subjected to a sucrose gradient:  5% sucrose/PBS overnight 
on rollers at 4oC followed by 15% sucrose/PBS at room temperature for 2 hours, rocking and 
then a further two hours in 30% sucrose/PBS, rocking. Samples were embedded in OCT (Cell 
Path) and frozen in an isopentane liquid (Fisher Scientific) bath on dry ice then transferred to 
-80oC freezer for at least 2 hours.  Samples were labelled and mounted on circular cork bases 
(Fisher Scientific) and stored at -80oC until they were sectioned.  Sections were made using a 
Kryostat (Model OTF, Bright 5040) using an MB35 Premier blade (Thermo Scientific) with 
sections mounted onto polylysine coated slides (Polysine, Thermo Fisher). 
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2.5. Microscopy 
2.5.1. Phase contrast time-Lapse 
Time-lapse sequences were taken using either a Nikon Eclipse TE200 with a Jencons PLS 
Nikon lamp, UV box, moveable stage and environmental chamber, running NIS Elements AR3 
using Nikon lenses:  Plan Fluor 10X/0.30 PH1 DL, Plan Fluor 20X/0.45 PH1 DM and Plan Fluor 
40X/0.60 PH2 DM or a Nikon Eclipse TiE with moveable stage and environmental chamber 
running NIS Elements software and PlanApo 10x DIC L lens with intermediate magnification 
changer (to give either x1 or x1.5 magnification).  The environmental chamber for each 
microscope was set at 37oC with a continuous flow of CO2 through the plate. 
Post-hoc image processing was conducted using NIS Elements and IMageJ software (Figure 
2.6) and Photoshop CS6 Extended. 
 
Figure 2.6.  Cells tracked using MtrackJ ImageJ plugin.  Each cell was tracked in a stepwise 
manner, each track appearing in a different colour.  If a cell divided one of the daughter cells 
was tracked from that point onwards.  Track measurements were generated and saved in 
Excel format.  Track data for each cells was then extracted and cell speed calculated. Scale 
bar= 100µm. 
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2.5.2. Epifluorescence microscopy 
A Zeiss Axioimager was used for epifluorescence microscopy of slides in combination with 
Zeiss Software version 4 and lenses (x5, x10, x20, x40). 
A Zeiss Axio Vert.A1 epifluorescence microscope with an inverted lens and moveable 
platform was used to take individual images of live cells to monitor experiment progress and 
check for fluorescent protein expression.  Lenses used were: x5 Planar Plan Neofl Ph1 0,15 ∞ 
/0,17, x10 Zeiss A Plan 0,25 Ph1 lens and x20 Zeiss LDA Plan 20x/0,35 Ph1 ∞ /1,0 (PS), x40 
Zeiss LDA Plan 40x 0.55 Ph1 ∞ /1,0 (PS). 
2.5.3. Confocal microscopy 
Live and fixed cell imaging was conducted using inverted confocal micros copes:  
Leica TCS SP2 (HCX PlanApo lbd.BL 63x oil immersion lens) running Leica Application 
Software version 2.61 or Nikon A1-R and A1 Plus microscopes running NIS Elements AR with 
environmental chamber and Nikon Intensilight CHGFI lamp were used with the following 
optics:  x4 Plan Fluor 4x 0.13 ∞ /1.2 WD 16.5; x10 0.30 Plan Fluor OFN 25 Ph1 D2; x20 0.75 
Plan Apo DIC N2 OFN 25 WD 1.0; x60 1.40 Plan Apo ∞ /0.17 WD 0.13; x100 APO TIRF1.49 ∞ 
/0.13 0.20 DIC. On the A1 Plus system a Visible Fiber Laser WFL P Series laser source was also 
used.  Images were processed and analysed using NIS elements AR (Nikon), ImageJ (FIJI, 
64bit) software and prepared for presentation using Photoshop CS6 Extended.   
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2.6. Statistical analysis 
2.6.1. Quantification of sample size 
The appropriate sample size required for statistical analysis for experiments was determined 
using power calculation software G*Power 3.1.9.2. (Franz Faul, Germany). For each 
experiment, an initial data set was gathered, mean value and standard deviation calculated 
for each experimental condition and these values entered using the F test/ ANOVA option.  
The required power (1-β error of probability) and significance (α error of probability) were 
selected and sample size calculated.  Ideally significance=0.05 and Power=0.95 were selected 
to give a highly probable outcome of difference but where this gave a sample size which was 
not possible within the time and resources available, the power and significance were 
reduced.  Microsoft Excel Office 365 was used for data preparation of data for statistical 
evaluation and to calculate mean and standard deviation for each experimental condition.   
2.6.2. Statistical analysis of experimental results 
GraphPad Prism version 6 for Microsoft Windows was used for statistical analysis and 
graphical presentation of results.  For each cell population, the distribution of data was 
investigated by conducting a normality test (Shapiro Wilk test).  Where a Gaussian or normal 
distribution of data was found for all cell populations to be compared, a parametric test was 
selected.  If one or more cell populations did not meet the conditions of the Shapiro Wilk 
test for normality, a non-parametric test was selected.   Where three or more groups of data 
were to be analysed for more than one comparative factor and these were normally 
distributed, a two-way Analysis Of Variance (ANOVA) was conducted.  If the data for one or 
more of the groups to be compared was not normally distributed a non-parametric 
statistical test was conducted, the Kruskal Wallis test.  Where multiple comparisons were 
made as part of the statistical analysis a multiple comparisons correction test was also run: 
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Tukey’s Test for ANOVA and Dunn’s test for the Kruskal Wallis test, this reducing the 
likelihood of a significant difference emerging due to the chance arising through making a 
number of comparisons within the same analysis. 
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3. Modelling Metastasis In Vitro   
3.1. Introduction 
Given that cancer metastasis is a complex multi-stage process, metastatic behaviour is 
challenging to model (Bradbury et al. 2012, Geiger and Peeper 2009, Kramer et al. 2013).  
Indeed the temporal nature of tumour growth, invasion, dissemination and development of 
metastases is one which takes place over months and years for most cancers and is 
therefore difficult to capture and study.  Understanding the molecular and cellular 
mechanisms involved is important if metastatic disease is to be contained and prevented 
(Hanahan and Weinberg 2011).  Experimental models provide a controlled environment in 
which to investigate metastasis and to test associated drugs during their development 
(Fischbach et al. 2007, Onion et al. 2016, Pampaloni et al. 2007).  
In vivo models are few, expensive, challenging to set up and are not necessarily 
representative of human metastatic disease (Khanna and Hunter 2005).  For example, where 
tumour explants are carried out into mammals such as mice, the tumour microenvironment 
is either absent, lost or maybe quickly overtaken by the development of murine ECM 
(Holliday and Speirs 2011, Khanna and Hunter 2005, Saxena and Christofori 2013).  
Furthermore capturing the steps of metastasis in a dense tissue environment in real-time is 
fortuitous due to the spontaneity and unpredictable timing of events and requires expensive 
equipment for observation and capture (Decaestecker et al. 2007, Kaufman et al. 2016).  
The biological complexity of tissue means that modelling metastasis in vitro requires 
materials and structural components which together give a biological context sufficiently 
relevant to yield meaningful results (Yamada and Cukierman 2007).  Successful models must 
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be tractable, reproducible and quantifiable, ideally requiring materials which are easily 
available and relatively inexpensive (Pampaloni et al. 2007).   
Early research in this field was conducted in a two dimensional context using cell lines 
derived from histological samples grown as monocultures and passaged numerous times on 
2D surfaces (Freshney 2010), for example the early subculture of fibroblasts, (Carrel and 
Ebeling 1923) and of HeLa cells (Lucey et al. 2009) .   Cell culture for research still largely 
follows this approach, with cells grown in monolayers on tissue culture plastic.  Cells typically 
adhere and proliferate but they lack the normal and necessary environmental cues provided 
by a natural biological context.  Furthermore, cells are continuously bathed in culture 
medium and provided with plentiful oxygen and carbon dioxide, a very different and alien 
context to a tissue environment (Yamada and Cukierman 2007).  Without the extra cellular 
matrix which surrounds most tissues, cells seeded in 2D lack structural support, the physical 
cues and the signals provided within their environment allowing differentiation and tissue 
polarity to be established (Doyle et al. 2013, Friedl et al. 2012, Yamaguchi et al. 2005).   The 
heterogeneous mix of cells within normal tissue was also absent in this context (Bissell and 
Radisky 2001).  Replicating essential environmental conditions in vitro with sufficient 
complexity to produce meaningful data is thus a challenge for the researcher.   
A successful in vitro model requires a tissue architecture and context with natural borders 
and boundaries which provide the important structural cues instructing co-operative cell 
behaviour (Haeger et al. 2015, Rørth 2012).  A basement layer for example is an important 
feature of most tissue types which contains cells and retains context (Kalluri 2003). 
Recent models have sought to provide a better contextual environment for the study of cell 
behaviour and the metastatic process.  ECM components such as collagen type 1, fibronectin 
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and laminin have been used to create gel like layers as a simple tissue based model (Bissell 
et al. 2003, Pampaloni et al. 2007, Schor 1980, Wolf et al. 2009).  Matrigel has also been 
used as a representative basement membrane layer with cells embedded and observed 
within it (Novaro et al. 2003, Zaman et al. 2006). 
Observation and quantification of behaviour and events requires an environment in which 
cell behaviours can be clearly identified (Driscoll and Danuser 2015).  Matrix density and 
opacity as well as suitable access to samples for microscopy are therefore important 
features.  The optics associated with time-lapse and laser scanning microscopy require that 
cells within their modelled context be within the working distance of the lens (Vasaturo et al. 
2012).  Back scatter of light and autofluorescence of matrix components may also interfere 
with observation techniques, especially when collagen is used within a matrix (Artym and 
Matsumoto 2010, Wu et al. 2003).  The development of a three dimensional model 
therefore needs to provide sufficient depth and context for cell interaction yet be sufficiently 
thin to be penetrable allowing observation and tracking of cell events.   The full range of cell 
behaviours observed in vivo should also be demonstrated. 
Starting with the simplest approach of 2D coating on tissue culture plastic, this project 
explored the opportunities for in vitro modelling.   
Hypothesis:  A simple in vitro model could be created using extracellular matrix components 
which would provide sufficient context for cells to display the range of morphologies and 
behaviours observed in vivo and would allow these behaviours to be observed and recorded. 
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3.2. Materials and methods 
3.2.1. 2D cell migration assays 
6-well tissue culture plates were coated with collagen (Rat Tail Collagen Type 1 at 0.5mg/ml), 
fibronectin (10µg/ml) and Matrigel (3mg/ml, from BDBioscience).  Fibronectin, collagen and 
Matrigel coatings were prepared as described in Section 2.2 at the above concentrations .    
Coatings were added to the wells and left to set in a tissue culture incubator at 37oC/5% CO2 
for 1 hour.  Fibronectin wells were then washed gently with PBS twice before use.  HT1080 
and MDA-MB-231 cells were trypsinized, re-suspended in medium and added to the coated 
culture wells to give a confluence of around 15% once cells were settled.  Cells were left to 
settle and adhere for two hours then transferred to and equilibrated in the environmental 
chamber of the time-lapse and multipoint time-lapse imaging set up.  Ideally a control cell 
line such as MCF-7 which is invasive with cells migrating as a sheet rather than individually 
(Gest et al. 2013, Holliday and Speirs 2011), would also have been used as a negative control 
as it has elsewhere in this project, however, as time and resources were limited, the work 
was not carried out as part of this project.  Images were taken at 10 minute intervals and 
analysis carried out for the first 8 hour period using ImageJ MtrackJ tool.  Thirty MDA-MB-
231 cells were tracked for each coating type initially (90 cells in total) and mean and 
standard deviation values calculated for each coating type for ‘distance from start’ cell 
migration.  These values were entered into G*Power to determine the appropriate sample 
size for a meaningful statistical analysis to be performed.  A sample size of at least 75 was 
determined to give a power of 0.95 and a significance of 0.05 (Appendix B.1).  A further 30 
cells were measured and tracked for each cell and coating type for each of three 
experiments in total n1-3 (with the exception of MDA-MB-231 cells in experiment n2 where 
only 15 cells were available to be tracked on collagen).  A two-way ANOVA was selected as 
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multiple populations of cells which were normally distributed, were to be conducted for 
multiple 2D coating types.  Tukey’s test for multiple comparisons test was also used to 
reduce the likelihood that a significant result arose due to multiple comparisons being made 
within one analysis.   
3.2.2. 3D collagen cell migration assay 
MCF7, MDA-MB-231 and HT1080 cells were trypsinized and re-suspended in growth 
medium.  Collagen was prepared as described in section 2.2, and cells suspended in medium 
were added to give a final concentration of 1mg/ml and 2mg/ml collagen.  Cells in matrix for 
each cell line were added to the centre of a 6 or 12 well tissue culture plate and left to set as 
described previously.  Further medium was added as required to give a total volume of 2mls 
per well.  Time-lapse microscopy was used to record migration characteristics over a 21 hour 
period with images taken at 10 minute intervals. ImageJ software was used to measure cell 
length and width and the aspect ratio of length:width calculated for 50 cells of each type in 
each matrix concentration.  Cell tracking was carried out (section 2.5.1) and initial mean and 
standard deviation values entered into G*Power to determine the required sample size 
needed based on ‘distance from start’ for 1mg/ml for all three cell lines. At least 45 cells per 
experiment were required to give a power of 0.95 and significance of 0.05 (Appendix B.2).   A 
further 100 cells per matrix per experiment were tracked (n1-3).  Graphpad prism 6 was 
used for statistical analysis with a two-way ANOVA followed by Tukey’s test for multiple 
comparisons, to analyse and interpret the significance of differences in behaviour between 
different cell lines in each environment and between the same cells in different collagen 
concentrations.  A two-way ANOVA was chosen as data were normally distributed and the 
behaviour of multiple populations of cells was to be compared for multiple matrix types.  
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Tukey’s test for multiple comparisons was used to reduce the likelihood of a significant 
result arising due to multiple comparisons being made within the same statistical analysis. 
3.2.3. 3D collagen and fibronectin cell migration assay 
MDA-MB-231 or HT1080 cells were added to collagen at 1mg/ml and 2mg/ml with or 
without fibronectin at 5µg/ml and 10µg/ml, prepared as described in Section 2.2.  The cell s 
in matrix were set for 20-30 minutes at 37oC/5% CO2 and growth medium added.  Cells were 
left to settle for 2 hours then time-lapse microscopy was used to capture cell migration 
behaviour for 21 hours with images taken at 10 minute intervals.  ImageJ software was used 
for quantification, cell length and width being measured for cells in each matrix type and cell 
tracking carried out using the MTrackJ tool.  G*Power was used to calculate an appropriate 
sample size based on the analysis of MDA-MB-231 cells for one experiment.  A sample size of 
90 cells was selected to give a power of 0.9 and significance of 0.1 (Appendix B.3) due to the 
fact that over 200 cells would be required per experiment to allow a power of 0.95 and 
significance of 0.05 which was outside the time and resources available.  Graphpad prism 6 
was used for statistical analysis, with a two-way ANOVA conducted followed by Tukey’s 
multiple comparison test to test for differences between matrix conditions for multiple cell 
populations.  A two-way ANOVA was selected as cell population data was normally 
distributed and multiple cell populations were to be compared for multiple matrix 
conditions.  Tukey’s multiple comparisons test was used to reduce the likelihood of a 
significant result arising due to multiple comparisons being made within the same analysis. 
3.2.4. Compressed Collagen (CC) assay 
Rat tail collagen type I was used to make compressed collagen gels with cells seeded either 
into or onto the gel.  2mg/ml collagen solution was made as described in section 2.2   2ml 
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quantities of collagen solution were added to wells of a 12-well plate which was used as a 
mold and allowed to set in an incubator at 37oC, 5% CO2 (20-40 minutes).  Set gels were 
turned out onto a sterile fine nylon mesh (average hole size of 0.37 mm) located above a 
stack of dry filter papers as shown in Figure 3.1.  A glass plate and weights totalling 126g 
were used to compress the gel for either 2 ½ or 5 minutes (Chen B. et al. 2012, Jones et al. 
2012).  Where cells were encapsulated within the collagen gel, a copper wire mesh (1.7 mm 
hole size) was also used to prevent too much cell compression resulting in cell death.  
Compressed gels were then placed onto a thin layer of liquid 1mg/ml collagen in a 6-well 
plate and left to set for 20-30 minutes in the incubator until set after which supplemented 
DMEM was added.  Time-lapse microscopy was used to observe and record population of 
the compressed collagen disc and the surrounding lower concentration collagen over a 
period of days following experimental set-up. 
 
   Glass plate + weight totall ing 126g 
Blotting papers 
Nylon mesh 
Gels 
Nylon mesh 
Wire mesh * 
Blotting papers 
Glass plate 
Figure 3.1.  Compressed collagen layering. A wire mesh was used *when cells were seeded 
into the gel to avoid cells being crushed. 
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3.2.5. 2D/3D invasion assay 
Cell-free collagen was prepared at a 2mg/ml pH 7.0 - 7.5 was prepared (section 2.2) and 
added to the centre of each well of a 6 well plate and left to set.  Cells  were re-suspended in 
normal growth medium (supplemented DMEM) and these added around the outside of the 
set collagen, Figure 3.2.  The cells were left to settle and adhere for 30-40 minutes and 
supplemented DMEM then added carefully to avoid washing cells  onto the collagen.  Cell 
behaviour was recorded using time-lapse microscopy (images every 10 minutes for 12 hours) 
and cell migration analysed using ImageJ based on cell location: plastic/2D, collagen border 
zones or 3D/collagen.  Initially ten HT1080 cells for each region were tracked, average and 
mean values calculated and entered into G*Power used to determine the appropriate 
sample size for statistical evaluation.  A sample size of thirty cells was determined to give a 
power of 0.95 and significance of 0.05 (Appendix B.4).  Tracking and analysis was repeated 
for three experiments for MDA-MB-231 cells.  A two-way ANOVA was carried out followed 
by Tukey’s test for multiple comparisons.  The two-way ANOVA was selected as cell 
population data was normally distributed and multiple cell populations were to be compared 
for multiple contexts.  Tukey’s multiple comparisons test was used to reduce the likelihood 
of a significant result arising due to multiple comparisons being made within the same 
analysis. 
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Figure 3.2, 2D/3D invasion assay. Collagen matrix solution was pipetted into the centre of a 
6-well (or 12-well) plate and left to set in an incubator at 37oC/5% CO2.  Cells suspended in 
medium were added around the outside of the matrix and left to adhere.  Additional cell 
growth medium was added. 
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3.3. Results 
3.3.1. Cell migration on coated 2D surfaces – HT1080 and MDA-MB-231 
Until recently, cell migration research has been conducted mainly in a two dimensional  
environment (2D) so a baseline 2D cell migration experiment was carried out for two cancer 
cell lines: MDA-MB-231 breast cancer cells and HT1080 fibrosarcoma cells.  These cell lines 
were chosen as they are known to migrate well having been used extensively in in vitro and 
in vivo research in this field (Artym et al. 2015, Taubenberger et al. 2013, Wolf et al. 2003).  
In this initial experiment set, cell migration was characterised for cells moving on 2D surfaces 
coated with collagen type 1 and fibronectin, both extracellular matrix constituents and for 
Matrigel, a basement membrane extract from a mouse tumour environment.  As the 
morphology of migrating cells can vary (Friedl and Wolf 2009a)  cells were observed and 
quantified by measuring length and width so that aspect ratio (length : width) could be 
calculated,  mesenchymal/elongated cells having a high aspect ratio and rounded or spread 
cells a low aspect ratio (Konen et al. 2016).   Images showing the typical morphology for both 
cell lines in each environment are shown in Figure 3.3 A-G.  Both HT1080 and MDA-MB-231 
cells adopted a flat, spread morphology on fibronectin (Figure 3.3 A, E) with a low aspect 
ratio (Figure 3.3 H, I).  On Matrigel, cells from both cell lines were rounded and compact 
(Figure 3.3 C, G) with a low aspect ratio (Figure 3.3 H, I) and tended to group together, 
frequently forming chains (Figure 3.3 C, D, G).  On collagen however, cells from both cell 
lines were elongated showing long thin protrusions (Figure 3.3 B,F) and had a significantly 
higher aspect ratio (HT1080 mean=3.55, MDA-MB-231 mean=4.19) than when migrating on 
either fibronectin (HT1080 mean=1.66, MDA-MB-231 mean=1.95) or Matrigel (HT1080 
mean= 1.86, MDA-MB-231 mean=1.20) (Figure 3.3 H,I).  For MDA-MB-231 cells the aspect 
ratio was significantly different between all three coating types (fibronectin and col lagen at 
56 
 
p≤0.001, fibronectin and Matrigel at p≤0.0001, collagen and Matrigel p≤0.0001) and for 
HT1080 cells there was a significant difference between collagen and Matrigel (p≤0.0001) 
and collagen and fibronectin (p≤0.0001). 
Figure 3.3, MDA-MB-231 and HT1080 cells migrating in two dimensions (2D) on tissue 
culture plastic with different coatings: fibronectin (10µg/ml), collagen (2mg/ml) and Matrigel 
(3mg/ml). A-C MDA-MB-231 on fibronectin, collagen, Matrigel, E-G HT-1080 on fibronectin, 
collagen, Matrigel.  D HT1080 chain formation on Matrigel (also visible for MDA-MB-231 in 
C).   Graphs H (MDA-MB-231) and I (HT1080) show cell aspect ratio which indicates their 
overall cell morphology on each coating (a high aspect ratio equating to a long narrow cell 
morphology).  Three experiments (n1-3) with 30 cells per experiment were measured (with 
the exception of MDA-MB-231 n2 which contained 15 cells).  Statistics were generated using 
Graphpad 6 via a two-way ANOVA with Tukey’s test for multiple comparisons. Error bars 
show standard error of the mean.  Significance is shown: *** p ≤ 0.001, **** p ≤ 0.0001 (Full 
statistical details for each test are shown in Appendix B.5). Scale bars on all images = 50µm. 
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Migration characteristics were compared for each cell line for the three coating types in 
terms of distance migrated and speed of migration.  Tracking data for the total track length: 
‘track length’ and for the distance a cell had travelled from its start point: ‘distance from 
start’ was used to quantify the extent of cell migration on each surface type.  A comparison 
of ‘track length’ and ‘distance from start’ is shown for each cell line in Figure 3.4 A, B.  The 
mean cell length for cells on each coating was also calculated to allow interpretation of cell 
migration in terms of cell lengths for both ‘track length’ and ‘distance from start’ (Table 3.1).  
Whilst cells from both cell lines had on average migrated at least one cell length from their 
starting point, the decrease and significant difference between ‘track length’ and ‘distance 
from start’ for each coating for MDA-MB-231 (fibronectin p≤0.0001, collagen p≤0.0001 and 
Matrigel p≤0.001) and for HT1080 (p≤0.0001 fibronectin, collagen and Matrigel)  showed 
that the cell migration route was indirect (Figure 3.4 A,B) .  However as the trend in ‘track 
length’ was similar to that for ‘distance from start’ for each cell line and as ‘distance from 
start’ gave the final cell position after eight hours, this was taken as the measure for cell 
migration.   
When comparing ‘distance from start’ for each cell line Figure 3.4 C, D; Table 3.1), a 
significant difference was evident between migration on fibronectin and collagen (MDA-MB-
231 p≤0.001, HT1080 p≤0.01) and between fibronectin and Matrigel (MDA-MB-231 p≤0.001, 
HT1080 p≤0.0001) with cells migrating further on fibronectin.  Cell migration between 
collagen and Matrigel for both cell lines was similar with no significant difference detected 
(Figure 3.4 C, D).   In terms of speed of cell migration (‘track length’/time), MDA-MB-231 
cells moved at a significantly different speed for each coating type (Fibronectin and collagen 
p≤0.0001, Collagen and Matrigel p≤0.01 and Fibronectin and Matrigel p≤0.0001, Figure 3.4 
E).  Speed of migration for HT1080 cells was significantly different between fibronectin and 
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collagen (p≤0.0001) and fibronectin and Matrigel (p≤0.0001) but not between collagen and 
Matrigel (Figure 3.4, F).   
Overall, these results indicated that varying the 2D coating on tissue culture plastic lead to 
different cell migration characteristics in two migratory cell lines, MDA-MB-231 and HT1080  
when cells from the same original population of each cell line were seeded and observed on 
fibronectin, collagen and Matrigel. 
Table 3.1 Average cell length of cells migrating on different coatings 
 MDA-MB-231 HT1080 
2D Coating 
Av. cell 
length 
µm 
(n1-3) 
Av. 
Total 
track 
length 
µm 
No. Cell 
Lengths 
Av. 
Distance 
from 
Start µm 
No. Cell 
Lengths 
Av. cell 
length 
µm 
(n1-3) 
Av. 
Total 
track 
length 
µm 
No. Cell 
Lengths 
Av. 
Distance 
from 
Start µm 
No. Cell 
Lengths 
Fibronectin 46 218 4.7 80 1.7 46 183 4.0 65 1.4 
Collagen 46 123 2.7 51 1.7 53 121 2.3 47 1.1 
Matrigel 16 89 5.6 50 3.1 31 102 3.3 40 1.4 
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Figure 3.4,   Cell migration on 2D coated surfaces for MDA-MB-231(A,C,E) and HT1080 
(B,D,F).   Graphs A and B show cell migration for cells tracked every ten minutes from an 8 
hour time-lapse movie.  Track length ‘Length’ for each coating is compared to distance from 
start (D2S).  Graphs C and D compare distance from start of cells migrating on different 
coated surfaces (Collagen (Col), Fibronectin (Fib), Matrigel (Mat)).  Graphs E and F show the 
speed of cells migrating on each surface.  Three experiments with 30 cells per experiment 
were tracked (with the exception of MDA-MB-231 n2 which contained 15 cells).  Statistics 
were generated using Graphpad6 via a two-way ANOVA with Tukey’s test for multiple 
comparisons.  Error bars show standard error of the mean.  Significance is shown: ** p ≤ 
0.01,   *** p ≤ 0.001, **** p ≤ 0.0001 (Full statistical details for each test are shown in 
Appendix B.5).  
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3.3.2. Cell migration in a 3D collagen matrix 
During metastasis, a migrating cancer cell is unlikely to move in two dimensions only.  Cells 
escaping a developing tumour are likely to migrate in the context of the extracellular matrix 
surrounding it.  As the major constituent of the extracellular matrix is collagen type 1, 
collagen type 1 (from rat tail) was used at two different concentrations (1mg/ml and 
2mg/ml) to create a simple in vitro 3D environment for the observation and quantification of 
cell migration.  MDA-MB-231 and HT1080 cells were selected due to their invasive and 
migratory phenotype (Barry et al. 2015, Kraning-Rush et al. 2011, Wolf et al. 2003) and MCF7 
breast cancer cells were selected as a control cell line known for its low migration 
characteristics (Peela et al. 2016).  
Cell morphology for each cell line at each collagen concentration (Figure 3.5 A-F) was 
quantified using aspect ratio (Figure 3.5, I).  The mean aspect ratio for MCF7 cells was low 
(2.01 in 1mg/ml collagen and 1.84 in 2mg/ml collagen) suggesting an oval/spread 
morphology (Figure 3.5 A, D, I).  For MDA-MB-231 cells the aspect ratio had a higher mean 
value (3.10 in 1mg/ml and 3.78 in 2mg/ml collagen) indicating a longer, narrower cell 
morphology, more mesenchymal in appearance (Figure 3.4 I).  Figure 3.4 B, E show several 
typical cells which are either elongated or rounded with elongated protrusions, which 
support this finding.  HT1080 cells in 1mg/ml collagen had a mean aspect ratio of 5.35 
whereas in 2mg/ml they had a lower mean aspect ratio of 4.57, a difference that was found 
to be significantly different at p≤0.01 level (Figure 3.5, C,F,I and Appendix B.6).  There was no 
significant difference between either MCF7 in the two collagen concentrations nor MDA-MB-
231 in the two contexts but again HT1080 cells were more elongated in 1mg/ml collagen 
(mean=77.16µm compared to 70.77µm) which was significantly different at p≤0.05 level in 
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line with that identified in the aspect ratio for the same cells (Figure 3.5 I,J).   Cell migration 
was quantified in the collagen matrices, using ‘distance from start’ and speed of migration 
based on cell tracking data.  A significant difference at the p≤0.0001 level was found for cells 
of both MDA-MB-231 and HT1080 for ‘distance from start’ between the two collagen 
concentrations, with cells of each type moving further from their start point in the less dense 
collagen during the 21 hour tracking period (Figure 3.5 G,J).  As expected, MCF7 cells moved 
less than one cell length (mean lengths:  31.3 in 1mg/ml and 27.3 in 2mg/ml) from their 
starting point, remaining in groups which expanded gradually as cells divided.  Migration 
speed was also quantified and a significant difference was found for all three cell lines 
between the different collagen concentrations (Figure 3.5 H).  MCF7 cells moved mainly on 
the spot (Figure 3.5 G) at 0.11 microns/minute in 1mg/ml collagen and 0.08 microns/minute 
in 2mg/ml collagen and so although the difference between these two values was significant 
at the p≤0.01 level, it is clear from the ‘distance from start’ values (Figure 3.5 G) that these 
cells didn’t migrate within this timeframe.  MDA-MB-231 and HT1080 cells moved faster in 
the 1mg/ml collagen matrix than in the 2mg/ml matrix (MDA-MB-231 mean values: 0.27 
microns/minute and 0.20 microns/minute and for HT1080 0.38 and 0.32 microns/minute 
respectively).  When compared with MCF7 cells, HT1080 and MDA-MB-231 cells moved 
significantly faster and further in both collagen concentrations (significant at p≤0001 for all 
comparisons, Figure 3.5 and Appendix B.6). 
In summary, cells from three different cancer cell lines showed different cell morphology 
and migration characteristics when each was compared in two different 3D collagen matrix 
concentrations.  Cells typically moved further and faster in the lower density collagen matri x 
and HT1080 cells were significantly more elongated in the lower density matrix.   
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Figure 3.5, Cell migration in collagen.  Cell migration in 1 and 2mg/ml collagen for MCF7, MDA-
MB-231 and HT1080 cells was tracked over a 21 hour period (images taken at 10 minute intervals).  
A-C shows cell morphology in 1mg/ml collagen and D-G in 2mg/ml collagen MCF7 (A, D), MDA-MB-
231 (B, F) and HT1080 (C, G).  Graphs: G shows the ‘distance from start’ for each cell line and H 
shows the speed of migration in 1 and 2mg/ml collagen.  Cell morphology was quantified using 
aspect ratio: I, and this is compared with the cell length for each cell type J. 100 cells were measured 
for each cell line and this repeated 3 times.  A two-way ANOVA with Tukey’s test for multiple 
comparisons was used to investigate whether differences were significant. Error bars show 
standard error of the mean. Significance is shown: ** p ≤ 0.01,   *** p ≤ 0.001, **** p ≤ 0.0001 
(Full statistical details for each test are shown in Appendix B.6).   Scale bars on all images = 50µm.  
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3.3.3. Does fibronectin affect cell migration when added to a 3D collagen matrix? 
On a 2D coated surface, MDA-MB-231 and HT1080 cell migration was significantly faster and 
further on fibronectin compared with collagen.  As fibronectin is an important and frequent 
constituent of the extra cellular matrix, type 1 collagen was augmented with fibronectin to 
provide cells with a more complex and biologically relevant matrix.  However, when MDA-
MB-231 cells were set in collagen at 1mg/ml and 2mg/ml with/without fibronectin at 5 or 10 
µg/ml, their morphology appeared similar (Figure 3.6 A-F for n1-3) and when cell length and 
aspect ratio were quantified, there was no significant difference (two-way ANOVA and 
Tukey’s test) in the measurements across the different matrix environments (Figure 3.6 G, 
H).  Indicative results for HT1080 cells taken from one experiment using the same six 
environmental contexts  (30 cells measured for each context), also showed similar 
morphology in each context (Figure 3.7 A-F) and no significant difference was found for 
aspect ratio between contexts (Figure 3.7 G).  However, there was a significant difference in 
cell length, cells being longer on average at the lower collagen concentration (mean values: 
1mg/ml =90.67 µm, 2mg/ml=61.47 µm, Figure 3.7 H).  In 2mg/ml collagen with 10 µg/ml 
fibronectin, HT1080 cells were also significantly longer (mean length= 61.47µm) than when 
in the 2mg/ml collagen only matrix (mean length= 77.63µm).  The difference in cell length 
but not in aspect ratio suggests that some cells were also wider or more spread thus 
reducing the aspect ratio so that it was similar in all contexts.   
Cell migration distance, both for ‘track length’ and ‘distance from start’ suggested that there 
was no difference when fibronectin was added to either collagen concentration, the only 
significant differences being between the 1mg/ml and 2mg/ml contexts with or without 
fibronectin (Figure 3.8 A,B).  A similar trend for both ‘track length’ and ‘distance from start’ 
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was also evident, with cells moving   ⅓ to ¼ of their track length from their starting position 
during the 21 hour period.  A similar pattern was seen for HT1080 cells for collagen only and 
collagen with 5 µg/ml fibronectin.  There was great variation in the 1mg/ml collagen with 
10µg/ml fibronectin so the difference was not significant (Figure 3.8 C).  A comparison of cell 
migration between cell lines in each context suggested that MDA-MB-231 cells moved 
further in the lower concentration collagen without or with 5 µg/ml fibronectin (Figure 3.8 
E).  Migration speed for both cell lines varied significantly between collagen matrix densities 
but not between collagen and fibronectin settings (Figure 3.8 D-F). 
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Figure 3.6, MDA-MB-231 cell migration in collagen and collagen with fibronectin. Cells 
were set in 1mg/ml collagen (Col 1mg) or 2 mg/ml collagen (Col 2mg) or collagen at 1 or 
2mg/ml with either 5 or 10µg/ml fibronectin (Col 1mg+5F, Col 1mg+10F and Col 2mg+5F, Col 
2mg+10F).  A-C show cell morphology in 1mg/ml collagen (A), Col 1mg+5F (B) and Col 
1mg+10F (C) and in 2mg/ml collagen (D), Col 2mg+5F (E), Col 2mg+10F (F).  Cell morphology 
was quantified via aspect ratio (G) and cell length in (H) for 30 cells in each matrix type, 
repeated three times (n1-3).  A two-way ANOVA with Tukey’s test for multiple comparisons 
suggested that there is no significant difference in either aspect ratio or cell length between 
any of the matrices.  Error bars show standard error of the mean. (Full details at Appendix 
B.7.) Scale bars on all images = 50µm. 
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Figure 3.7, HT1080 cell migration in collagen and collagen with fibronectin. Cells were set in 
1mg/ml collagen (Col 1mg) or 2 mg/ml collagen (Col 2mg) or collagen at 1 or 2mg/ml with 
either 5 or 10µg/ml fibronectin (Col 1mg+5F, Col 1mg+10F and Col 2mg+5F, Col 2mg+10F).  
A-C show cell morphology in 1mg/ml collagen (A), Col 1mg+5F (B) and Col 1mg+10F (C) and 
in 2mg/ml collagen (D), Col 2mg+5F (E), Col 2mg+10F (F).  Cell morphology was quantified via 
aspect ratio (G) and cell length in (H) for 30 cells in each matrix type in one experiment set 
up for comparison with MDA-MB-231 cells.  A two-way ANOVA with Tukey’s test for multiple 
comparisons suggested that there was no significant difference in aspect ratio but that cell 
length did vary significantly between collagen concentrations. Error bars show standard 
deviation. (Full details at Appendix B.7.) Scale bars on all images = 50µm. 
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Figure 3.8, Cell migration tracked in collagen and collagen with fibronectin. Cells were set 
in 1mg/ml collagen (Col 1mg) or 2 mg/ml collagen (Col 2mg) or collagen at 1 or 2mg/ml with 
either 5 or 10µg/ml fibronectin (Col 1mg+5F, Col 1mg+10F and Col 2mg+5F, Col 2mg+10F).  
30 cells were tracked for each condition/ cell type over a 21 hour period with images at 10 
minute intervals. The experiment was replicated three times for MDA-MB-231 cells (MDA) 
and once for HT-1080 cells (HT). Graph A shows ‘track length’ for MDA-MB-231 cells 
migrating in each matrix type and B the distance from start (error bars show standard error 
of the mean for n1-3, 30 cells for each replicate). A two-way ANOVA with Tukey’s test was 
used to test significance of differences for MDA-MB-231 cells.  Graph C shows cell migration 
for HT1080 cells for 30 cells in one experiment (error bars show standard deviation) A 
Kruskal-Wallis ANOVA with Dunn’s test for multiple comparisons was used. For both cell 
lines a significant difference for cells migrating between different collagen concentrations 
was evident.  In E cell migration distance from start is compared for each cell line by matrix 
type using a Kruskal-Wallis ANOVA with Dunn’s test for multiple comparisons.  Graphs D and 
F show cell migration speed for MDA-MB-231 and HT1080 cells respectively (Full details at 
Appendix B.7.).  
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3.3.4. Fibrillar structure of the 3D collagen matrix 
To examine further the properties of the 3D environments being used, the matrix contexts 
were visualised using reflectance microscopy.  Figure 3.9 A shows collagen at 2mg/ml which 
appears disorganised with many short fibres at different orientations.  Figure 3.9 B shows 
2mg/ml collagen with 10µg/ml fibronectin which appears to be denser, with shorter fibres.  
Despite these visual differences in the matrix, it seems that adding fibronectin to collagen 
did not impede cell migration nor significantly change the cell morphology for MDA-MB-231 
cells and indicative results for HT1080 cells suggested a similar pattern of behaviour may be 
evident for this cell line. 
 
 
Figure 3.9 Collagen matrix structure determined by reflectance microscopy.  A 2mg/ml 
collagen, B 2mg/ml collagen with 10µg/ml fibronectin.  Images taken using Leica TCS SP2 
using 488 argon laser and Apochromat 60x oil immersion lens. Scale bars = 20µm. 
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3.3.5. Compressing collagen to increase matrix stiffness and elasticity  
To provide a stiffer more biologically relevant environment a compressed collagen assay was 
used (Jones et al, 2012).   MDA-MB-231 cells set into compressed collagen (CC) moved and 
divided, gradually populating the compressed collagen over a number of days (Figure 3.10). 
Whilst a few cells emerged into the lower concentration collagen base (L) at CC borders, the 
majority of cells remained within the higher density collagen until it was highly populated 
(Figure 3.10 C-F).  When cells did emerge, they moved individually and many moved along 
borders and returned to the denser CC (Figure 3.10 A, E, F).  Cells were both 
elongated/mesenchymal and rounded in the CC environment (Figure 3.10 A, B).  Once the CC 
was well populated, some cells at border zones were seen to emerge in a rounded 
morphology, budding out and moving into the lower density collagen (Figure 3.11 A-C and 
E).  Some cells however, seemed to move away in a collective manner, following each other 
along tracks (Figure 3.11 D).  To further investigate and visualise cell behaviour at 
compressed collagen borders, lentiviral GFP+ transduced HT1080 cells (preparation: section 
2.3.2; testing: section 4.32 and figure 4.14) were seeded onto compressed collagen and set 
into 1mg/ml collagen.  Many cells with rounded morphology could be seen at the CC borders 
as well as mesenchymal/ elongated cells (Figure 3.12 A-C).  Reflectance microscopy indicated 
a denser structure for CC with collagen fibres more aligned (Figure 3.12 D, compared with 
Figure 3.9 A). 
This assay showed that colonisation of a stiffer matrix appeared to be more important than 
migration away from it.  Cells on and in the stiffer compressed collagen adopted both 
elongated and spherical morphologies and cell morphology.  Cell behaviour at border zones 
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showed distinctive features different to that seen in either the higher or lower density 
collagen matrix and warranted further investigation.  
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Figure 3.10, Compressed collagen populated with MDA-MB-231 cells.  A Cells starting to 
move out (yellow arrows) into 1mg/ml collagen (L) from compressed collagen environment 
(CC).  B Cells populate and constantly move within the compressed collagen and many are 
rounded (red arrows).  C, D cell migration away from the compressed collagen – cells form 
chains but move individually indicated by yellow arrows (D= C+ 5 ½ hours).  E, F cells 
populate the compressed collagen but few move out into 1mg/ml collagen indicated by 
yellow arrows (E=+24 hours after set-up and F=48 hours after set-up at same location).  
Scale bars = 100µm. 
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Figure 3.11, MDA-MB-231 cells leaving compressed collagen are rounded.  Cells appeared 
to bud out from the compressed collagen (CC) into the surrounding 1mg/ml collagen (L).   
A-C shows a sequence in which rounded cells move out into 1mg/ml collagen (yellow 
arrows) or along the compressed collagen border (red arrows). D shows rounded cells 
moving out in a group along a track like pathway (yellow arrows). E shows rounded cells 
leaving compressed collagen close up (yellow arrows).  Scale bars = 20µm. 
 
  
73 
 
Figure 3.12 Cell morphology and structure of compressed collagen. HT1080 GFP+ cells 
seeded onto compressed collagen (CC) showed mixed morphology as they colonised the 
matrix.  A, C Fluorescent HT1080 cells adopted a rounded morphology (red arrows) and 
elongated/mesenchymal morphology (yellow arrows) when colonis ing the compressed 
collagen. B shows a bright field image for the same view as A.  D shows a reflectance image 
of the compressed collagen structure in which fibres appear to be more aligned and densely 
packed than in uncompressed collagen. A-C were imaged using Zeiss Axio Vert.A1 
epifluorescence microscope. D was imaged using Leica TCS SP2.  Lower density collagen base 
(L). For A-C, scale bars = 100µm.  For D, scale bar = 20µm.   
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3.3.6. Cell migration from 2D to 3D – can the context be simplified? 
It was clear from observation of cells moving between CC and the 1mg/ml collagen base, 
that cell behaviour at borders may be different from that within either a 3D matrix or on a 
2D coating.  To investigate this further, the novel CC was adapted to provide a 2D/3D assay 
(Figure 3.2) using an uncompressed collagen matrix which provided border zones for cells to 
exploit or invade (Figure 3.13 A,B).  This allowed cell behaviour and morphology to be 
observed and quantified in three distinct regions: 2D, 3D and border zones, as well as their 
transition between them.  Both MDA-MB-231 and HT1080 cells were observed in this assay 
and when quantified over a period of twelve hours (n1-3, 10 cells for each region per 
experiment), significant differences in cell speed were observed for cells migrating in 2D and 
3D and between border zones and 3D collagen for both cell lines (Figure 3.13 C, D).  MDA-
MB-231 cells had mean values of 0.53µm/minute in 2D, 0.65 µm/minute at border zones 
and 0.29 µm/minute on the 3D collagen matrix.  HT1080 cells were slower moving and had 
mean values: of 0.25µm/minute in 2D, 0.39 µm/minute at border zones and 0.13 µm/minute 
on the 3D collagen matrix.  For HT1080 cells there was also a significant difference in 
migration speed between border zones and 3D, with cells moving three times as fast at 
border zones (means: border = 0.39 µm/minute, 3D= 0.13 µm/minute, difference significant 
at the p≤0.0001 level.)  MDA-MB-231 cells moved more quickly on 2D/plastic and at border 
zones than they did on 3D collagen. 
These data not only demonstrated cell migration differences between 2D and 3D 
environments but also that environmental features such as border zones are important for 
cell migration, with cells using border zones as migration tracks to achieve effectively 1D 
migration at significantly faster speeds.  Cells were also observed transitioning between the 
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2D and 3D environments but the speed and dynamics for this needed more careful 
quantification and were not analysed and included as part of this experiment.   
Figure 3.13, MDA-MD-231 and HT1080 cells move faster at collagen borders.  MDA-MB-231 
cells colonized and used border zones as tracks for cell migration A, B.  Cells moving on 
plastic (2D), at borders (red arrows) and on collagen (3D) were tracked for a 12 hour period 
and migration speed compared for each region.  10 cells migrating in each region were 
tracked for three separate experiments (n1-3) for MDA-MB-231 cells C and HT1080 cells D. A 
two-way ANOVA was conducted with Tukey’s test for multiple comparisons. Error bars show 
standard error of the mean.  (Full details at Appendix B.8.) Scale bars = 100µm. 
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3.3.7. Cell invasion at border zones 
Cell invasion could be observed closely at border zones (Figure 3.14) either in the live 
environment (Figure 3.14 A) or fixed and stained for protein expression (Figure 3.14 B, C).  
This simple assay allowed cells to be observed simultaneously interacting with different 
surfaces of both two and three dimensional matrices as well as giving the opportunity to 
observe behaviour at border zones such as invasion.   
 
Figure 3.14, Cell invasion at collagen borders.  An HT1080 cell migrating from 2D to 3D 
collagen matrix pushes its way into the gaps between collagen fibres, time-lapse phase 
contrast image taken from a sequence, Nikon TiE, A.  An HT1080 GFP+ cell invading a 
2mg/ml collagen matrix – confocal imaging, Leica SP2.  Fluorescence and reflectance images 
are overlaid, B.    MDA-MB-231 myristoylated GFP+ cells invading at a 2mg/ml collagen 
border, C.  Confocal imaging using Leica TCS SP2. A, scale bar = 50µm; B and C,  
scale bars = 20µm.   
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3.4. Discussion 
Tissues are complex, comprising multiple cell types in a highly structured dynamic matrix 
environment (Nelson and Bissell 2006).  A successful in vitro model must provide a context in 
which cells show the range of morphologies and behaviours observed in vivo.  Simple 
approaches to modelling such as coating tissue culture surfaces with ECM components have 
provided a basis for the investigation of metastasis in vitro but cells adhering to and moving 
over these surfaces are known to behave atypically compared to their 3D tissue context 
(Doyle et al. 2013).   
Extracellular matrix components used to create 2D and 3D contexts have resulted in 
interesting observations relating to cell behaviour and matrix interactions but understanding 
the relevance compared to the live context is critical if results are to be interpreted and 
extrapolated in a meaningful way (Hickman et al. 2014, Pampaloni et al. 2007).  Collagen 
type 1 and fibronectin are both important constituents of the ECM and have been found in 
high proportions in the matrix surrounding some tumours (Lu et al. 2012, Provenzano et al. 
2006, Provenzano et al. 2008).  Matrigel, a basement membrane extract produced from a 
murine tumour microenvironment  containing collagen IV, laminin, heparin sulfate 
proteoglycans, nidogen and growth factors,  (Hughes et al. 2010) has been used to model 
basement membrane as both a 2D and 3D model .  There is also evidence that basement 
membrane is remodelled within the tumour microenvironment (Cox and Erler 2011).    These 
three components were used as a starting point to coat 2D surfaces in this project.  Whilst 
experiments reported here showed differences in cell behaviour on 2D coated surfaces 
between surface type for two different cancer cell lines, cell morphology on collagen and 
fibronectin was elongated/mesenchymal when compared to in vivo findings (Wang et al. 
2002).  Cell migration over fibronectin was faster than for collagen.  There is evidence that 
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although focal adhesions are expressed by cells adhering on both surface types, that focal 
adhesions on fibronectin are non-fibrillar and therefore facilitate a faster migration with 
lower adhesion (Cukierman et al. 2001).   Whereas cells on fibronectin and collagen moved 
individually over the matrix, cells seeded onto Matrigel in these experiments moved towards 
each other forming groups and chains and appeared to contract the matrix.  This behaviour 
on Matrigel has been reported by other researchers (Gest et al. 2013, Yu and Machesky 
2012) and cells are known to pull on matrix fibres causing contraction (Doyle et al. 2015, 
Foster et al. 2015).  Matrigel is a basal lamina derived matrix comprising a number of 
components including growth factors which will have influenced cell behaviour on this 
coating type (Hughes et al. 2010).  Cell proliferation and differentiation in response to the 
collagen type IV, growth factors and other constituents of the Matrigel may well have 
contributed to the behaviours observed with cells forming groups and potentially starting to 
interact and form tissue structures (Uemura et al. 2010).  These results clearly showed that 
each cell type responded differentially according to the 2D tissue component coating and 
that these behaviours were similar when comparing the two different cell lines used.  MDA-
MB-231 cells were sourced from a metastatic lesion in the lung but are epithelial in origin s o 
could be classed as metastatic and adapted to invade a new niche environment.  HT1080 
cells however were taken from a primary tumour and although fibroblastic in morphology 
and behaviour have not necessarily gained the range of behaviours that a metastas izing cell 
might display.  The fact that cells from both cell lines displayed similar behaviours on all 
three coatings suggests that it was the 2D ECM context that drove the cell behaviour.  Whilst 
differences in cell behaviour were observed, the 2D coating context lacked the structure, 
support and complexity provided by ECM and therefore how relevant to the in vivo 
environment could these cell behaviours be deemed to be?  On fibronectin and collagen, 
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cells were elongated with no amoeboid morphology or migration mode observed (Friedl  
and Wolf 2003).  On Matrigel however, cells adopted a largely ovoid or amoeboid 
morphology.  Adhesive strength on softer matrices has been associated with low adhesion 
modes of migration such as amoeboid migration, yet matrix contraction has been associated 
with stronger matrix adhesion (Discher et al. 2005).  This begs the question: what behaviours 
were elicited in these cells by the matrix conditions? Were cells migrating, colonis ing or 
adapting to enable their survival in an alien environment?  In the case of adaptation, was 
this behaviour closer to niche colonisation than solely about cell transition over a surface?  
To investigate these questions, the properties of this environment were enhanced in an 
incremental way, with cells encapsulated into a simple 3D collagen or collagen/fibronectin 
matrix. 
In three dimensions, collagen density has been shown to affect cell migration, with different 
migration strategies adopted according to fibrillar structure and matrix porosity (Wolf et al. 
2009, Wolf et al. 2013).  ECM components collagen type 1 and fibronectin were used here to 
construct a simple 3D matrix in which to study cell behaviour.  MCF7 breast cancer cells 
were used as a comparison to MDA-MB-231 and HT1080 cells as they tend to divide and 
remain in groups, rather than to migrate.  Results from these experiments showed a clear 
difference in both migration speed and distance for the migratory cell lines (HT1080 and 
MDA-MB-231) with cells moving more slowly within the denser collagen.  Both HT1080 and 
MDA-MB-231 cells adopted an elongated/mesenchymal morphology.  MCF7 cells however 
had a more ovoid morphology when encapsulated and as expected remained in groups 
rather than migrating through the collagen matrix.  The addition of fibronectin (for MDA-
MB-231 and HT1080 cells) however did not make a significant difference for either speed or 
distance, despite the fact that the matrix appeared to be denser. If cells were able to use the 
80 
 
same migration mode in 3D as on the 2D fibronectin coating then perhaps this isn’t 
surprising, as matrix impedance could have been countered by the ability of cells to bind to 
fibres and move through the matrix (Cukierman et al. 2001).   Slower migration in 3D 
collagen matrices could also have been related to the need for cells to adapt to their new 
environment (Friedl et al. 2012).  Encapsulated cells had been cultured in 2D flasks so could 
be expected to be adapted to their 2D growth environment. The enzymatic cleavage of 
adhesive proteins during cell detachment prior to encapsulation would also affect the initial 
ability of cells to adhere and migrate.   
The introduction of an intrinsically amoeboid cell line to the models developed, such as 
melanoma cells A375M2, would have allowed the interaction of cells within the different 
contexts to have been characterized still further.  The plasticity of these highly metastatic 
cells has been demonstrated in vivo, cells switching from amoeboid to mesenchymal 
morphology within tumours, A375M2 cells using the mesenchymal mode to infiltrate 
densely packed tumour tissue or fast amoeboid movement at tumour borders (Pinner and 
Sahai 2008, Sanz-Moreno et al. 2008).  In the models presented here, it would be expected 
that A375M2 cells would adopt an amoeboid morphology at the interfaces and border zones 
presented in the 2D/3D assay and compressed collagen assay at the border zones  or when 
seeded onto a thick layer of collagen (Calvo et al. 2011).  Within a 3D matrix environment, 
the A375M2 cells have been shown to secrete matrix metalloproteases (MMP-9 and MMP-
13) which would allow them to migrate within the 3D collagen and compressed collagen 
matrix environment (Orgaz et al. 2014).  Where cells became densely populated, A375M2 
might be expected to switch to a mesenchymal morphology to move between gaps and into 
new spaces, for example in the compressed collagen assay once the matrix was well 
colonized.  
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The 3D matrix as a model facilitated a longer experimental run-time, the depth and context 
providing cells with the opportunity to colonise and interact with each other and with the 
matrix in multiple orientations, the added dimension providing a much greater surface area 
for this interaction.  In comparison, cells in a 2D environment typically grow as a monolayer 
and when fully confluent become quiescent or die.  It takes time for cells to colonise a 3D 
matrix and even in these simple experiments, cells could be left for 2-3 days whilst 
observation of events took place.  This temporal issue is an important one, with metastatic 
initiation difficult to capture due to its spontaneity.  Some cell behaviours may take time to 
develop, for example the collective invasion of MCF7 cells would require seeded cells to 
form cell-cell junctions and tissue to become polarised before invasion commenced (Cheung 
et al. 2013, Gest et al. 2013).   
The 3D collagen with/without fibronectin provided a simple ECM based environment but for 
each cell line, cell behaviour was restricted to one cell morphology and migration mode.  
Under the experimental conditions described, the full range of in vivo behaviours from 
amoeboid to mesenchymal and collective cell migration (Table 1.4), to be modelled was not 
evident.  Reflectance images of the 3D matrix indicated that collagen fibres were short and 
randomly oriented in a loosely packed matrix.  As ECM surrounding many tumours is known 
to become denser and tissue more rigid (Cox and Erler 2011, Wang et al. 2002), a stiffer 
more structured ECM model would seem a more relevant environment. 
Tissue engineering techniques have been used for some time in an attempt to create 
biologically relevant contexts for appropriate cell culture and tissue growth for transplant 
(Edmondson et al. 2014, O'Brien 2011).  Stem cells have been seen to differentiate in 
response to the elasticity of their microenvironment (Engler et al. 2006, Wen et al. 2014).  
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Indeed when mesenchymal cells were seeded onto 2D gel substrates with varying elasticity 
values (E, kPa) spindly neuronal phenotypes emerged on a soft matrix (0.1 – 1kPa elasticity), 
mesenchymal phenotypes on medium matrices (8-17kPa) and spread phenotypes on firm, 
more rigid matrices of 25-40 kPa (Engler et al. 2006).  A more highly organised cytoskeleton 
has been evident on more rigid 2D surfaces coupled with the upregulation of focal adhesions 
for cell-substrate adhesion (Wyckoff et al. 2006).  Furthermore the traction forces of cells on 
or in a matrix contribute to the matrix structure and assembly (Kraning-Rush et al. 2011, 
Lemmon et al. 2008).  In recent corneal tissue engineering research, a compressed collagen 
matrix was constructed and used as a model of the cornea for the differentiation of stem 
cells into limbal epithelial cells (Jones et al. 2012).  When characterised, Jones et al, showed 
the compressed collagen matrix to be denser and stiffer, with an elastic modulus 100 times 
greater than the equivalent uncompressed matrix.  This tissue engineering approach was 
adapted and used here as a novel assay in which to observe cell behaviour in relation to 
metastasis with HT1080 and MDA-MB-231 cells seeded either onto or encapsulated within 
the compressed collagen (CC).  A range of cell morphologies was observed from rounded 
and amoeboid to elongated/mesenchymal, that is, spanning the range described in the cell 
migration tuning model (Friedl and Wolf 2009a) and those associated with in vivo cell 
migration (Bravo-Cordero et al. 2012, Condeelis et al. 2001, Gligorijevic et al. 2012, Sahai and 
Marshall 2003, Wang et al. 2002).  Matrix features were observed to play an important role, 
with cells colonising some areas of the matrix first.  Cells also remained within the 
compressed collagen matrix in preference to migration out into the lower density 
uncompressed collagen in which the CC was seated.   Indeed, cells seen escaping at 
boundaries frequently moved along the CC edge and re-joined it further along the border 
rather than move out and away from it.  Cells also formed layers at border zones perhaps 
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using the more rigid edges as a scaffold along which to layer and commence the formation 
of a basic tissue structure (Berzat and Hall 2010).  This engineering approach adapted here, 
has some similarities to that recently developed in the Condeelis lab, a thin high density 
fibrillary collagen layer (HDFC) prepared via centrifugation which has been reported to 
stimulate the production of invadopodia (Artym et al. 2015).  The stiffer style matrix (HDFC) 
was found to stimulate invasive behaviour in a range of cells and so is suitable for the study 
of metastatic invasion on a 2D surface.  The CC used in this work however, has the additional 
advantage of cell encapsulation so that metastatic events such as niche colonisation can be 
visualised within a full 3D ECM based environment. 
Cell migration in 1D, for example along muscle fibres (Otto et al. 2011) and in tumour 
invasion (Wang W. et al. 2002) has been seen both in vivo and ex vivo. Guidance cues have 
been reported as important both within living tissue and have been observed in vitro (Berzat 
and Hall 2010, Sapudom et al. 2015).   Border zones in the results for both the CC and the 
2D/3D assay seemed to provide guidance cues, similar to the discrete cell migration paths 
along which cells orient themselves in vivo and as such could be used for the study of cell 
properties associated with 1D migration and invasion or emergence across border zones 
(Katz and Lasek 1980, Tsai et al. 2012).  Recent research in biomaterials engineering has 
indeed sought to mimic the properties of tissue boundaries as an important tool for cell 
research in this field (Sapudom Jiranuwat et al. 2016).  Whilst cells in/on CC showed a range 
of cell migration strategies including rounded cells budding out from CC into lower density 
collagen, cells in the 2D/3D assay were elongated/mesenchymal and did not show either the 
range of morphology or migration strategies.  Discher et al. (2005) have stressed the 
importance of the need for variation within a 3D model, natural variation in ECM being a 
feature of the tissue environment (Bissell and Radisky 2001, Bissell et al. 2002, Lu et al. 
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2012).   There are many additional factors likely to make CC more complex other than its 
stiffness/elasticity, including nutrient and oxygen availability and the associated gradients 
which are known to affect cell migration in vivo and may be represented in this denser ECM 
environment (Cox and Erler 2011, Yamada and Cukierman 2007).   
In summary, this chapter has demonstrated that whilst simple 2D and 3D models using ECM 
components are able to support some of the cell behaviours associated with metastasis, 
only the denser more structured compressed collagen based on tissue engineering 
techniques came close to representing a suitable 3D structure useful for modelling living 
ECM.  An ECM based in vivo model which could be used to observe metastatic cell behaviour 
would potentially provide a more complex and biologically relevant environment, with the 
benefits of blood flow for nutrient and gas exchange.  Techniques from the in vitro work 
described in this chapter were used and applied to such a model: the chick embryo model, 
described in the next chapter.  
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4. Modelling Metastasis In Vivo   
4.1. Introduction 
The developing chick embryo has been used in the study of developmental biology for 
hundreds of years with early studies using it as a model to understand blood circulation, 
heart development and heart function (Kain et al. 2014).  More recently it has been used as 
a vertebrate model to study specific processes relating to abnormal development and 
disease (Deryugina and Quigley 2008b, Ribatti 2014, Ribatti et al. 1996).  As a vertebrate 
model it has the benefit of a short developmental timeline of just 21 days between the start 
of incubation and the chick hatching. 
In the very early stages of development during gastrulation, three germ layers form from 
which the chick embryo and associated tissues develop, these being:  ectoderm, the outer 
layer; mesoderm, the middle layer and endoderm, the inner layer (Lillie 1919, Romanoff 
1967).  There is a division in developing tissues between embryonic and extraembryonic 
layers, the extraembryonic layers functioning to provide nutrition, respiration and excretion 
of waste products (Romanoff 1967) .  Membrane folds develop at the interface between the 
embryo and extraembryonic layers and four distinct extraembryonic membranes are 
formed: the amnion, chorion, allantois and yolk.  The ectoderm and mesodermal layers grow 
to form the amnion and chorion and the allantois and yolk sac are formed from the 
endoderm and mesodermal layers.  The chorion develops from the blastoderm at the same 
time as the amnion (the fluid filled sac surrounding and cushioning the embryo) but the 
chorion lies outside.  The allantois, starts to develop on the second day of incubation, 
gradually spreading over the developing embryo and forming a flattened sac.  The 
mesodermal layer of the allantois which is presented on the outer surface, merges with the 
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mesodermal layer of the chorion between days 4 and 5 to form the chorioallantoic 
membrane (CAM) (Romanoff 1960).   By day 6 the combined chorioallantoic membrane 
fuses with the shell membrane to form a mechanism for gas exchange and a portal through 
which calcium can be imported this being needed for bone growth and development in the 
chick embryo (Gilbert 2010), Figure 4.1.   Vascularisation of the allantois begins within the 
mesodermal layer around day 4 (Gabrielli and Accili 2010).  Between days 5 and 10, a 
capillary plexus forms within the mesodermal layer.  This initially lies just beneath the thin 
ectodermal layer but then pushes outwards towards the shell so that by day 12 it lies above 
the ectodermal layer close to the shell membrane to enable efficient gas and nutrient 
exchange (Gabrielli and Accili 2010, Romanoff 1960).  The arterioles and veins however 
remain within the mesodermal layer.  Two arteries and a single vein serve to move blood to 
and from the CAM to the embryo beneath (Ribatti 2010).     
Figure 4.1, In ovo development of chick embryo and extra-membranous tissues.  The 
allantois and chorion fuse to form the chorioallantoic layer which spreads over the 
developing embryo to cover it completely by day 6.  (Diagram based on schematic 
(Valdes et al. 2002)). 
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A lymphatic network also develops from around day 6 alongside the blood vessels 
(Romanoff 1960).  The chorioallantoic membrane thus comprises three layers, the outer 
layer derived from ectoderm which fuses with the inside of the porous egg shell, the 
mesoderm a highly vascularised stromal layer and the endoderm located on the inner 
surface of the membrane at the interface with yolk sac and amnion (Lillie 1919).  The 
epithelial and stromal components of the chorioallantoic membrane (CAM) of the vertebrate 
chick also bear many similarities to human epithelia and associated extracellular matrix, the 
CAM providing an epidermal layer with a stromal compartment beneath comprising: 
collagen type I, fibronectin and laminin of similar composition to that found in human 
stroma beneath the epidermal layer (Alberts et al. 2002, Gabrielli and Accili 2010, Lokman et 
al. 2012). The CAM therefore provides a suitable model which can and has been exploited 
for the investigation of angiogenesis and metastatic processes (Kain et al. 2014, Ribatti 
2010).  In particular the main components of ECM:  collagen type I, laminin and fibronectin 
are all major constituents found within the tumour microenvironment (Lokman et al. 2012, 
Provenzano et al. 2006).   
The CAM not only provides a tissue of suitable composition for experimental purposes, but 
as cell mediated immunity within the chick does not start to develop until the second week 
of incubation (Jankovic et al. 1977).  The immature immune system can thus be exploited for 
experimentation purposes allowing exogenous cells and tissues to be introduced without 
rejection (Kain et al. 2014, Ribatti 2010).  Cell based immunity within the developing chick 
develops first within the thymus and bursa and by day eight lymphocytes are evident.  By 
the eleventh day lymphocytes and granulocytes are present in the spleen and granulocytes 
in the bone marrow of the developing embryo (Jankovic et al. 1977).    
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Xenografts and explants have been placed on CAM in experiments dating back to the early 
20th century, in which mammalian tissues and cells were found to be accepted by the 
developing CAM (Kain et al. 2014).  Early experiments in which rat tumour explants placed 
on CAM grew successfully until day 18 of incubation (but not in chicks) conducted by 
Murphy in 1914 (Ribatti 2014) provided evidence that mammalian cells and tissue could be 
supported in the developing chick model.   Cells have also been injected into the CAM 
vasculature to enable the investigation of the steps of metastasis, in particular, intravasation 
and extravasation of cancer cells and transit to distal sites (Deryugina and Quigley 2008b, 
Ribatti 2014).   
It has been suggested that the CAM assay provides an easy and inexpensive model for the 
investigation of all the steps of metastasis (Kain et al. 2014, Ribatti 2014).  Whilst the CAM 
has been used for the study of tumour growth, cellular escape, intravasation and 
extravasation, it also has great potential for its use in the detailed study of the interactions 
of cells within the tumour microenvironment.  The potential to investigate cell -cell and cell-
ECM interactions in detail within CAM using emerging tools and technologies provided the 
basis for a novel application of the CAM assay in relation to metastasis. 
The aim of this part of the project therefore, was to use the CAM assay as a model to explore 
the interaction of cancer cells with CAM tissue using it as a model for both the tumour 
microenvironment as cells invaded down through the ECM layers and for colonization of the 
metastatic niche.  The introduction to the CAM of cancer cells originating from both a 
primary tumour (HT1080 cells) and from metastatic sites (MDA-MB-231 and MCF7 
metastatic breast cancer cells) enabled the comparison and contrast of cell morphology and 
mechanisms employed during invasion, migration and colonization.  Using specifically 
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developed GFP expressing cells of each cell type, different methods of fluorescence 
microscopy were explored for tracking cancer cells and probing mechanisms of interaction 
during: cell invasion and migration, tissue interaction and ECM colonization.   
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4.2. Materials and methods 
Fertilized chicken eggs obtained from Henry Stewart and Co. Ltd. were allowed to settle 
overnight at 19oC following transportation, then placed in a humidified incubator at 37oC 
(Day 0).  Eggs were windowed on Day 2-3 (Figure 4.3 shows timeline) by removing 2-3 ml of 
the albumen with a syringe through a small hole made at the blunt end of the egg with sharp 
pointed scissors, then cutting an oval window longitudinally, approximately 3 x 2 cm, using 
curved scissors.  The window was then covered with clear adhesive tape (Figure 4.2 A).   
Windowed eggs were racked and returned to the humidified incubator until Day 8 (Figure 
4.2 B). 
Figure 4.2, Eggs windowed at day 2-3:  A, a windowed brown egg showing syringe access 
and window with adhesive tape covering; B, windowed brown eggs racked for return to 
incubator. 
Cells from human cancer cell lines were counted using a haemocytometer, suspended in 
growth medium or in liquid collagen and  added to the CAM beneath the windowed area 
either directly to the CAM surface or to an area which was firs t injured by scratching the 
CAM surface with a 0.12mm diameter tungsten dissecting probe (World Precision 
Instruments).  Once on the CAM, cells were kept moist by adding a drop of un-supplemented 
DMEM (Appendix A) containing 1% Penicillin/Streptomycin (Gibco, Invitrogen).   
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Human cancer cells were observed in situ on the CAM using a stereoscopic dissection 
microscope (either Leica DC500 or Zeiss Steri SV6).  CAMs with seeded cells were harvested 
for either ex vivo microscopy or for fixation on or by Day 14 (Figure 4.3).   
eggs to          window                  add cells                                 all harvested                        chicks 
incubator        eggs                       to CAM                              by 75% development             hatch 
 
 
 
 
 
Figure 4.3 Timeline for CAM in vivo experiments.  Eggs transferred from holding incubator 
at 19oC to a humidified incubation incubator at 37oC on Day 0.  Eggs incubated and chicks 
harvested within 75% of in ovo development.  
4.2.1.1. Ink staining of CAM vasculature 
Indian ink (Daler Rowney) was mixed at 1:5 concentration in a small dish.  Three to four days 
after cell seeding (10-11 days incubation) the shell was removed from the developing chick, 
keeping the membranes intact.  The chick sternum was opened up and an incision made into 
the chick embryo’s heart.  Using a fine glass needle (1.3mm diameter, hand-made) ink was 
blown gently into the pumping heart through a mouthpiece at the top of fine rubber tube 
attached to the glass needle.  The chick heart pumped the ink through the vasculature of the 
embryo and the CAM for around twenty minutes.  The CAM was harvested and fixed with 
4% Paraformaldehyde/PBS. 
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4.2.2. CAM fixing and staining  
Whole CAM was first fixed in 4% paraformaldehyde/PBS for 2 hours then washed in PBS 
twice and stored in PBS at 4oC until required.    
The primary antibodies used were: anti-GFP antibody: GFP Rabbit IgG antibody (A11122 
Invitrogen) used at a 1:250 dilution and anti-Ki67 antibody: anti-rabbit (abcam16667) used at 
a 1:500 dilution. The secondary antibodies used were: anti-rabbit Alexafluor 488 and anti-
rabbit Alexafluor 647 (Fisher Scientific) both used at a 1:500 dilution. 
Cell stains used were: Phalloidin Atto 565 stain at a 1:250 dilution, added with secondary 
antibody and DAPI (Sigma) stain added to give a 10µg/ml final concentration. 
4.2.2.1. Immuno-staining 
CAM was permeabilized and blocked using 10% goat serum in 1% Triton-X 100/PBS 
overnight at 4oC then washed twice with 0.1% Triton X-100/PBS.  Primary antibodies were 
diluted into blocking solution and samples were incubated for 2-3 days at 4oC.  Samples were 
washed twice for 30 minutes in 0.1% Triton/PBS then secondary antibodies and phalloidin 
stain were added in block solution and incubated for 2-4 hours in the dark at room 
temperature.  Samples were washed again twice for 30 minutes in 0.1% Triton/PBS and 
mounted.  DAPI was added to a final 30 minute PBS wash.  All wash and incubation steps 
took place on rocker/rollers so that samples were kept in constant motion.  A quick PBS 
wash was carried out before mounting for microscopy or embedding for sectioning.   
4.2.2.2. Staining only 
Where phalloidin/DAPI only staining was carried out, samples were removed from PBS. 
Phalloidin was added to 1% Triton-X 100 solution at 1:250 and samples left overnight at 4oC 
on rollers.  CAM tissue samples were washed twice with 0.1% Triton-X 100/PBS for 30 
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minutes then DAPI added to PBS for a further 30 minute wash.  A quick PBS wash was carried 
out before mounting for microscopy or embedding for sectioning. 
4.2.2.3. Mounting tissue 
Whole CAM was mounted from PBS onto Superfrost microscope slides using either 
Vectashield H-1000 (Vectorlabs) or Hydromount (Agar Scientific) as mounting media. 
4.2.3. Embedding and sectioning 
Whole CAM tissue was rolled up (like a layered tube) before placing it into OCT so that 
multiple layers could be seen within the same section to maximise the chance of finding 
GFP+ cells within the section.  Fourteen micron sections were made using a Kryostat (section 
2.4.1) and mounted onto polylysine coated slides (Polysine slides, Thermo Scientific), 
allowed to dry and stored at -80oC until required.  Further staining was carried out for 
specific proteins.  An anti-rabbit anti-GFP antibody (Sigma) was also used to enhance GFP 
fluorescence.  Details of the primary and secondary antibodies used are given above and in 
section 2. 4.    
4.2.4. CAM microscopy 
Live imaging was conducted using a Leica DC500 fluorescence dissection microscope and 
images acquired with Adobe Photoshop software (Version 6).  Fixed and stained samples 
mounted on slides were analysed using Zeiss Axioimager (x5, x10, x20, x40 lens details) 
running Axioimager 4 software.  Confocal images were taken using the equipment described 
in section 2. 
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4.2.5. Confocal spectral unmixing microspcopy 
A series of baseline samples was imaged on the Nikon A1 Plus Confocal Microscope using the 
spectral unmixing acquisition software.  Each sample had either no stain or just one stain.  
Samples were as follows: 
1. CAM only (no stain) 
2. CAM with phalloidin atto 565 
3. CAM with DAPI 
4. Lentiviral transduced GFP+ HT1080 cells on plastic 
Images were acquired for CAM tissue samples with and without GFP+ cells using all four 
lasers and then the predetermined spectral profiles were extracted from the spectral image 
via a spectral unmixing algorithm.  Unmixed images showed only those cells and areas of the 
CAM fluorescing within the ranges determined by the baseline profiles.  These images could 
be compared to regular confocal images for control purposes. 
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4.3. Results 
The chick embryo model is well characterized and has been extensively used to study both 
development and disease.  Exploiting the ability to drop the albumen level and use the 
highly vascularised ECM-like chorioallantoic membrane, this work explored the extent to 
which the chick embryo model could be used to visualise and probe cell-cell and cell-ECM 
mechanisms using fluorescence microscopy.  
4.3.1. Developing CAM assay for ECM interaction 
Development of the CAM metastasis assay took place over a series of experiments based at 
the Institute of Child Health, University College London.  The aim of the initial experiments 
conducted was to find the best way of seeding cells onto the CAM beneath a window made 
on day 2/3 of incubation (Figure 4.4 A, A1) so that their spread and dissemination over and 
through CAM tissue could be observed and quantified.   
Three approaches were explored: 
1. Cells re-suspended in medium, seeded directly onto CAM; 
2. Cells re-suspended in medium seeded into small rings onto CAM; 
3. Cells re-suspended in collagen and seeded onto CAM. 
In the initial set of experiments myristoylated GFP+ cells which expressed GFP at the cell 
membrane were used.  A heterogeneous mix of either HT1080 myristoylated GFP+ cells or 
MDA-MB-231 myristoylated GFP+ cells (section 2.3.1) was seeded at a density of 8.5 x 105 
cells/ml either directly onto scratched CAM (Figure 4.4 B) or into small rings which had been 
made by cutting lengths of a sterile 1ml pipette tip and glued with surgical glue onto the 
CAM surface (Figure 4.4 C).  Alternatively, cells in 1mg/ml collagen were seeded onto the 
scratched CAM surface beneath the windowed area (Figure 4.6).  The scratch made to the 
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CAM surface was fine and around 0.25-0.5cm in length, made in an area distant to the major 
CAM blood vessels. The aim of the scratch was to cause minor damage and allow the human 
cancer cells a point of access into CAM ECM.  In all cases only one application of cells/ cells in 
collagen was applied to each CAM /egg to enable spread of cells to be investigated from the 
initial seeding point.  Figure 4.4 shows images of cells seeded either directly onto scratched 
CAM or into rings, these acting as wells to hold cells in medium.  The three experiments 
were observed and images taken one day, three days and seven days after the addition of 
cells or cells in collagen.  Figure 4.5 shows images of cells in medium added at day one 
(Figure 4.5 A, B, C) and after three days (Figure 4.5 D).  It was difficult to find cells using the 
Leica DC500 microscope beyond this stage on the CAM.  HT1080 myristoylated GFP cel ls 
were particularly difficult to see as they did not fluoresce very brightly over the background 
auto-fluorescence of the chick tissues, CAM being collagen rich and fluorescing in the green 
emission range in particular, as can be seen in the images presented here  (Figure 4.5 B-D).  
Whilst some of the introduced GFP+ cells may not have survived at the CAM surface, others 
may have moved down into the CAM quickly and so their fluorescence may have been 
masked by the background auto-fluorescence of the CAM.  The variation within the 
heterogeneous mix of transposed cells would also have resulted in a variation in levels of 
GFP expression between cells, some being brighter and more easily detected than others.  
Seeding of cells into rings appeared to be successful initially but vasculature failed to 
develop beneath these rings, perhaps due to the effects of the surgical glue.  Also bacterial 
infection was seen in a number of the experiments where cells were applied in this way.  
Seeding cells in 1mg/ml collagen allowed the cells to remain in a specific location / patch at 
the CAM surface which could be found successfully on subsequent days (Figure 4.6).  
1mg/ml collagen was chosen for suspension due to its successful use in in vitro assays for cell 
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migration.  Cells have also been observed to sink within collagen at low concentrations 
during experiments conducted within this project and this has also been observed and 
reported by other researchers (Artym and Matsumoto 2010).  This in vitro behaviour was 
exploited to allow cells to gain close proximity to the CAM surface whilst still providing 
encapsulation to give an identifiable seeded patch.   
Figure 4.4, Development of CAM metastasis assay.  A Shows a windowed egg with CAM 
exposed and vasculature evident (note that the window in this image has been expanded for 
the purposes of demonstration so is larger than the 3 x 2cm window made at Day 2 or 3). A1 
shows an expanded image of the CAM surface and vasculature in the windowed egg (not to 
scale).  B MDA-MB-231 myristoylated GFP+ cells have been added in medium to the CAM 
surface which looks slightly pink due to the DMEM medium they were suspended in 
(between yellow arrows).  C a ring (yellow arrow) glued to the CAM surface provides a well 
for cells to be added (red arrow).  Brightfield images A1-C taken with a Leica DC500 
microscope.  B, C Scale bars = 2mm. 
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Figure 4.5, Development of CAM metastasis assay: MDA-MB-231 myristoylated GFP Cells / 
cells in collagen seeded onto the CAM surface. A Brightfield image of cells seeded in 
medium onto scratched CAM (in area of blue arrows).  B Epifluorescence image showing 
cells seeded and spread over surface of CAM (white arrows).  C Cells on CAM at higher 
magnification – individual cells can be seen (white arrows).  A-C Images taken 1 day after 
seeding cells. D shows cells in media spread over the CAM surface, 3 days after seeding. 
Yellow arrows indicate vasculature in all images.  Images taken with a Leica DC500 
microscope.  A,B Scale bars = 1mm, Scale bar in C = 0.5mm, Scale bar in D = 2mm. 
Brightfield and fluorescence images taken one day after seeding showed that for some 
experiments cells and collagen remained in a small patch (Figure 4.6, A, B).  For other 
experiments the cells in collagen seemed to spread out well and individual cells could be 
seen within the collagen on the surface of the CAM one day after addition to the CAM 
surface (Figure 4.6 C, D).  There was evidence however that over subsequent days the 
collagen tended to dry out (Figure 4.7 A, B).  Samples from the initial experiment were 
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harvested after six days, fixed, stained and investigated further using fluorescence and 
confocal microscopy to determine the extent of spread of cells into CAM tissue.   
Two methods of harvesting CAM were explored, firstly harvesting of the whole CAM from 
the ex ovo chick and secondly, enlarging the window and excising the CAM from beneath the 
windowed area.  This second approach was more successful as the original seeding area 
could be determined under a dissection microscope for harvesting and cell dissemination 
could be investigated within a sample of at least 6 cm2.  Initial samples were fixed, stained 
and mounted and images taken with a Zeiss Axioimager (Figure 4.7).   Cells could be seen 
spread out in collagen on the CAM surface and many were rounded and flat.  Several cells 
seemed to be aligned or in chain formation.  Further images were taken using confocal 
microscopy to explore the extent and depth of spread of myristoylated GFP+ MDA-MB-231 
cells (Figure 4.8) and HT1080 cells (Figure 4.9) on the CAM. 
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Figure 4.6, Development of CAM metastasis assay – cells in collagen on CAM surface.   
A, Brightfield image of cells in collagen on CAM (white arrows).  B MDA-MB-231 
myristoylated GFP (MDA GFP+) cells in collagen on CAM surface indicated by white arrows.   
C  Brightfield image of CAM with cells in medium (cells not individually visible) and D 
epifluorescence image showing the same area and patch of cells in collagen (white arrows in 
figure D) these appearing more dispersed than cells in A, B.  In all images vasculature is 
indicated with yellow arrows.  Images were taken with a Leica DC500 microscope.   
Scale bars = 1mm. 
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Figure 4.7, MDA-MB-231 myristoylated GFP cells on harvested CAM.  A, B After 2-3 days, 
collagen appeared to be clumped and dried out in places on the CAM (yellow arrows). Red 
channel shows CAM tissue, green shows collagen/cells.  Scale bars = 500µm. Images taken 
with Leica DC500 microscope.  C-F Fixed and stained CAM mounted and imaged using a Zeiss 
Axioimager.  C GFP+ cells (blue arrows) appeared to sit on and around a blood vessel  (red 
arrows).  Cells appeared rounded and flat.  D Cells appeared to be well spread in collagen 
over the CAM surface (red arrows indicate vasculature) and appeared to line up along edges 
of the collagen (yellow arrows) D, E.  E, F Rounded flattened cells can be seen on the CAM 
(blue arrows). D Scale bar= 200µm, C, F scale bars= 50µm, E scale bar = 100µm.  
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Figure 4.8, Confocal images of MDA-MB-231 myristoylated GFP cells on CAM.  A GFP+ cells 
indicated by yellow arrows grouped on CAM surface (green) with CAM phalloidin shown in 
red channel. B Cells adopted compact shapes (yellow arrows).  Myristoylated GFP is clearly 
seen outlining the cell membrane.  C Cells are grouped and spread over the CAM (white 
arrows indicate cells).  Confocal images were taken with a Leica TCS SP2 confocal 
microscope.  Scale bars = 50µm. 
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Figure 4.9, HT1080 myristoylated GFP cells on CAM membrane, 6 days after seeding.  Cells 
are seen in small groups or individualy, some still within the collagen. A Combined image, B 
Phalloidin in red channel,  C DAPI in blue channel. D GFP+ in green channel.  Images were 
taken using Nikon A1 confocal system.  Scale bars = 100μm and as shown in 3D scale at the 
base of images C and D. 
Following the initial cell seeding trials onto the CAM, suspending and seeding cells in 
collagen proved to be the most successful method.  To improve the chances of cell survival 
for invasion, the cell seeding density was increased to give 35-40,000 in 20µl instead of the 
initial 15-20,000 cells per application.  Following seeding on CAM, a drop of growth medium 
was added on the following 1-2 days to keep collagen moist on the CAM surface.   
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Although the membrane-tagged myristoylated GFP+ cells had proved successful on the 
surface of the CAM, it was difficult to see them within the CAM tiss ue.  Further work to 
characterize myristoylated GFP+ cells was carried out to assess their suitability as a tool 
within this assay.  MDA-MB-231 myristoylated GFP+ cells were added to a 2D/3D assay 
(section 3.2.5) and observed over a 24 hour period to check cell migration and morphology 
characteristics.  They were placed in a humidified tissue culture incubator at 37oC and 
monitored using an Etaluma LED microscope with x40 lens.   Figure 4.10 A-C show cells 
migrating on collagen.  Cells can be seen to move in and out of the highlighted area (red 
elipse) and to change their morphology from rounded to elongated or vice versa.  
Figure 4.10, MDA-MB-231 myristoylated GFP cells migrating on 2mg/ml collagen.   
Images (A-C) were taken over a 24 hour period every 10 minutes using an in incubator 
Etaluma LED microscope.  Red arrows indicate the same two cells on each image and show 
that over the 10 hour period these cells changed morphology and moved on the collagen.  
The red elipse depicts an area of collagen in which a number of elongated cells can be seen 
in image A.  In B and C changes in cell morphology and location can be seen within the red 
elipse, compared with A, over the 10 hour period.  Scale bars = 100µm. 
Cell migration speed and total track length for a 24 hour period were compared for MDA-
MB-231 and the modified myristoylated GFP cells  using time-lapse microscopy (Figure 4.11 
A,B).  The results suggested that both cell migration speed and total distance migrated over 
24 hours differed between the two cell populations, with the modified GFP+ cells moving 
less distance and more slowly.  Whilst the aspect ratio of the GFP+ cells compared with the 
parent cell line migrating on collagen (Figure 4.11 C) appeared to be similar, many of the 
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GFP+ cells appeared to have a more crinkled membrane (red arrows in Figure 4.11 D,E). The 
characteristics of these cells meant that they were not idealy representative of the parent 
cell line.  Immuno-staining using an anti-GFP antibody to enhance the fluorescence and aid 
identification of myristoylated cells against the autofluorescent CAM was an option 
considered but this would have increased the time and resources employed for each 
experiment and would only be of use in harvested fixed tissue. 
Figure 4.11, Comparison of MDA-MB-231 Cells (MDA) with MDA-MB-231 myristoylated 
GFP cells (MDA myr GFP).  A, Speed of migration; B Total track length for a 24 hour period;  
C Aspect ratio. Each spot represents a cell.  Error bars show standard deviation.  D shows 
MDA-MB-231 cells migrating in 1mg/ml collagen with D1 an expanded view.  E shows 
myristoylated GFP+ cells with E1 an expanded view of the area in the yellow rectangle.  Cells 
indicated with red arrows have unusual crinkly looking membranes when compared to MDA-
MB-231 cells (red arrows). Scale bars = 100μm. 
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4.3.2. Are lentiviral GFP+ cells easier to identify in CAM? 
As the morphology and invasive capacity of the cells observed in CAM was important as well 
the ability to identify them, lentiviral green fluorescent protein (GFP) expressing cell -lines 
were developed for MDA-MB-231, HT1080 and MCF7.  These cell lines were developed to 
express GFP in the cell cytoplasm and were expected to be brighter and easier to identify in 
CAM.  The assembly of the virus and transduction of each cell line is described in section 
2.3.2.  Following clonal expansion for each cell line, clones were screened for fluorescence, 
cell morphology and proliferation rate, selection made based on those most resembling the 
parent cells.  Three clones for each cell line were chosen and these were cultured following 
the cell culture procedures described in section 2.1. for the relevant parent cells.  For each 
parent cell line and clone, an in vitro comparison was carried out and repeated three times 
(n=3), in which cells were encapsulated in 1mg/ml collagen, left to settle then tracked 
following the procedure outlined in section 2.5.1.  Cell morphology was quantified using 
length and width measurements to give aspect ratio and ‘distance from start’ was 
determined from cell tracking data extracted from the ImageJ MTrackJ measurements file.  A 
combination of descriptive statistics and statistical difference was used to establish similarity 
in this context based on a group of 30 cells for each independent experiment observed in the 
3D collagen context in vitro.  
Results were summarised and quantified and are presented for MCF7 (Figure 4.12), MDA-
MB-231 (Figure 4.13) and HT1080 (Figure 4.14).  There was no significant difference found 
between MCF7 parent cells and clones for either distance from start or for aspect ratio 
(Figure 4.12, C, F).  Cells for all three clones were fluorescent in the green emission spectral 
range (≈ 500-600nm) and grew in group formation in a similar way to parent cells (Figure 
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4.12 A-B, D-E).  MDA-MB-231 clones were also similar to parent cells in their cell migration 
characteristics (Figure 4.13, F) and aspect ratio, with no significant difference for clones YA1 
and ZB2 but a slightly more elongated/mesenchymal cell morphology evident for clone XB5 
(significantly different at p≤ 0.05, MDA mean=2.293, XB5 mean=3.758). All three clones 
fluoresced green as expected and could be seen within the 1mg/ml collagen under 
epifluorescence light with a green filter (Figure 4.13 B, D, E).  In order to establish similarity 
rather than difference using statistics, a larger data set would ideally be used, however in 
this case the approach of identifying difference in combination with cell fluorescence has 
been employed as a reasonable method of clone selection. 
When HT1080 lentiviral GFP+ clones were compared with parent cells (Figure 4.14) the 
aspect ratio for each clone was similar to that of the parent cells, with a mean aspect ratio 
close to 4 for each cell type (Figure 4.14 C).  All clones showed good fluorescence (Figure 
4.14 A-B and D-E).  However, GFP+ clones migrated less distance when compared to parent 
cells, this being significantly different in each case (Figure 4.14 F).  However, cells of each 
clone were still able to migrate so were used in subsequent experiments.   
Clones selected for each cell line were used and seeded at least three times each onto CAM 
both with and without first scratching the CAM surface.  Lentiviral cell -lines were clearly 
visible at the CAM surface (Figure 4.15).  When visualising cells in CAM, identifying the s hape 
and form of the vasculature was an important consideration.  In order to visualise this in 
relation to invading cells, ink injection was explored (Figure 4.16).  This allowed cells seeded 
onto CAM to be seen in relation to the vasculature and could be used as a technique which 
did not require fluorophores, these then being available for staining CAM and cancer cells.  
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Figure 4.12, Comparison of MCF7 and MCF7 lentiviral clones. MCF7 cells and lentiviral GFP+ 
transduced clones were encapsulated in 1mg/ml collagen and cell migration tracked over a 
21 hour period with images taken at 10 minute intervals using a Nikon TiE microscope.  The 
length and width of 10 cells from each of 3 experiments was measured and 10 cells tracked 
for each experiment and cell type using ImageJ MTrackJ tool.  A shows MCF7 using bright 
field microscopy, and clones are shown: B D6F2, D D1B6 and E DPF5, all imaged using a Zeiss 
Axio Vert.A1 epifluorescence microscope.  Scale bars on all images are 100µm. Graph C 
shows aspect ratio and graph F distance from start for tracked cells.  A two-way ANOVA 
followed by Tukey’s multiple comparisons test indicated no significant difference for either 
aspect ratio or distance from start between parent cells and clones. Error bars show SEM. 
(Statistics shown in detail in Appendix C.) 
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Figure 4.13, Comparison of MDA-MB-231 with lentiviral clones. MDA-MB-231 (MDA) cells 
and lentiviral GFP+ transduced clones (XB5, YA1, ZB2) were encapsulated in 1mg/ml collagen 
and cell migration tracked over a 21 hour period with images taken at 10 minute intervals 
using a Nikon TiE microscope.  The length and width of 10 cells from each of 3 experiments 
was measured and 10 cells tracked for each experiment and cell type using ImageJ MTrackJ 
tool.  A shows MDA cells in collagen using bright field microscopy and clones are shown: B 
XB5, D YA1, E ZB2, all imaged using a Zeiss Axio Vert.A1 epifluorescence microscope.  Scale 
bars on all images are 100µm.  Graph C shows aspect ratio and graph F distance from start 
for tracked cells.  A two-way ANOVA followed by Tukey’s multiple comparisons test 
indicated no significant difference for distance from start between parent cells and clones.  A 
difference at p≤0.05 was detected for aspect ratio between MDA and XB5 clone cells.  Error 
bars show SEM. (Statistics shown in detail in Appendix C.) 
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Figure 4.14, Comparison of HT1080 cells with lentiviral clones. HT1080 cells (HT) and 
lentiviral GFP+ transduced clones (A1D9, B696, ZB5) were encapsulated in 1mg/ml collagen 
and cell migration tracked over a 21 hour period with images taken at 10 minute intervals 
using a Nikon TiE microscope.  The length and width of 40 cells from each of 3 experiments 
was measured and 27 cells tracked for each experiment and cell type using ImageJ MTrackJ 
tool.  A shows HT cells in collagen using bright field microscopy, B shows clone A1D9, D 
B696, E ZB5, all imaged using a Zeiss Axio Vert.A1 epifluorescence microscope.  Scale bars on 
all images are 100µm. Graph C shows aspect ratio and graph F distance from start for 
tracked cells.  A two-way ANOVA followed by Tukey’s multiple comparisons test indicated no 
significant difference for aspect ratio between parent and clones.  For distance from start, 
differences were seen between parent and clones * p≤0.05, ** p≤0.01, *** p≤0.001. Error 
bars show SEM. (Statistics shown in detail in Appendix C.) 
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Figure 4.15, Lentiviral cells seeded at 
CAM surface.  
 A LV MCF7 GFP+ (D6F2) cells are 
clearly seen in two large groups on 
CAM surface.  B shows a patch of LV 
MDA-MB-231 GFP+ (ZB2) cells in 
collagen on CAM surface.  C LV HT1080 
GFP+ (ZB5) cells are dispersed over 
CAM.  All images were taken using a 
Nikon Confocal A1 microscope.   
Scale bars A, C = 100μm and B = 50μm.   
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Figure 4.16,  Ink injection to show CAM 
vasculature.   
Indian ink was injected into the chick embryo 
heart 3 days after cells were seeded onto the 
CAM surface.  Ink was pumped into the CAM 
and vasculature by the beating heart.  CAM 
was fixed and stained with phalloidin and 
DAPI. Ink in blood vessels can be seen using 
bright field imaging A (red arrows). B shows  
merged brightfield and fluorescence images – 
GFP fluorescing cells can be seen in CAM 
tissue (yellow arrows).  C Confocal image 
showing phalloidin in the red channel, GFP+ 
cells in the green channel and DAPI in the 
blue channel for the same CAM sample 
shown in A, B.  GFP+ cells are visible in CAM 
tissue (yellow arrows) and close to blood 
vessels (white arrows).  Images were taken 
using Nikon A1-R confocal microscope. 
Scale bars = 100µm for A and  
50µm for B and C. 
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When imaging fixed and stained whole CAM seeded with lentiviral cell lines, the auto-
fluorescence from nucleated chick erythrocytes was a confounding issue (Figure 4.17, 4.18) 
as the erythrocytes were nucleated and fluoresced in the green spectral range.  The chick 
erythrocytes appeared as disc shaped with a central nucleus and in some samples were seen 
in vasculature and within CAM tissue (Figure 4.18).  Comparison of CAM both with and 
without lentiviral cell lines seeded was conducted using identical confocal settings across 
samples (Figure 4.19).  Whilst a clear difference could be seen between samples with GFP+ 
cells at the surface of Figure 4.19 B and D, compared with A and C respectively, when looking 
at individual cells within the CAM, it was difficult to determine whether cells were definitely 
human cancer cells.  Individual cells in Figure 4.18 C, appeared to vary in shape and be 
morphologically different to those marked with white arrows in Figure 4.18 D, which were 
almost certainly chick erythrocytes due to their symmetrical morphology.   
Figure 4.17 Chick erythrocytes fluoresce in the green spectrum.  Nucelated erythrocytes 
within a large blood vessel (yellow arrows) and the CAM, white arrow.  They are round and 
flat with a centralised nucleus (DAPI stained – blue). Image taken using Nikon A1 Plus 
confocal microscope.  Scale bar = 10µm. 
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Figure 4.18,  Nucleated red blood cells in chick.  Chick erythrocytes are autofluorescent in 
the green and far red light emission spectral ranges.  As erythroctes leave capillaries and 
perfuse the CAM this means that they could potentially be misidentified as GFP+ cancer 
cells.  A CAM at low magnification with no GFP+ cells seeded. White arrows indicate blood 
vessels.  Green fluorescence in blood vessels is from nucleated erythrocytes.  B LV MDA-MB-
231 GFP+ YA1 cells seeded onto CAM (blue arrows).  It is difficult to determine which cells in 
vasculature (white arrows) are GFP+ and which are erythrocytesusing green fluorescence 
alone. Yellow arrows indicate likely GFP+ cells on/in CAM ECM.  C, D.  Higher magification 
images of green fluorescent cells in CAM from LV MDA-MB-231 GFP+ ZB2 cells seeded CAM.   
Erythrocytes are more regular in shape and those indicated with white arrows in D are likely 
to be erythrocytes.  Those indicated in C are irregular shaped and appear to be larger and 
likely to be GFP+ cancer cells.  Images taken with a Nikon A1 Plus microscope.   
A, B Scale bars = 100µm. C Scale bar = 20µm. 
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Figure 4.19, Determining GFP+ cells in CAM.  CAM with no cells and CAM seeded with LV 
HT1080 GFP+ ZB5 cells from the same egg batch are compared using the same confocal 
settings. Spectral unmixing was used to obtain process these images using three filters: blue 
for DAPI, red for phalloidin and green for GFP from lentiviral cells.   A, C CAM at low 
magnification with no GFP+ cells seeded. Some auto-fluorescence seen in the green range 
but there is no evidence of  GFP+ cells at the CAM surface. B, D CAM onto which LV HT1080 
GFP+ (ZB5) cells have been seeded.  White arrows indicate GFP+ cells and yellow arrows 
indicate GFP+ cells in blood vessels. Images were taken with Nikon A1 Plus confocal 
microscope.  Scale bars = 100µm.  
 
Spectral unmixing confocal microscopy was used as a technique to reduce the auto-
fluorescent background of CAM tissue and to help differentiate between GFP+ human 
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cancer cells and nucleated chick erythrocytes.  Figure 4.20 A, shows a regular confocal image 
in which a large number of cells in collagen can be seen on the CAM surface, these appearing 
as GFP+ and roughly spherical with blue nuclei (DAPI).  The larger rounded green cells 
indicated by blue arrows had a cell diameter in the range of 13-17µm and are likely to be the 
lentiviral transduced GFP+ cancer cells in this image.   Figure 4.20 B shows the phalloidin 
only channel for image A, in which the actin cytoskeleton (blue arrows) can be seen for many 
of the GFP+ cells within the collagen.  The cell characteristics of cytoskeletal staining, cell 
morphology and a nucleus all suggest that these can be identified as the GFP+ human cancer 
cells seeded within the collagen at the CAM surface.    However, in Figure 4.20 A, some 
smaller green fluorescing cells with a round/ ovoid morphology (cell diameter 12-13µm) can 
also be seen at some locations within the collagen.   These were fluorescent only in the 
green channel and were smaller than chick erythrocytes.  The breakout panel in Figure 4.20 
A, shows these more clearly.  In Figure 4.20 B, in the equivalent phalloidin breakout panel, 
these small green cells are not visible so they do not appear to have an actin cytoskeleton.  
Using spectral microscopy to probe this mix of green fluorescent cells further, the hig her 
magnification image at Figure 4.20 C, shows an image taken using three extraction filters: 
blue (DAPI), green (GFP) and red (phalloidin).  The erythrocytes appear as bright yellow, 
rounded discs due to the diffuse actin within them picked up by the red filter in combination 
with the green auto-fluorescence.   Other cells within the collagen however appear to be 
mainly green in colour, the interaction of the red filter for the actin cytoskeleton being much 
lower, thus the two cell types are distinct.  The morphology of the cells indicated by white 
arrows, likely to be erythrocytes,  is clearly different to the cells indicated with blue arrows 
as human cancer cells, with the erythrocytes being regular and round but flat when seen 
side on (cell diameter 12-13µm) with a central nucleus around 4µm in diameter.   
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Figure 4.20 D, shows a mix of green fluorescing cells within collagen on CAM in further detail 
and here again a clear distinction can be drawn based on the interaction of fluorescence 
filters and cell morphology. 
Thus despite developing lentiviral GFP+ cell lines to allow better identification of metastatic 
invasion and colonisation of CAM, human cancer cells could not always be identified by their 
GFP expression alone and therefore their presence needed further qualification. 
4.3.3. Immuno-staining of human cancer cells in CAM 
Although morphological features of human cancer cells in CAM compared to those of chick 
cells could aid identification and differentiation, a clear and unequivocal method for the 
identification of human cancer cells was needed.  To this end an anti-GFP antibody was used 
to detect the GFP within the cytoplasm of the lentiviral GFP+ cancer cells when staining.  
Images of stained whole CAM are shown for each cell line (Figures 4.21-25).  LV MDA-MB-
231 GFP+ (ZB2) cells were clearly labelled by the anti-GFP antibody (Figure 4.21) and cells 
could be identified within the mesodermal layer of the CAM in all three channels based on 
their fluorescence and additional labelling in the green channel, their morphology and by the 
phalloidin labelled cytoskeleton seen in the red channel.  A negative control for primary and 
secondary antibodies was run on CAM with no GFP+ cells seeded and a control for the 
primary antibody was run with secondary antibody only for each condition (Figure C1 at 
Appendix C).  Individual cell morphology for the ZB2 cells is shown in Figure 4.21 with most 
cells appearing compact and rounded or ovoid.  Cells were also captured during cell division 
in these images (indicated by yellow arrows).  In Figure 4.21 A, the indicated cells seem to 
form a group or chain, with two cells attached, one of which is dividing.  LV HT1080 GFP+ 
(A1D9) cells were also clearly identified in CAM and in CAM vasculature when anti -GFP 
118 
 
staining was carried out (Figure 4.22-23).  In Figure 4.23 the 3D rendered images show cells 
adopting a variety of morphologies as they move between CAM cells and through gaps in the 
ECM structure.  In Figure 4.25 LV MCF7 GFP+ DPF5 cells are shown counter-stained with the 
anti-GFP antibody in whole CAM images.  These cells are seen spread across the CAM 
surface (Figure 4.25 A) and within CAM vasculature (Figure 4.25 B).  At higher magnification, 
the cells can be seen squeezing through gaps in the CAM tissue (Figure 4.25 C) with nuclei 
distorted as they move through it (Figure 4.25 D).  Two pairs of cells can also be seen 
invading CAM tissue together (Figure 4.25 C-D). 
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Figure 4.20  Spectral unmixing confocal imaging to differentiate GFP+ cells from 
erythrocytes. A, B Confocal images showing LV HT1080 GFP+ cells (ZB5 + 3 days after 
seeding) in collagen seeded at CAM surface.  A GFP+ cells seeded at CAM surface in collagen.  
Expanded section shows both human cancer cells (blue arrows) and erythrocytes (red arrows 
in box and white arrows in larger image) which fluoresce green.  B phalloidin only channel 
for A shows that GFP+ cells have actin cytoskeleton (blue arrows) which is not see in 
erythrocytes (red box).  Baseline samples for CAM, DAPI, phalloidin and GFP were imaged 
using spectral confocal settings.  Seeded CAM samples were imaged and the specific 
emission spectra for phallodin, GFP+ and DAPI were extracted.  C erythrocytes show as 
bright yellow discs (white arrows) whereas GFP+ cells (ZB5 + 3 days) are more green and 
irregular in shape (blue arrows) with larger nuceli. The green arrow indicates a dividing GFP+ 
cancer cell. D shows a mix of LV MCF7 GFP+ (D6F2 4 days after seeding) and other chick cells 
in collagen on CAM using spectral filters.  Cancer cells are larger and indicated with blue 
arrows.  Erythrocytes appear yellow/green and are smaller than cancer cells, and there are a 
number of other small green cells within the collagen, for example those indicated with a 
red arrow.  Scale bars for large images: A, B = 50µm and scale bars for C = 25µm.   
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Figure 4.21, LV MDA-MB-231 GFP+ cells, ZB2 clone invading CAM.  Whole CAM imaged at 
low resolution, 4 days after cells were seeded onto scratched CAM.  Staining of whole CAM 
was conducted using phalloidin (red channel) DAPI (blue channel) and an anti-GFP antibody 
to enhance fluorescence of GFP+ cells in the green channel.  Cells can be seen to have 
invaded CAM and are compact/rounded in morphology. A three channels merged, B green 
channel shows GFP cells only, C DAPI, blue channel, D red channel.  Yellow arrows indicate 
the same cells in each image.  Scale bar is 50µm. Images were acquired using a Nikon A1 Plus 
confocal microscope. 
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Figure 4.22,  LV MDA-MB-231 GFP+ ZB2 cells on whole CAM.  Cells can be seen within CAM, 
rounded up and dividing.  Yellow arrows indicate cells in which two nuclei are visible. A 
Yellow arrow indicates two GFP+ cells, one which is dividing and the other seems to be 
attached. B Blue channel for A enlarged to show the nuclei for the same two cells in A 
indicated by the yellow arrow.  C and D show rounded cells in CAM at high magnification.  
Images were taken using Nikon A1 Plus confocal microscope.  A, B scale bars= 25µm,  
C scale bar= 20 µm and D scale bar = 10 µm.  
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Figure 4.23, LV HT1080 GFP+ (A1D9 ) cells invading CAM.  Whole CAM images with anti-GFP 
antibody to enhance GFP of cells against background auto-fluorescence of CAM.  Cells can be 
seen within CAM tissue (white arrows) and blood vessels (yellow arrows).  A three channel 
merged image, B GFP+ cells in green channel, C DAPI staining in blue channel, D phalloidin 
staining in red channel. Scale bars = 50µm.  Images taken using Nikon A1 Plus confocal 
microscope.  
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Figure 4.24, LV HT1080 GFP+ (A1D9) cells invading CAM.  Whole CAM images were taken 
with anti-GFP antibody used to enhance the visibility of GFP cells against background auto-
fluorescence of CAM. 3D reconstructions generated using NIS Elements software with 
dimensions as labelled.  White arrows show rounded cells on CAM.  Blue arrows s how 
elongated/ ovoid cells on CAM.  A shows GFP+ cells on/in CAM at lower magnification and 
cells appear to be well spread. Cells invading CAM are shown at higher magnification in B-D.  
Images were taken using Nikon A1 Plus confocal microscope.   
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Figure 4.25, LV MCF7 GFP+ (DPF5) cells on/in whole CAM.  A  Whole CAM 3D image 
showing rounded and ovoid shaped GFP+ cells at CAM surface.  B GFP+ cells can be seen 
located in blood vessels – yellow arrows.  C GFP+ cells moving through CAM – two pairs of 
cells are indicated by yellow arrows and in D their nuclei (DAPI) are shown squeezing 
through CAM within the yellow circles.  Channels: GFP+ in green, DAPI in blue and phalloidin 
stain for actin in red.  Images taken using Nikon A1 Plus confocal microscope.   
Scale in B=50 µm.  3D scale for C and D is shown below C. 
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4.3.4. Determining a timeline of invasion 
Whilst whole CAM imaging was informative, to be able to observe and investigate the 
timescales of invasion and cell interaction within the CAM in more detail, CAM sections were 
made and then probed using immuno-staining. An example CAM section is shown at Figure 
4.26, labelled to show the different CAM layers and to give some orientation for the figures 
that follow.  LV MCF7 GFP+ cells are shown within all layers of the CAM ECM and are 
compact in shape. 
A timeline for CAM invasion was constructed for LV MCF7 and LV MDA-MB-231 GFP+ cells 
(Figures 4.27-8). In Figure 4.27 LV MCF7 GFP+ D1B6 cells can be seen invading scratched 
CAM with samples spanning a 5 day period shown. By the third day cells can be seen within 
CAM vasculature and have pervaded the CAM ECM well by day 5.  In Figure 4.28 LV MDA-
MB-231 GFP+ XB5 cells are shown at day1-3 and a 5 day sample for ZB2 is also shown.  These 
sections show that cells have invaded CAM within the first 24 hours and are found both in 
CAM ECM and vasculature by day 3.  Figure 4.29 shows sections for CAM that was not 
scratched prior to seeding in which both LV MCF7 GFP+ and LV MDA GFP+ cells were still 
invasive. Figure 4.30 shows that LV HT1080 GFP+ cells were also invasive on non-scratched 
CAM and could be found both in CAM ECM and in the vasculature amongst the chick 
erythrocytes. 
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Figure 4.26, CAM sections showing the layered structure.  The three layered structure of 
CAM is labelled in this section, according to the origin of the layer.  ET (blue star) is derived 
from ectoderm, M from mesoderm and ED from the endoderm. The mesoderm is highly 
vascularised – a blood vessel is labelled V in this section.  Image taken using Nikon A1 Plus 
confocal microscope and shows LV MCF7 GFP+ cells invading CAM (white arrows). 
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Figure 4.27, Timeline for invasion of scratched CAM for LV MCF7 GFP+ cells (D1B6). CAM 
was harvested from eggs at daily intervals, fixed, stained with phalloidin, DAPI and anti-GFP 
antibody to enhance GFP+ cell fluorescence.  Sections were made, mounted and images 
made with Nikon A1 Plus confocal microscope. Samples range from 1 to 5 days after seeding. 
A +1 day sample.  GFP+ cells at surface and beginning to invade CAM (yellow arrows).   
B +2 day sample, GFP+ cells can be seen in CAM tissue (yellow arrow) and close to CAM 
vasculature (blue arrows).  C +3 day sample.  GFP+ cells (yellow arrows) can be seen in CAM 
blood vessel (blue arrows). D +5 day sample. Many GFP+ cells can be seen throughout ECM 
tissue.  Blue star at lower left on A, B, denotes top surface of CAM (See Figure 4.26).  Scale 
bars:  A, D 25µm and B 20µm. 
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Figure 4.28, Timeline for invasion of scratched CAM for LV MDA GFP+ cells. CAM was 
harvested from eggs at daily intervals, fixed, stained with phalloidin, DAPI and anti-GFP 
antibody to enhance GFP+ cell fluorescence.  Sections were made, mounted and images 
made with Nikon A1 Plus confocal microscope. Samples for 1-3 days are from XB5 and 5 day 
sample is ZB2 clone. A +1 day sample.  GFP+ cells can be seen within mesenchymal layer of 
CAM (white arrows).  B +2 day sample, GFP+ cells can be seen throughout CAM tissue (white 
arrow) and within CAM vasculature (yellow arrow).  C.1 + 3 day sample.  One GFP+ cell 
shown close to blood vessel (white arrow) and C.2 Green channel only shows the cell 
morphology in CAM more clearly.  D +5 day sample for ZB2 clone. GFP+ cells can be seen 
located throughout ECM tissue (white arrows).  Scale bars:  B, C 25µm. 
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Figure 4.29, MCF7 and MDA-MB-231 cells were invasive on unscratched CAM.  LV MCF7 
GFP+ cells (DPF5) are shown within CAM A 3 days and D1B6 B 5 days after seeding at CAM 
surface.  LV MDA-MB-231 GFP+ cell are seen 3 days after seeding for YA1 C and ZB2 at D, 
cells indicated with white arrows in CAM tissue and on/in blood vessels with yellow arrows.  
Images were taken with Nikon A1 Plus confocal microscope.  Scale bars A= 20µm,  
C = 50µm and D = 25µm.   
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Figure 4.30, LV HT1080 GFP+ cells invaded without scratching CAM.  A  A1D9 cells 3 days 
after seeding are seen within mesodermal layer of CAM tissue (white arrows).  B ZB5 after 3 
days with GFP+ cells in blood vessel (white arrows) seen amongst erythrocytes (imaged in far 
red channel and appear yellow here), C B696 after 3 days seen within CAM tissue.   
Scale bars = 25µm.  D 3D reconstruction of CAM with no cells stained with anti-GFP 
antibody.  Images taken with Nikon A1 Plus confocal microscope. 
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4.3.5. Migration or colonisation? 
A number of CAM images have shown evidence of cell division of GFP+ cells on or in CAM 
tissue and so to examine proliferation of these cells further, counter staining for the protein 
marker for proliferation, Ki67, was conducted using a far-red secondary antibody and the 
fourth available laser on the Nikon A1 Plus confocal microscope to image CAM tissue 
containing GFP+ cells.  Figure 4.31 A and B show  images of GFP+ cells which seem to be 
dividing within CAM, these having been counter stained with ant-GFP antibody to check 
their provenance.  Figure 4.31 C and D show CAM stained for Ki67 (far red laser shown in 
white) which indicates a number of proliferating (human) cells within the CAM tissue.  
Control images for CAM with no cells seeded for the far red channel are shown at Figure 
4.32. These two pieces of evidence together suggest that human cancer cells were 
proliferating within the CAM tissue. 
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Figure 4.31, Cell division on CAM.  A, B Images of LV HT1080 GFP+ B696 cells immuno-
stained with anti-GFP antibody were captured showing two nuclei within one cell (white 
arrows) which suggested that cells were dividing within CAM.  Further immuno-staining for 
Ki67 for LV MDA-MB-231 cells showed that the Ki67 marker for cell division was expressed in 
cells within CAM (yellow arrows), C and D. Images taken with Nikon A1 Plus confocal 
microscope.  Scale bars = A, B 20µm and C 10µm. 
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Figure 4.32, CAM with no cells seeded stained for Ki67.  A shows the merged image for all 
four channels.  B shows D DAPI in the blue channel, G green channel (no GFP+ cells seen 
here so green is auto-fluorescence only), P phalloidin in the red channel shows CAM 
structure and F is the Far Red channel which shows a small amount of back ground noise 
(yellow).  Confocal images were taken using a Nikon A1 plus microscope.  Scale bars = 25µm.  
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4.4. Discussion 
The chorioallantoic membrane (CAM) of the developing chicken provides a highly 
vascularised extracellular matrix environment with many similarities to human tissue.  This 
living model quickly develops a useful and relevant tissue structure for the study of cell 
interactions within ECM and to visualise and monitor progress of intravasation and 
extravasation of cancer cells added topically.  Used and developed initially for the 
investigation of developmental processes, in more recent years it has been used to explore 
the cell biology relating to disease processes.  The metastatic process has been explored in 
the developing chick embryo model in a number of ways at different times (Kain et al. 2014, 
Ribatti 2010).  In this project, the chick embryo and in particular the CAM, was investigated 
as a potential in vivo model for the exploration of cell-cell and cell-ECM interactions which 
take place as part of the metastatic process.  Ideally the full range of cell morphologies and 
behaviours seen within human cancer metastasis should be represented within the model.  
Using staining techniques and microscopy, cell interactions between seeded human cells and 
human cells and chick cells could be explored with reference to cell morphology and cell 
position on or in the CAM. 
Initial work was carried out in partnership with Dr Alan Burns’ laboratory at University 
College London, in which the chick model is used to study diseases associated with abnormal 
childhood development.  The skills transfer and ideas generated as a result of working with 
both Dr Alan Burns and Dr Jean-Marie Delalande enabled the development of a working 
assay which could be transferred, set up and further explored at the University of Reading . 
The initial results were gained using green fluorescent cells which expressed a myristoylated 
GFP membrane insertion protein, the plasmid for their development having been kindly 
gifted by Dr Mike McGrew of The Roslin Institute, Edinburgh.  However, when these cells 
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were observed on CAM and characterised in vitro, the low levels of GFP expression meant 
that the cells were difficult to identify once within the CAM tissue.  The cell membranes of 
myristoylated GFP+ cells also appeared to be deformed and so they were not a suitable 
representative cell line for the original parent cells.  It was determined that the ideal tool for 
further work would be an invasive/migratory metastatic cell line which could be clearly 
identified above the auto-fluorescence of the CAM.  Based on recent work within other 
laboratories, lentiviral transduced permanently expressing fluorescent cells were likely to 
provide a good GFP+ signal without affecting the cell membrane and so were proposed as a 
good tool to develop for the purpose.  A set of three plasmids which could be assembled to 
make a lentiviral vector for the expression of GFP in the cell cytoplasm was provided for the 
purpose by the Foster laboratory at University of Reading.  The expansion of plasmid stocks, 
creation, infection and production of the GFP lentiviral vector was carried out as part of this 
project, ultimately leading to the transduction of three stock cell lines which could be used 
to investigate invasion and metastasis in CAM these being: MCF7 and MDA-MB-231 breast 
cancer cells and HT1080 fibrosarcoma cells. Clones from these cell lines were clearly visible 
at the CAM surface when seeded however, once within the CAM tissue and vasculature they 
were more difficult to identify.   
Whilst GFP+ cancer cells could be identified for some samples, the natural auto-fluorescence 
of chick tissue and cells was problematic when imaging using fluorophores to differentiate 
between different cells and structures of the assay.  With the available light emission 
spectrum for confocal laser microscopy spanning blue light to far red (400-700nm), four laser 
lines / channels were available to detect fluorophores used for staining and detection.  In 
order to stain the CAM, DAPI and phalloidin were used to identify nuclei and tissue 
structure.  Cancer cells were identified using DAPI (nuclei), phalloidin (actin cytoskeleton) 
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and GFP (cell cytoplasm).  The peak emission and detection channel for each stain used was: 
DAPI: 461nm – blue channel, (enhanced) GFP: 509nm – green channel and phalloidin atto 
565 at 592nm – red channel, leaving the far red channel available for a further stain if 
required.  The extracellular matrix of the CAM auto-fluoresced mainly in the green channel, 
however erythrocytes auto-fluoresced in both green and far red channels.  This meant that 
fluorophores used whose emissions were detected in these channels had to be much 
brighter that the background auto-fluorescence of the CAM and CAM cells.  Unfortunately 
the auto-fluorescence of some CAM cells was similar to the GFP fluorophore emission and so 
it was difficult to differentiate between human and CAM cells.  In particular the chick 
erythrocytes fluoresced brightly in the green channels.  As chick erythrocytes are nucleated, 
they could not be deducted due to lack of nuclei, however as they were also auto-
fluorescent in the far red channel, collecting emissions from all four laser channels meant 
that the erythrocytes could be identified and discounted from images. 
The confocal imaging technique, spectral unmixing was  employed to reduce the confounding 
effect of auto-fluorescence, however,  CAM cells were still detected within the defined filters 
and so they could not be exclusively identified or excluded using this technique.   Other 
research published in which GFP+ cancer cells have been employed within the CAM assay, 
have viewed the cells mainly in the live context.  Where research has entailed the growth of 
a GFP+ tumour at the CAM surface, evidence of the outward migration of cells has clearly 
shown GFP+ cells moving over CAM.  Intravital imaging has been successfully employed to 
conduct fluorescence time-lapse movies in this way and GFP+ cells have been successful in 
their application (Klingenberg et al. 2014, Zijlstra et al. 2008). However, the GFP+ cells have 
an origin in this case and can be tracked from their start point so their provenance is known.  
When searching for GFP+ cells using a green filter in either whole CAM or in sections, the 
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researcher is reliant purely on the emission spectra from the fluorophores used plus cell 
characteristics to determine their provenance.  In fact when reviewing the evidence 
presented by other researchers, specific identification of human cancer cells is always 
necessary, for example using anti-CD44 for the identification of cells in tissue (Zijlstra et al. 
2004).  In the case of this research, the GFP expression alone against the background auto-
fluorescence was insufficient to identify the human cells and had to be augmented by an 
anti-GFP antibody for clear identification.  When further staining was required to probe for 
specific mechanisms with cancer cells, the far red channel could be used but care to exclude 
background auto-fluorescence from CAM and erythrocytes was necessary. 
Cancer cells for all three cell lines, were seen within the CAM and CAM vasculature within 
three days of seeding.  Individual MDA-MB-231 GFP+ cells were seen to adopt a rounded 
compact morphology whether in CAM tissue or vasculature, quite different to the elongated 
mesenchymal morphology seen when the same cells where encapsulated in 1mg/ml 
collagen in vitro.  HT1080 GFP+ cells also adopted a more compact morphology in CAM 
however they were often more irregular in shape as they appeared to be pushing their way 
through the CAM tissue layers.  HT1080 protrusions into the CAM were smoother and more 
rounded than the spikey invasive protrusions for the same cells seen in collagen in vitro.  
MCF7 GFP+ cells used as a control cell line in CAM because in vitro they do not typically 
migrate, were seen to have migrated into CAM tissue and were evident either as individual 
cells or as pairs.  This suggests that in CAM, cells were either migrating together or they were 
dividing, with daughter cells remaining attached to each other following division.  Further 
staining for cell junction proteins such as e-cadherin or keratin would elucidate this 
behaviour.  The MCF7 cells behaviour in CAM was thus different to that seen in vitro.  When 
cultured on a 2D surface, MCF7 cells proliferate to form mounds with cells making tight 
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junctions which can be seen when cells are stained for e-cadherin (Borley et al. 2008), 
however in a 3D environment these cells are known to be more invasive (Nguyen-Ngoc et al. 
2012, Vantangoli et al. 2015).  The CAM provides not only a 3D context but also a whole 
range of growth factors and nutrients which give potential for chemotactic guidance cues for 
cell migration (Berzat and Hall 2010).  Cells from all three lines and clones were seen to have 
invaded throughout the CAM and were seen within CAM vasculature.  From these 
experiments it was not clear whether cells moved mainly down through the CAM from the 
surface or whether they moved into vasculature and then escaped to colonise CAM at 
distant sites.  Both of these behaviours have been reported within the literature.  In a 
recently published paper studying the tumour microenvironment of Burkitt lymphoma on 
CAM, the lymphoma cells were seen to migrate mainly down through the CAM ECM tissue 
(Klingenberg et al. 2014).  In research reported by the Quigley lab, HT1080 cells from 
engrafted tumours were seen to wrap themselves around blood vessels and when GFP+ 
HT1080 cells were injected into the CAM vasculature they were seen to cling to blood vessel 
walls (Deryugina and Quigley 2008b).  Extravasating GFP+ cancer cells were also identified in 
groups in CAM ECM at distant sites, having emerged from blood vessels.  Thus steps involved 
in both intravasation and extravasation have been reported for the CAM assay and it is likely 
that intravasation and extravasation had occurred in these experiments based on the 
location of cells seen both within and near vasculature as well as throughout the CAM within 
just 3-5 days of seeding.  Although a specific quantification of cell morphology of cells that 
had invaded into the CAM was not conducted as part of this project, it is clear from the data 
shown in this chapter that were a number of sections to be made from CAM seeded with 
cells from the three different cell lines and these imaged under the same conditions, that the 
aspect ratio for the cells could be quantified and compared.  Indeed this could be carried out 
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for cells found according to the timeline of invasion as well as for the CAM layer in which 
cells were found. 
In these experiments, cells were found throughout the CAM, regardless of whether the CAM 
surface had been scratched.  This suggests that cells are able to penetrate the CAM ECM and 
or vasculature using their own mechanisms such as matrix metalloproteases to break down 
tissue.  However, it is possible that just the action of placing cells on the CAM could cause 
minor damage to the delicate two celled ectodermal layer at the CAM surface and that this 
is sufficient to aid the cells in their initial invasion.  Indeed, previous research suggests that 
the ectoderm of the CAM is indeed easily susceptible to such injury (Armstrong et al. 1982). 
However, in the developing microenvironment surrounding a tumour, the action of cell 
growth and division and pressure on surrounding tissues may not be dissimilar in nature.  
Within the CAM, there was evidence of an immune response which occurred following the 
addition of human cancer cells, with small nucleated leukocytes seen within the collagen at 
borders around the GFP+ cancer cells.  Evidence of an inflammatory response when either 
wounding the CAM  (Ribatti et al. 1996) or when collagen onplants were added has been 
documented in other research, with the infiltration of leukocytes visible in onplants within 
24 hours of their addition on the CAM (Deryugina and Quigley 2008a, Zijlstra et al. 2006).  
The developing immunity and ability of the chick embryo to generate an immune response 
can be seen as a benefit of using the CAM model providing the opportunity to investigate 
the interactions between immune cells and cancer cells, one that is absent in the 
immunocompromised mouse model for example.  In fact the Burkitt Lymphoma s tudy found 
that chick leukocytes infiltrated the developing lymphoma on CAM providing useful 
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information regarding stromal interactions in the tumour microenvironment (Klingenberg et 
al. 2014).  
With the clear mobility and invasion of cells within the CAM and its vasculature, there is 
potential for the use of the CAM assay as an in vivo model as part of a range of assays to 
investigate metastasis further.  There are many advantages to its use but also a number of 
drawbacks and these are summarised in Table 4.1 below.  When using fluorescent staining 
and probes, careful staining and analysis is important to ensure that the high background 
auto-fluorescence does not interfere with interpretation of data.  For harvested and fixed 
samples, panel staining is possible to identify specific proteins present in interacting cells. 
Cross reactivity with chick antibodies must also be considered and carefully controlled for if 
this approach is taken.   
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Table 4.1, The advantages and disadvantages in using the CAM as an in vivo model to 
study cancer metastasis 
Aspect Advantages Disadvantages 
Time Short and fast development 
time of chick embryo in ovo 
enables many experiments and 
replicates. 
Metastasis is a process that occurs 
over time in the real environment and 
so the establishment and colonisation 
of a metastatic niche in just 5 days is 
too short in real terms.   
Set Up Easy and cheap.  No licence 
required if harvesting within 
75% of development cycle.   
Developing tissue may not respond in 
the same way as established tissue 
surrounding a tumour. 
Equipment Readily available and obtainable 
equipment required - Incubator 
and dissection microscope. 
Ideally need fluorescence microscope 
for live work with camera and 
acquisition software and access to 
confocal microscope for fixed and 
stained tissue. 
Tissue 
Histology 
Living system with all the 
benefits of blood flow and live 
tissue accessible for 
experimentation. CAM is similar 
to human ECM and highly 
vascularised.  Thin and partially 
transparent.  Developing 
immune system allows 
exogenous tissues to be added. 
Tissue auto-fluorescence; 
Inflammatory response when cells are 
added to CAM. 
 
Application Well researched as a vertebrate 
model and can support 
mammalian cells.  Used as an in 
vivo model for a number of 
processes and diseases 
including angiogenesis and 
metastasis. 
For drugs testing: cells / explants 
ideally need to be treated before 
addition to CAM and drugs tested 
could adversely affect CAM and chick 
so that model is compromised. 
 
The interaction of cells with other cells and with the ECM in vivo in this model is challenging 
due to the tissue auto-fluorescence of developing chick and associated tissues. Ex ovo 
approaches to cell study on/in CAM generally require special equipment such as intravital 
microscopy equipment.  Imaging of GFP+ cells on excised CAM was explored as part of this 
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work but even though weighted down or stretched out, samples tended to shrink and 
contract soon after harvesting and so time-lapse imaging was only possible over short 
periods.   Taking the idea of CAM excision further, harvesting and decellularizing CAM was 
considered as a possible option for the study of cell interactions in a 3D environment which 
could be compared and contrasted to interactions seen both in in vivo CAM assay and with 
the in vitro assays already described. 
 Decellularization of tissue is a biomaterials approach that has been taken in recent years in 
the development of allografts and implants for reconstructive surgery, for example in 
skeletal muscle (Fishman et al. 2013) and heart valve development (Theodoridis et al. 2015).  
Decellularized tissues have great potential in providing a biologically relevant three 
dimensional matrix in which to explore cell behaviours and interactions.  Decellularization 
was explored in this project as a method of providing the structure of the CAM in which to 
study cell-cell and cell-structure interactions, without the complication of the chick/CAM 
cells.  This novel approach to studying cancer metastasis using the CAM could provide useful 
insight into the cellular mechanisms involved in cancer metastasis yet benefit from the ease, 
low cost and simplicity of the developing chick embryo environment as a host for the 
provision of sample tissue.  The decellularization of chick chorioallantoic membrane tissue is 
presented in the next chapter as a novel ex vivo approach to link the study of metastasis in 
vivo in the CAM assay to that taken in vitro described in the first chapter. 
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5. Development of Decellularized Tissue as a 3D Context for the 
Exploration of Metastasis  
5.1. Introduction 
Cell culture in two dimensions places cells in an atypical environment in which they lack the 
tissue context and cues of a relevant biological niche.  Many attempts at constructing a 
suitable 3D cell culture environment have been made, frequently using tissue extracts such 
as collagen, or using non-biological matrix materials such as the proprietary Alvetex 
polystyrene scaffold (Reinnervate). However, many of these are either overly simplistic, 
lacking the structure and variable features of a natural matrix or they are unnatural in 
construction and therefore not representative of the live environment.  The ability to image 
cells interacting in a 3D environment is also an important consideration, with any model 
ideally providing the ability to image interactions in real-time as well as post harvesting. 
Tissue engineers have developed a range of approaches to both study and develop artificial 
tissue environments.  Artificial matrices have formed an important part of this development 
but in recent work acellular living tissue has been prepared and used for population as a 
more relevant and host compatible structure.  Tissue engineering using decellularized  tissue 
as a framework for tissue reconstruction is being pioneered in a number of surgical 
specialties including: orthopaedics – cartilage grafting (Schwarz et al. 2012) and 
musculoskeletal reconstruction (Cheng et al. 2014, Fishman et al. 2013); in ophthalmology 
for corneal replacement (Gonzalez-Andrades et al. 2011, Shafiq et al. 2012) and in all or 
partial organ reconstruction such as liver (Mazza et al. 2015), heart valve (Theodoridis et al. 
2015) and the myocardium (Guyette et al. 2016).  A number of different approaches and 
protocols for decellularization have been developed and compared, each tissue offering its 
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own specific features and challenges.  One approach has been the decellularization of whole 
organs such as liver and heart (Crapo et al. 2011, Guyette et al. 2014) and others have 
sought to decellularize tissue sections (Medberry et al. 2013).  Different approaches to the 
decellularization protocol have included the use of osmotic pressure, variation in pH and use 
of chemicals or more typically a combination of all three (Crapo et al. 2011, Guyette et al. 
2014).  Recently decellularization under pressure for whole organs has also been 
investigated as a means of better retaining tissue integrity (Momtahan et al. 2015, Struecker 
et al. 2015).  
Stem cell differentiation based on the cues provided by a decellularized matrix environment 
has been important when exploring the repopulation of material and organs (Gilpin et al. 
2014, Hoshiba et al. 2016).  Where stem cells are able to respond to the matrix and populate 
it in a natural way the resultant artificially produced tissue is likely to be a more robust and 
useful product, especially where donor stem cells are provided by the eventual recipient of 
reconstructed tissue. 
There is an opportunity then to decellularize relevant tissues for use in the study of cancer 
metastasis.  Processes involved in the early stages of metastasis such as cell migration and 
invasion could be studied in this context as well those of metastatic seeding and niche 
colonization relating to the later stages of the development of metastatic disease.   
Surprisingly decellularized tissue has not been used extensively in this field to date, perhaps 
because protocols and tissue integrity of product material are still  being developed.  
However, the relevance of work with these materials has been shown in a recent publication 
in which healthy and diseased human tissues were decellularized, characterized and 
repopulated with metastatic cells, these adhering more readily to the diseased tissue and 
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showing differences in morphology and migration characteristics between the two 
environments (Dunne et al. 2014).  Recently published breast cancer research used 
decellularized lung and liver tissue to explore the speed of invasion and colonization of three 
breast cancer cell lines: MDA-MB-231, MCF7 and 4T1.  The highly mobile lines (MDA and 
4T1) migrated deep into decellularized tissue sections and colonized them well, however the 
MCF7 cells stayed closer to the surface and did not populate the matrix as easily.  The 
researchers also used the matrix to explore the importance of an epithelial-mesenchymal 
transition related protein, ZEB1, in migration and invasion, finding that its reduction lead to 
reduced invasion in the decellularized tissue environment (Xiong et al. 2015).   
The matrix composition of decellularized tissue has also been investigated and utilized in 
tissue colonization studies as an in vivo implant. Recent research used liquefied 
decellularized lung and liver tissue as a coating for an artificial matrix to investigate cancer 
cell response to the decellularized tissue ECM components from diseased (DCM) and healthy 
tissues (HCM).  When implanted, cancer cells colonized the DCM coated artificial matrix 
more quickly and extensively than the matrix coated with HCM (Aguado et al. 2016). 
It is clear from this research that the ECM components of decellularized tissues are 
important for cells colonizing a matrix as they provide biological cues as well as a dynamic 
three dimensional structure.  The composition and contribution of each component to the 
ECM within different tissues is known to vary, each tissue having its own unique tissue 
specific combination (Frantz et al. 2010, Nelson and Bissell 2006).  It is, therefore, important 
to select an appropriate tissue for decellularization and recolonization based on the 
characteristics and features of the niche environment that is to be represented and to carry 
out the decellularization in way that maintains the structure and characteristics of the ECM 
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components of that tissue (Balestrini et al. 2015, Xiong et al. 2015).  The main residual 
components of decellularized lung tissue have been characterized as: collagen IV, fibronectin 
and laminin.  Epithelial ECM typically comprises collagen type 1, fibronectin and laminin and 
these are the main components known to be present in the chick chorioallantoic membrane 
structure (Deryugina and Quigley 2008b, Gabrielli and Accili 2010, Romanoff 1967).   
The aim of this ex vivo section of the project was to assess the potential for the use of 
decellularized tissue as an approach to 3D cell culture in the study of cancer metastasis both 
for the study of invasion and for seeding and colonization of the metastatic niche.  The 
overall aims were to develop decellularization and culture techniques using ECM materials 
relevant to the study of cancer metastasis. 
The initial aim was to use decellularized rat lung provided by the CASE partnership company, 
Natural Biosciences, to establish the best method of preparing decellularized tissue for 
tissue culture purposes and then to facilitate, monitor and assess the extent of colonization 
of cells introduced.  As the lung is a common site for the metastatic spread of breast cancer, 
it was a relevant tissue for the initial testing for the seeding and colonization of breast 
cancer cells.   Methods of sample preparation and microscopy to determine the best 
approach to gather data for interpretation formed an important part of this investigation.  
Once a successful protocol for preparation, seeding and colonization had been established, 
the aim was to develop and optimize a protocol for the decellularization of CAM.  This novel 
approach to the preparation of CAM would provide a second stage assay for the in vivo CAM 
work allowing the further exploration of cell-cell and cell-ECM interactions in a more 
tractable environment and over a longer period of time, in vivo assays being limited to just a 
few days.  The final aim was to extend and modify the decellularization approach for a third 
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tissue type to provide an alternative tissue structure for comparison and contrast with the 
dLung and dCAM and to enable the further study of cell behaviours in different types of ECM 
in the study of cancer metastasis.  
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5.2. Materials and methods 
5.2.1. Decellularization of chick chorioallantoic membrane 
Decellularization was carried out using an adapted protocol based on that published by 
Medberry et al, 2013.  Chorioallantoic membrane of chick eggs was harvested at day 9 or 10, 
and immediately flash frozen flat in liquid nitrogen then stored at -80oC until required. For 
decellularization, frozen CAM tissue was defrosted and placed in double distilled water at 
4oC for 30 minutes. Once drained it was added to pre-warmed 0.02% trypsin (Gibco)/0.05% 
EDTA (Sigma) and stirred at 37oC for five minutes, washed with ddH2O, then soaked in 3% 
Triton X100 for 5-10 minutes, washed twice in ddH2O, soaked in 1M sucrose (Fisher) for 5 
minutes, washed with ddH2O, soaked in 4% deoxycholate (Sigma) for 5 minutes, washed 
twice in ddH2O, soaked in 0.1% peracetic acid/4% ethanol (Sigma/ Fisher) for 5-15 minutes, 
washed twice then soaked in ddH2O for five minutes. Decellularized CAM (dCAM) was then 
freeze dried and stored.   
5.2.2. Decellularization of rat lung 
Decellularized lung was prepared and freeze dried based on the protocol described by 
Medberry and colleagues for bladder tissue (Medberry et al. 2013) by Dr Mark Cranfield of 
Natural Biosciences (PhD CASE industrial partner) using lungs from 12 week old Sprague 
Dawley rats.  The decellularized freeze dried rat lung was used as decellularized material 
(dLung) for seeding cells.  
5.2.3. Decellularization of rat pup skin 
Rat pup skin was harvested from pups at postnatal day 12-13 and frozen.  Defrosted skin was 
treated with Immac (Veet) for ten minutes and hair/fur gently scraped from the surface, 
then cut into squares approximately 1cm2 using blunt ended scissors.  A protocol based on 
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that described by Medberry and colleagues was used as follows: rat skin pieces were stirred 
in double distilled water in a flask at 4oC overnight. Once drained it was added to pre-
warmed 0.02% trypsin/0.05% EDTA  and stirred at 37oC for sixty minutes, washed with 
ddH2O, then soaked in 3% Triton X100 for 70 minutes at room temperature (all steps from 
here were at room temperature), washed twice in ddH2O, soaked in 1M sucrose for 30 
minutes, washed with ddH2O, soaked in 4% deoxycholate  for 60 minutes, washed twice in 
ddH2O, soaked in 0.1% peracetic acid/4% ethanol  for 120 minutes, washed twice then 
soaked in ddH2O for five minutes. Decellularized rat skin (dSkin) was then freeze dried and 
stored.  Prior to use dSkin was placed under a UV lamp for at least 15 minutes for UV 
sterilisation.   
5.2.4. Culture of cells on dCAM 
Decellularized CAM tissue was prepared for use as a growth matrix.  dCAM was cut to size 
and placed in tissue culture labware under a UV lamp for at least 15 minutes for UV 
sterilisation.  Sterile PBS was added and dCAM/PBS placed into a tissue culture incubator at 
37oC / 5% CO2 and left for 1-2 days.  PBS was carefully aspirated and replaced with 
supplemented culture medium suitable for the cells that would be seeded. The tissue was 
returned to the incubator and left for at least 2 days.  Medium was aspirated and either new 
medium (controls) or medium containing cells (experiments) were added to dCAM with just 
enough to cover the tissue.  Plates were returned to the incubator for 2-6 hours until cells 
were seen to be attached to the matrix, then additional medium was added.  The tissue/cells 
were monitored and medium replaced or tissue was transferred to new dishes as required.  
Images were taken to track colonisation using an inverted epifluorescence microscope (Zeiss 
Axio Vert.A1). 
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5.2.5. Culture of cells on dSkin 
Decellularized rat pup skin was prepared in a similar way to dCAM.  Pieces were placed in 
tissue culture labware dishes/plates and placed under a UV lamp for 15-20 minutes for 
sterilisation.  They were soaked in PBS for at least 24 hours and then culture medium for 
another 2 days.  Cell were added and left to adhere and then additional medium was added, 
ensuring the skin samples were completely covered.  These were monitored and medium 
changed every three days.  Samples were harvested, fixed, permeabilized, stained and then 
embedded for sectioning. 
5.2.6. Culture of cells on dLung 
Decellularized rat lung was prepared for use as a 3D culture matrix in a similar way to that 
described for dCAM.  Slices were made using a sterile razor blade and these placed in tissue 
culture labware and sterilized under the UV lamp for 15-20 minutes, or placed in 70% 
ethanol for 5 minutes.  After this PBS was added and plates placed in a tissue culture 
incubator as previously described.  PBS was aspirated after 24 hours and culture medium 
was added.  Samples were left for at least 2 days before cells were added.  Cells were re-
suspended and added in a minimum amount of media to allow for some cells to adhere to 
the tissue surface.  After 2-6 hours depending on cell adhesion, additional medium was 
added.  Cell growth in the scaffold was monitored using an epifluorescence microscopy and 
samples were harvested, fixed and embedded for sectioning. 
5.2.7. Fixing and staining cells and decellularized tissue 
Cells and tissue were fixed with 4% paraformaldehyde/PBS.  Colonized decellularized tissue 
was permeabilized and blocked with 1% TX100/PBS / 10% Goat Serum (Fisher Scientific) 
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overnight.  Colonized tissue was permeabilized and blocked using 0.3%TX100/PBS for at 
least 2 hours.  Immuno-staining was conducted and antibodies were used according to the 
manufacturers recommendations:  Ki67 (abcam 16667, 1:500),  vimentin (abcam RV202 
ab8978, 1:250), keratin (Abcam ab118817 1:200) ecadherin (#3195 cell signalling, 1:200), 
anti-GFP (A11122, Molecular Probes).  Phalloidin atto 565 (Sigma) and a DAPI (Sigma)/PBS 
wash were also used. 
5.2.8. Embedding and sectioning decellularized tissue samples 
Decellularized tissue was soaked in sucrose solution (5% overnight at 4oC, then 15% and 30% 
for 2 hours each at room temperature) then embedded in OCT (Fisher) before sectioning 
(14µm sections) using a Cryostat (Bright Model OTF).  Sections were then stained as 
described above. 
5.2.9. Scanning Electron Microscopy (SEM)  
SEM was conducted for decellularized tissue which was first gold coated using an Edwards 
S150b gold sputter coater, mounted on 12mm carbon discs (AGG334N, Elektron Technology) 
and 12.55mm aluminium stubs (SP12, EM Resolutions) and imaged using a Quanta FEI 600F. 
5.2.10. Confocal microscopy 
A Nikon A1 plus or Nikon A1 confocal microscope was used with either predefined filters (A1 
or A1 plus) or using spectral unmixing (A1 plus), as described in Chapter 4.  
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5.3. Results 
Tissue context plays a vital role in cell behaviour in vivo, therefore the development of 
relevant 3D cell culture systems is important for the intelligent exploration of cell behaviour 
and processes in both healthy and diseased tissue.  Recently, tissue engineering approaches 
have been employed to help develop biologically relevant 3D cell matrix environments.  
Decellularizing tissue is one approach used initially by surgeons seeking to provide better 
alternatives for patients needing reconstructive surgery.  This native acellular environment 
provides a useful and relevant environment for cell culture and the study of cell -cell and cell-
ECM interactions.  The results presented here explore the development and use of three 
decellularized tissue types for the exploration of cancer metastasis. 
5.3.1. Decellularized rat lung as a 3D biological scaffold for cell culture 
Decellularized rat lung provided by Natural Biosciences (CASE industrial partners) was used 
as a 3D growth matrix as a starting point for development of culture protocols and 
microscopy trials.  The structure and surfaces of the dLung were visualized using SEM (Figure 
5.1) to determine that the dLung was indeed cell free and also for later comparison with 
colonized samples.  Two samples were gold coated and imaged.  The sample shown in Figure 
5.1 A and C had surfaces that were smooth and folded, showing the structure of the outer 
surfaces of the lung.  The second sample shown in Figure 5.1 B and D was porous showing an 
open lattice structure containing the many tunnels and surfaces consistent with gas 
exchange in the lung tissue.   
The approach to cell culture started by optimizing the approach to sterilization and seeding 
of cells on the dLung.  Freeze dried decellularized lung tissue was  sliced using a sterile blade.  
Two approaches to sterilization were trialed: samples were either soaked in 70% ethanol or 
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exposed to UV light, each followed by soaking in PBS overnight to wash and rehydrate the 
tissue.  On the first round of seeding cells  resuspended in medium, the cells (LV MDA-MB-
231 GFP+ breast cancer cells) did not appear to adhere to either of the treated tissue 
samples.  The protocol was then amended so that tissue rehydrated in PBS was then soaked 
in complete medium (which contained 10% FBS) for at least a further 48 hours before cells 
were seeded.  This was more successful and cells were re-suspended at a 1:5 ratio with 
sufficient volume added to cover and form a bubble around the decellularized lung tissue 
fragments, around 200µl, giving 1cm2 confluence per application equivalent once cells 
settled and adhered (approximately 1 x 105 cells).  Giving cells sufficient time to adhere but 
keeping cells and tissue covered by the medium, was important to retain cell health and 
tissue integrity, therefore samples were monitored regularly.  Between two and six hours 
provided a good time window of opportunity for this to occur before additional medium was 
added.  As many cells ended up on the tissue culture dish, whilst samples floated freely in 
medium, after 3 days samples were transferred to new dishes using sterile pippette tips.  
This meant that most cells proliferating were on the decellularized tissue and not on the 
base of the tissue culture plate.  Images were taken to determine the extent of colonisation 
of both the UV and the ethanol treated dLung and the extent of colonization compared.  
Figure 5.2 shows images taken of colonized dLung.  Figure 5.2 A and B show images of 
ethanol treated lung, four days after seeding.  GFP+ cells can be seen to adopt both 
elongated and rounded morphologies as they colonize the dLung.  Comparative images 
seventeen days after cell seeding are shown in Figure 5.2 C and D, the UV treated sample 
being well populated compared to the ethanol treated sample which had many un-colonized 
areas.  Whilst both approaches were successful, UV treatment for sterilization was adopted 
as the standard, given that samples were small and the UV light was likely to gain access to 
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the tissue well.  Further colonization experiments were conducted with MDA-MB-231 cells, 
LV MDA GFP+ cells and a co-culture of MDA-MB-231 with LV HT1080 GFP+ (A1D9). 
Figure 5.1, Decellularized rat lung.  Scanning Electron Microscopy was conducted for two 
samples of decellularized rat lung using a Quanta FEI.  A, B Images showing two different 
surfaces presented by decellularized rat lung.  A showed a smoother folded surface, which is 
shown at higher magnification in C.  D shows B at higher magnification this being porous and 
more fibrous in nature.  Scale bars: A and B = 200µm and C and D = 20µm. 
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Figure 5.2, MDA-MB-231 GFP+ cells colonizing decellularized rat lung (dLung). A MDA cells 
on rat lung 4 days after seeding (low magnification) and B at higher magnification.  Cells can 
be seen to adopt a variety of morphologies at the surface of the dLung. Red arrows indicate 
elongated cells and yellow arrows indicate rounded cells (A and B). C dLung 18 days after 
MDA GFP+ cells were added was well colonized – white arrows indicate layers of flattened 
cells forming a covering over the surface. UV light treated sample.  D Ethanol treated sample 
took longer to colonize (pink arrows indicate spaces where little or no colonization has taken 
place).  White arrows indicate areas where MDA GFP+ cells have formed layers on dLung 
surface.  Images were taken using a Zeiss Axio Vert Epifluorescence microscope.  Scale bars 
for A, C, D = 100µm and B = 50µm. 
Decellularized rat lung samples harvested after 21 days looked well colonized externally but 
due to the sample density it was not possible to obtain good images at higher magnification 
at this stage.  Consequently samples were stained, embedded and sectioned for 
fluorescence microscopy to identify the level of colonization throughout the whole dLung 
tissue matrix.  Figure 5.3 shows a cross section of colonized lung tissue with MDA-MB-231 
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cells seeded for 21 days and LV HT1080 GFP+ cells added for the last 4 days. Whilst there a 
number of MDA-MB231 cells had migrated into the lung matrix, there were areas 
completely un-colonized after three weeks of culture.  Higher magnification images in Figure 
5.4 show that cells were able to cluster and form tumour type growths with both cell types 
present.  Phalloidin staining showing the acto-cytoskeleton location shows coterminous 
boundaries for cells which is suggestive of the formation of cell-cell junctions (Figure 5.4 C 
and D – white arrows). 
Figure 5.3, Rat dLung co-culture.  Confocal microscopy of a decellularized rat lung section 
colonized with MDA-MB-231 cells ( after 21 days) shown with DAPI (nuclei – blue) and 
phalloidin stain (actin – red) and LV HT1080 GFP+ (A1D9) cells (after 4 days) – green.  The 
dLung matrix also appears green in the image due to autofluorescence of the collagen 
matrix.  MDA-MB-231 cells can be seen both at the outer surface of the dLung (white 
arrows) and to have moved into the lung tissue (blue arrows) where they can be seen on the 
many surfaces of the open and porous structure. 2-3 LV HT GFP+ cells are seen to have 
adhered to the outer surface (yellow arrows). Nikon A1 Plus confocal microscope image. 
Scale bar = 50µm.  
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Figure 5.4, Decellularized rat lung co-culture shows cell cluster formation comprising both 
cell types.  MDA-MB-231 (MDA) breast cancer cells were cultured for 17 days then LV 
HT1080 GFP+ cells (A1D9) were added and cultured for a further 4 days together on 
decellularized rat lung before fixing, embedding staining and sectioning.  Confocal images 
were taken with a Nikon A1 Plus microscope.  A low magnification image showing both MDA 
cells growing and covering surfaces of dLung.  B 3D reconstruction of a group of cells in 
which both MDA and HT GFP+ cell types appear to be growing together and possibly making 
cell-cell junctions. For A and B white arrows indicate MDA cells and yellow arrows indicate 
HT GFP+ cells. C and D show different slice positions of the same z stack shown in B.  Yellow 
arrows indicate HT GFP+ cells and white arrows indicate possible junctions formed between 
MDA cells. Scale bars: A = 50µm and C and D = 20µm.  
  
158 
 
Immuno-staining was conducted on co-culture samples to test this as an approach in the 3D 
decellularized tissue and to determine whether differences in protein expression could be 
determined in cells growing within the dLung matrix.  Vimentin expression was chosen as 
this expression is usually a marker for epithelial mesenchymal transition with expression 
increased in migrating cells.  Figure 5.5 shows dLung colonized by MDA-MB-231 and LV 
HT1080 GFP+ (A1D9) cells stained for vimentin.  In Figure 5.5 A and C, two GFP+ cells (green) 
can be seen within the lung matrix (indicated with white arrows) and MDA cells stained for 
phalloidin (not green) are seen, indicated with blue arrows.  Vimentin expressions appears to 
be low but visible (Far red laser channel – shown in yellow in B) and is indicated with white 
arrows for the LV HT GFP+ cells.  Vimentin expression in MDA-MB-231 cells is hardly visible 
in comparison (blue arrows). 
Decellularized rat lung tissue thus provided a suitable 3D matrix for cell culture and study 
using confocal microscopy and immuno-staining and allowed the optimisation both these 
techniques.  Given that the protocol for rat lung decellularization had yielded tissue suitable 
for successful 3D tissue culture, the decellularization protocol was used as  a basis for the 
decellularization of chorioallantoic membrane of chick. 
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Figure 5.5, Decellularized rat lung colonized with MDA-MB-231 and LV HT1080 GFP+ 
(A1D9) cells stained for vimentin expression.  Phalloidin is shown in the red channel, GFP+ 
in the green channel and Vimentin in the far red channel – shown yellow.  The dLung tissue 
is blue in these images.  White arrows indicate LV HT1080 GFP+ cells in which vimentin 
expression is clearer and possibly a higher expression levels than in MDA cells is indicated 
with blue arrows.  A combined image.  B vimentin (yellow) and dLung.  C GFP+ and dLung.   
D phallodin, red and dLung.  Images taken with Nikon A1 Plus confocal microscope.    
Scale bars = 20µm.   
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5.3.2. Optimization of decellularization of chick chorioallantoic membrane 
The chick chorioallantoic membrane (CAM) is a delicate extracellular tissue comprising three 
layers and between 30 - 100µm thick (Deryugina and Quigley 2008b).  It has been reported 
that protocols used for decellularization are harsh and can leave damaged material as a 
result (Balestrini et al. 2015).  The approach taken to decellularization of CAM therefore had 
to be sufficient to remove the cells from the matrix but leave the basic collagen matrix intact 
to facilitate its use as a 3D biological scaffold for cell culture and study.  The Medberry 
protocol had proved successful with rat lung decellularization and so was used as a starting 
point for CAM decellularization. The chemicals used in the protocol act to denature proteins 
(trypsin), break up cell membranes and detach proteins from DNA (detergent: Triton-X 100) 
and emulsify fat (deoxycholate) and then clear debris from the tissue (peracetic acid). 
Osmotic pressure also forms part of the protocol with an initial soaking of tissue in water, 
and later a 1M sucrose step to help further disrupt cell integrity. Whilst the general protocol 
is given in section 5.2, optimization of the protocol was conducted over a series of 
experiments, the main details of which are now described. 
Frozen CAM tissue (Figure 5.6 A) was used for decellularization, harvested in line with 
timings for samples used in in vivo experiments.  CAM tissue was therefore frozen for 
decellularization at time points 9-11 days into incubation, that is 1-3 days after cells would 
have been added to the CAM for in vivo experiments.  All steps from the Medberry protocol 
used for rat lung decellularization were retained but the exposure times were shortened 
significantly.  After defrosting CAM tissue, the first step was a water soaking/stirring stage.  
CAM was found to disintegrate if left for more than 2 hours at this stage and too much 
agitation also caused tissue to break up so the protocol was optimised to start with a soaking 
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step of just 30 minutes.  Initial experiments allowed CAM to free float in each of the 
treatment solutions but the CAM tissue became difficult to harvest with much tissue lost 
during the process.  To maintain CAM integrity, keeping CAM tissue flat, adding solutions 
then gently draining them was determined as the best approach.  On this basis a series of 
different receptacles were trialled, the best proving to be a metal colander type sample 
holder such as that shown in Figure 5.6 B.   
 
Figure 5.6, Decellularizing CAM. A frozen CAM tissue prior to decellularization.   
B Metal sample holder used to freeze and process CAM during decellularization.   
Dish diameter = 3.5cm. 
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Scanning electron microscopy was used to examine decellularized CAM at each stage.  
Initially dCAM yield was low and dCAM tissue appeared damaged and stringy, Figure 5.7.  
Keeping the CAM flat whilst treating it and draining it more gently helped to reduce abrasion 
and damage in subsequent preparations.  Staining with DAPI and phalloidin followed by 
fluorescence microscopy was used to identify the extent of decellularization.  Nuclear 
fragments identified by the DAPI stain (blue) were seen within the decellularized tissue in 
some samples (Figure 5.7) but no associated cell structure was evident when viewed in the 
red channel (phalloidin) and green channel (autofluorescence for CAM tissue and cells).  
 
Figure 5.7, Scanning Electron Microscopy for dCAM before protocol optimisation.  A Image 
shows folded and damaged dCAM.  B Shows a higher resolution image with vascular 
structure still evident.  There also appears to be damage to the surface which looks almost 
leaf like.  Red arrows indicate areas of damage and folded or stringy tissue by blue arrows.  
Evidence of original vasculature is indicated with yellow arrows.  Images taken with an FEI 
Quanta.  Scale bars A = 50µm, B = 20µm. 
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To ensure decellularization was complete, two treatment steps were optimized: firstly the 
peracetic acid step, which acts to clear tissue debris.  The time for this step was extended so 
three different soaking times were compared.  SEM and staining followed by fluorescence 
microscopy were used to assess the effects of the different soaking times on the final dCAM 
(Figure 5.9-10).  Results showed that both five and ten minute soaking times gave similar 
results and were sufficient.  The ten minute peracetic acid step was adopted to ensure good 
clearance of debris.  The second optimisation conducted was to increase the trypsinization 
step, the enzymatic action acting to break up proteins within the tissue by cleaving 
polypeptide chains.  The aim of this was to improve the fragmentation of cellular material 
prior to clearance.  
Figure 5.8, Decellularization of CAM – was decellularization complete?  
dCAM was stained with phalloidin (actin – red channel) and DAPI (nucleus – blue channel) 
and confocal / reflectance microscopy used to examine the dCAM tissue to detemine the 
extent of decellularization.  A shows that whilst many areas appeared acellular (for example 
within the red elipse), some cellular material could be present – yellow arrows.  B 
examination at higher resoltion showed some blue stained material within the remaining 
dCAM, likely to be nuclear material.  However, there was no evidence of phalloidin stained 
material remaining, this staining for the actin cytoskeleton of cells and no green 
fluoresecene evident which would indicate CAM cellular tissue.  Images were taken with a 
Nikon A1R confocal microscope. Scale bars are A = 50µm and B = 20µm. 
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Figure 5.9, Optimization of peracetic acid clearance of CAM tissue during decellularization. 
Decellularized tissue was stained with DAPI (blue) and phalloidin atto 565 (red).  Images 
were taken with a Nikon A1 Plus confocal microscope using all four laser channels and 
spectral unmixing conducted using three filters: DAPI, phalloidin and dCAM without stain.  
Figures A and B show dCAM following a full protocol with a 5 peracetic clearance step and C 
and D following the decellularization with a 10 minute clearance with peracetic acid step.  
A shows dCAM using all three filters and B DAPI and phalloidin only. C shows dCAM with all 
three filters and D shows the blue channel only in which anumber of small particles less than 
2µm can be seen (yellow arrows) but none as large as an intact nucleus.  Scale bars = 20µm. 
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Figure 5.10, Scanning Electron Microscopy images for peracetic acid step optimization.  
A and B show images of dCAM following a full decellularization protocol with a 5 minute 
peracetic acid tissue clearance step.  C and D show images for the same protocol but with a 
10 minute peracetic acid step.  Yellow arrows indicate remaining vascular structure. dCAM is 
intact in each case.  Scale bars A and C = 50µm, B and D = 5µm. SEM images were taken 
using a Quanta FEI. 
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5.3.3. dCAM as a 3D Growth Matrix  
CAM was prepared for seeding using the protocol developed and optimized for 
decellularized rat lung.  MDA-MB-231, MCF7 and HT1080 cells were all seeded and cultured 
on dCAM either individually or as a co-culture.  Colonization was easier to monitor with GFP+ 
cells seeded (Figure 5.11 A v B).  
Figure 5.11, Cells seeded on dCAM proliferate over the surface.  Cells were seeded on 
dCAM and survival and proliferation were monitored using an inverted microscope.  
A MDA-MB-231 cells on dCAM 9 days after seeding. B MDA-MB-231 cells and MCF7 GFP+ 
cells on dCAM.  Fluorescence shows MCF7 cells in patches on dCAM surface.  Images taken 
using a Zeiss Axio vert inverted microscope using brightfield and epifluorescence.   
Scale bars = 1mm. 
Once harvested and fixed, colonized dCAM could be imaged either intact to investigate 
interactions between cells or between cells and matrix throughout the tissue or it could be 
sectioned in a similar way to seeded live CAM.  Figure 5.12 shows images of MDA-MB-231 
colonized whole dCAM stained with phalloidin (actin cytoskeleton - red) and DAPI (nucleus – 
blue).  Cells had formed layers over the dCAM which appears green in these images. 
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Figure 5.12, MDA-MB-231 cells colonize dCAM.  Cells appeared to proliferate over the 
dCAM surface forming layers of rounded, flattened cells (yellow arrows). Cells were stained 
with DAPI (nucleus- blue) and phalloidin (actin cytoskeleton- red).  Images were taken with a 
Nikon A1R confocal microscope. A 3D reconstruction of MDA cells on dCAM.  B cross section 
through tissue in which cells appear as layers.  Scale bars: A = 100µm and B = 25µm. 
Differences in colonization habit when cells were co-cultured on dCAM could be seen 
between the two cell lines: MDA-MB-231 and LV MCF7 GFP+ (Figure 5.13).  The MCF7 cells 
formed small groups on dCAM, whereas MDA-MB-231 cells spread out along edges and 
formed flattened patches.  They may also have formed junctions but these were not 
specifically stained for in these experiments.  Cells colonizing dCAM were stained for Ki67, an 
antigen marker expressed during the active phases of the cell cycle(Jonat and Arnold 2011).  
Figure 5.14 shows that a large number of cells stained positively for the proliferation marker 
Ki67, suggesting that these cells were in the active stages of the cell cycle: G1 (Growth 1), S 
(Synthesis), G2 (Growth 2) and M (Mitosis) phases.  Some cells showed no Ki67 nuclear 
staining which suggested they were quiescent, cell cycle phase: G0 (Growth 0).    
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Figure 5.13, dCAM co-culture colonized with MDA-MB-231 and LV MCF7 GFP+ cells.  
Colonized tissue was fixed and stained after 10 days, stained with phalloidin (actin – red 
channel) and DAPI (nucleus – blue channel).  GFP+ cells appear brighter than autofluorescent 
dCAM tissue.  White arrows indicate GFP+ cells and blue arrows MDA-MB-231 cells.  Images 
taken with a Nikon A1R confocal microscope.  A 3D reconstruction of colonized dCAM.  B A 
slice through the 3D construction shown in A.  C higher magnification image showing both 
MDA and MCF7 cells on dCAM.  D Shows a group of LV MCF7 GFP+ cells which have formed 
a group and cell-cell interactions (yellow arrows) on dCAM.  MDA-MB-231 cells are also 
present.  Scale bars: B = 100µm, C and D = 20µm. 
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Figure 5.14, HT1080 cells proliferate over dCAM.  HT1080 cells colonizing dCAM were fixed 
and stained: Ki67 protein marker for proliferation (FITC – green), DAPI for nuclei (blue) and 
phalloidin for actin (red).  White arrows indicate cells which are actively proliferating in 
which green fluoresecence highlights nucleosomes in the nucleus.  Yellow arrows indicate 
cells in which this is absent and these cells were not actively proliferating. A shows a cross 
section through a number of cells populating the dCAM surface in which the majority of cells 
are proliferating.  B 3D rendered image of cells populating dCAM for the same sample and 
experiment. Images were taken using a Nikon A1 plus confocal microscope.   
Scale bar for A = 20µm. 
The results in this section show that chick chorioallantoic membrane can be decellularized 
successfully and the product used for 3D cell culture.  Cells can be imaged successfully 
without the need to embed and section tissue, this enabling cell-cell and cell-matrix 
interactions to be probed without loss of tissue integrity due to the processing associated 
with embedding and sectioning.  
To test the approach further decellularization of a third tissue was investigated, this being 
rat pup skin, an epithelial tissue which could be of interest for colonisation and as a 
comparator for dCAM.  
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5.3.4. Decellularization of rat pup skin (dSkin) 
The same basic protocol for decellularization was used for rat skin (Medberry et al. 2013) 
starting with the original timings and adapting the protocol accordingly.  As epithelial tissue 
is much tougher than CAM, stirring in water overnight was chosen as the first step to start 
the process.  Sample tissue was kept in suspension whilst treated, in comparison to the very 
careful tissue handling of CAM in which tissue was kept flat and drained during 
decellularization.  SEM images for freeze dried whole rat skin versus the resultant 
decellularized rat skin are shown in Figure 5.15 and stained, sectioned images in Figure 5.16.  
Figure 5.15, Rat skin and decellularized rat skin compared via Scanning Electron 
Microscopy (SEM).  A freeze dried sample of whole and decellularized rat pup skin was 
compared using SEM.  A and B show images of whole rat skin.  Yellow arrows indicate fur.  
The skin surface appears textured and uneven.  C and D show decellularized rat skin which 
still shows fibrous material likely to be fur (yellow arrows) but appears smoother (blue 
arrows) in many places. Red arrows indicate breaks in the tissue which may have occurred 
during sample preparation.  Images were taken using a Cambridge S360 SEM.   
Scale bars: A and C = 500 µm, B = 200µm, D = 50µm. 
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Figure 5.16, Sectioned whole rat pup skin compared with decellularized rat skin.   
A 3D rendered image of a section of whole rat skin stained with phalloidin (red) and DAPI 
(blue).  Hair follicles (orange and elongated ovals) and cell nuclei (blue) can be seen clearly 
within this image.  B The decellularized structure has an open honeycomb texture and there 
are no cell nuclei, cells or hair follicles evident in the 3D image. Images taken with a Nikon 
A1R confocal microscope. 
Surface fur was removed from rat skin before decellularization when the protocol was 
repeated.  This allowed SEM images to be taken at closer range due to a more even sample 
texture.  The images in Figure 5.17 show an open meshwork structure similar to that shown 
in Figure 5.16 B.  There was no obvious evidence of cellular material within the sectioned 
skin sample. Following successful decellularization, attempts were made to use dSkin as a 3D 
growth matrix.   However cell seeding onto dSkin was problematic as samples floated easily 
and were difficult to cover with cells.  dSkin pieces were approximately 1cm2 so these were 
fragmented further to attempt to create a greater surface area.   
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Figure 5.17, Rat skin decellularization with rat pup hair removed first.  SEM images taken 
with FEI Quanta show a meshwork of fibres but no obvious cellular structres within the 
decellularized tissue. A scale = 100µm and B scale = 25µm. 
Cells were seeded and samples cultured for 3 weeks alongside dLung samples and then 
harvested, stained, embedded then sectioned.  Initial sections made showed no evidence of 
cell growth within the decellularized matrix however due to the varied surfaces presented 
within the dSkin samples, it is possible that a small number of cells were present but were 
sparse and therefore not found in the sections made and viewed.   
The results from this section show that decellularized tissue from another host and organ 
can be decellularized successfully using the protocol adopted for the decellularization of 
chick chorioallantoic membrane (and rat lung), with adjusted timings.  Overall the results 
reported in this chapter show that decellularized tissue offers an opportunity for 3D cell 
culture in a structured biologically relevant environment.  A range of microscopy images has 
shown both the structure of the matrix and cells interacting with each other and with the 
matrix.  In particular CAM has been decellularized to provide a novel 3D matrix which can be 
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imaged intact once colonized.  The opportunities and implications for these findings is 
discussed in detail in the next section.  
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5.4. Discussion 
Cells operate within a tissue context, their behaviour guided by the extracellular matrix 
structure, mechanical and biological cues from cells and tissue infrastructure and from the 
soluble factors in which they are bathed.  To understand cell behaviour in context, the 
culture and study of cells thus needs to reflect this rich and complex environment (Baker and 
Chen 2012, Pampaloni et al. 2007).  The construction of a three dimensional cell culture 
environment has been attempted in a number of ways in recent research, ranging from 
simple gels using components of the extracellular matrix, through to artificially constructed 
porous matrix products.  However these products lack the natural and varied structure of a 
native extracellular matrix structure.  Recent advances in tissue engineering have explored 
and exploited the decellularization of organs and tissues allowing their repopulation and use 
for the development of allografts and xenoplants for patients.  The opportunity for the use 
of these products for cell culture has also been explored and extended to 3D tissue culture 
where they provide a natural and biologically relevant matrix in which to explore and further 
understand cellular mechanisms in both healthy and diseased tissue (Badylak et al. 2009, 
Brown et al. 2010, Gilpin et al. 2014, Lu et al. 2014).   
The approach to using decellularized tissue within this project enabled the exploration of 
three different tissue scaffolds as 3D culture matrix environments: rat lung, rat skin and 
chick chorioallantoic membrane (CAM).  Due to this novel ex vivo use of the CAM, the 
protocol for decellularization of chick CAM was developed and optimized for the first time 
here with a view to the further investigation of behaviours and interactions observed in in 
vivo CAM experiments. 
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All three tissues were decellularized using a biochemical approach based on the Medberry 
protocol (Medberry et al. 2013) with adaptation and adjustment to minimize tissue damage 
yet still achieve an acellular product.  Scanning electron microscopy and immuno-staining 
were used to confirm that resultant matrix products were indeed cell free.  Recently 
published literature shows that other researchers have adopted similar approaches for 
verifying the absence of cells following decellularization, with the addition in some cases of 
histological staining such as a trichrome assay or haemotoxylin and eosin staining to identify 
the tissue components (Balestrini et al. 2015, Xiong et al. 2015).  In this work as in other 
recent research, DAPI staining has typically been used to confirm that cell nuclei (and 
therefore cells) were absent from the decellularized tissue (Guyette et al. 2014, Xiong et al. 
2015).  In addition some researchers have used a quantitative DNA assay to assess levels of 
residual DNA following decellularization (Crapo et al. 2011, Guyette et al. 2014).  Residual 
DNA can result in an inflammatory response from host cells and is particularly important if 
the decellularized matrix is to be used in vivo (Balestrini et al. 2015).  During the 
development of the decellularization protocol in this work, DAPI and phalloidin staining 
allowed the identification of cell remnants after each trial so that the protocol could be 
suitably refined enabling an intact acellular tissue to be produced.  In their research Xiong et 
al, reporting a ‘DNA smear’ in some samples and optimized their protocol to include a DNAse 
wash step to in the breakdown and removal of these.  This could be adopted as a further 
refinement to the protocols used here. (DNAse was also reported to help remove any 
residual detergent which might complicate seeding.) 
CAM tissue is delicate and easily disintegrated in the early stages of decellularization when 
the protocol was in the early stages of development and optimization.  Tissue handling 
proved to be extremely important especially as chemical treatment made the tissue sticky 
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and as a result it clung both to itself and to anything used to manipulate it.  Placing CAM 
tissue in a suitable receptacle in which it could remain throughout treatment whilst solutions 
and washes were carefully administered and drained resulted in intact decellularized tissue.  
Timings for chemical treatment steps were then optimized to ensure that decellularization 
was complete but using minimum treatment time to avoid unnecessary degradation of the 
residual ECM structure. Freeze dried and rehydrated dCAM proved relatively easy to seed, 
providing it was first soaked in medium containing FBS.  Balestrini et al have also reported 
that washing decellularized tissue in serum helped to remove DNA fragments and so a serum 
wash could be introduced in the preparation of the matrix for cell culture to improve both 
tissue clearing and the initial adhesion of cells when seeding.  dCAM and dLung colonization 
was successful for all cell types used in this work once cell seeding had been optimized.  
dLung was well colonized at the surface after 17 days using an initial seeding density of 
around 1 x 105 cells of however there was still a large amount of uncolonized surface area in 
the deeper lung tissue.   However, Xiong et al achieved a better population rate in just 9 days 
using twice the number of cells, indicating that denser seeding could improve colonization.   
One of the great benefits of using decellularized tissue is well illustrated here in that cell 
population and colonization can continue for as long as is necessary.  The extent of 
colonization can be observed using live microscopy or by harvesting samples in stages to 
monitor progress.  This flexibility in culture time is in sharp contrast to the strictly limited 
time available in live CAM experiments of just 5 days following cell seeding.  In comparison 
to 2D culture however, proliferation of cells in the 3D decellularized matrices was slower and 
cell morphology more consistent to that seen in vivo (Baker and Chen 2012, Kremmer et al. 
1991). 
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Whilst cells seeded on dLung were able to migrate into the porous structure of the tissue in 
these experiments, cells colonizing dCAM appeared to colonize in layers or formed small 
tumours at the surface.  As cells preferentially proliferated over the dCAM surface it may be 
that experiments needed a longer time course to allow cell invasion into the dCAM itself.  
Ki67 staining suggested that during the colonization of dCAM that many cells were actively 
proliferating, however some cells seemed to show no Ki67 staining suggesting that they 
might have entered a quiescent phase of the cell cycle (G0).  Ki67 localization to 
chromosomes in some cells provided evidence of cell mitosis (M) whereas the more general 
nuclear localization of Ki67 in other cells indicated the transcription of ribosomal RNA during 
the active growth and DNA synthesis phases of the cell cycle (Bullwinkel et al. 2006, Scholzen 
and Gerdes 2000).  Again this is a more realistic cell cycle profile for cells in a tissue than for 
that seen in 2D culture where cells are constantly dividing. It is possible that reduced tissue 
elasticity plays a role in the ability of cells to migrate and invade, however whilst atomic 
force microscopy measurements have showed a slight reduction in elasticity following 
decellularization, these matrices are still closer to the live tissue equivalent than gel matrix 
environments such as collagen (softer) or agarose (stiffer) (Wu et al. 2003, Xiong et al. 2015).  
It is clear that decellularized tissue architecture provides a structure which carefully seeded 
cells can inhabit however, in removing the cellular element of the matrix much of the 
dynamic element and response of the tissue is lost.   In live tissue, cells move to 
accommodate each other, breaking and reconnecting at cell junctions (Yap et al. 2007) so 
this is absent initially in the decellularized tissue setting.  However, with careful and 
appropriate cell colonization, a dynamic niche could be recreated which could then be used 
for further studies such as metastatic invasion and colonization.  In addition the biochemical 
components and chemotactic gradients provided within living tissue are also no longer 
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present.  The creation of specific niche environments is very much the focus of tissue 
engineers in their quest to provide tissue and organ grafts using donor decellularized matrix 
and patient cells, so much can be learnt as this field matures. 
As a model for the study of cell migration and colonization the decellularized tissue allows 
the quantification of cell behaviour via either live microscopy or by fixing and staining 
samples for quantification.  Cell morphology could be quantified within the decellularized 
tissue in a similar way to that conducted in the models shown in Chapter 3, by measuring 
length and width of a number of cells and calculating the aspect ratio.  Thus cells seeded 
onto and colonizing the decellularized tissue could be directly compared with those seeded 
in both CAM in Chapter 4 and in the simpler in vitro models described in Chapter 3  allowing 
the behaviour of cells from the same cell line to be directly compared for the different 
model contexts. 
Many researchers working with decellularized tissue have reported that damage to the 
tissue during decellularization process leads to variation in adhesion and colonization as well 
as on occasion either a stiffer or a weaker resultant matrix (Badylak and Gilbert 2008, Crapo 
et al. 2011).  Producing and optimizing protocols for decellularization is therefore important 
as is characterizing the matrix produced.  Further work to stain and characterize the matrices 
produced here would provide necessary information to allow further refinement of 
protocols. 
The results presented for the decellularization and colonization of decellularized matrices in 
this chapter demonstrate the potential of these products as natural 3D scaffolds for tissue 
culture and the study of disease mechanisms and processes at the cellular level.  Table 5.1 
summarizes the advantages and disadvantages associated with their use in this context. 
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The development of a protocol for the decellularization of chick chorioallantoic membrane 
for the first time allows the further use and exploitation of this well characterized model to 
be extended in a novel way for the comparison and characterization of cell behaviour in this 
context.  In addition dCAM has the potential to be used for the probing of specific cell 
behaviours and resultant protein expression as well as to be used as a basis for the ex vivo 
testing of drug compounds (Loessner Daniela et al. 2014).  
In the next chapter, dCAM is used as an ex vivo comparative assay alongside two in vitro 
assays for the investigation of protein expression and drug response in these three different 
culture environments. 
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Table 5.1 Benefits and disadvantages of decellularized tissue for the exploration of cell 
behaviour 
 Advantage Disadvantage 
Preparation Quick - 48 hours from 
harvest 
Takes time to optimize 
protocol 
Extent of Decellularization Optimized protocol should 
provide a good output with 
controls 
Need controls for each 
batch 
Composition Structural composition can 
be left intact to enable the 
study of cell interaction 
with these components. 
Loss of biochemical 
components and cells 
means many of the cues 
stimulating cell behaviour 
are lost. 
Seeding Different cell types can be 
introduced either as a 
monoculture or co-culture. 
Each tissue varies.  dSkin 
proved difficult to populate. 
Colonization More realistic proliferation 
profile and timescales than 
2D tissue culture  
Where tissue is dense this 
can be difficult to monitor.  
Thin sections of tissue (eg 
rat lung) have been 
adopted by some 
researchers (Gilpin et al. 
2014). 
Experimental versatility Tractable and easy to use Batches may vary so need 
quality control for 
components present. 
Harvesting Fixing and staining in line 
with normal tissue culture 
protocols 
Slightly longer times 
needed and slightly higher 
background for immuno-
staining may occur. 
In vivo cell morphologies 
and behaviours replicated? 
Yes  
Visualization More accessible than live 
tissue and less 
autofluorescence 
Thicker and more densely 
populated tissue may still 
need sectioning eg dLung. 
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6. An Integrated Approach to the Study of Metastatic Mechanisms  
6.1. Introduction 
In the previous chapters the development of several different 3D growth matrices has been 
described and presented for the investigation of cell migration and colonisation in the 
context of metastasis.  The 3D contexts developed have included ECM based in vitro assays, 
the in vivo chick CAM model and ex vivo assays using decellularized tissues.  In this chapter 
three of these assays are used to explore the differential expression of intermediate 
filaments in the different 3D contexts.   
Intermediate filaments are known to contribute to cell structure, morphology and 
compartmentalization of organelles within the cell (Fuchs and Weber 1994, Kidd et al. 2014, 
Mendez et al. 2010).  Recent research has also indicated their involvement in cell signalling 
pathways (Ivaska et al. 2007, Kidd et al. 2014).  Intermediate filaments play a role in 
desmosomes, cell-cell junctions which bind cells together enabling tissue to resist shear 
stress (Fuchs and Weber 1994).  In epithelial cells, keratin filaments complex with cadherins 
to form tight junctions and in cardiac and muscle cells the intermediate filament desmin 
plays the equivalent role (Lowery et al. 2015).  Vimentin filaments on the other hand form a 
structural network in migrating cells driving their mesenchymal morphology (Mendez et al. 
2010) and are involved in anchoring moving cells to a substrate through their role in focal 
adhesion complex assembly (Leube et al. 2015, Lowery et al. 2015).  Cells undergoing 
epithelial-mesenchymal transition (EMT) frequently show an upregulation in vimentin 
expression as e-cadherins are lost and cell-cell junctions disrupted (Hanahan and Weinberg 
2011, Onder et al. 2008).  Filamentous vimentin forms a network which contributes to the 
cytoskeletal structure enabling the switch from a tissue resident, polarized epithelial cell to 
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the characteristic elongated mesenchymal morphology of a migrating cell (Lowery et al. 
2015, Mendez et al. 2010, Murray et al. 2014).  Indeed, vimentin has been identified as a 
marker of EMT and also endothelial-mesenchymal transition (EndMT) in disease conditions 
such as cardiac and kidney fibrosis, inflammation and many cancers (Kalluri and Weinberg 
2009, Kidd et al. 2014, Thiery 2002).  The down regulation of e-cadherin, loss of cell-cell 
junctions and cell polarity as cells detach from host tissue and invade into surrounding 
tissue, thus involves changes in the location and function of both keratin and vimentin 
intermediate filaments.  Expression of both vimentin and keratin in these 3D environments 
provide interesting reporters for cellular response to the 3D matrices compared to a two 
dimension tissue culture environment. 
The involvement of intermediate filaments in cell migration and adhesion gives the further 
opportunity to test inhibitors against two kinases known to be involved in the regulation of 
focal adhesions, namely Focal Adhesion Kinase (FAK) and SRC Kinase 1 (SRC) (Huveneers and 
Danen 2009, Li et al. 2002).  Integrin activation of FAK causes auto-phosphorylation of FAK, 
recruiting SRC to form a FAK-SRC complex, the binding of SRC triggering further 
phosphorylation and upregulation of FAK (Huveneers and Danen 2009).  The FAK-SRC 
complex drives both focal adhesion (FA) turnover and the phosphorylation of the focal 
adhesion protein paxillin, which in turn activates Rac1, Cdc42 and other proteins involved in 
driving the formation and extension of membrane protrusions during cell migration 
(Huveneers and Danen 2009, Lawson and Schlaepfer 2013).  Research also indicates a role 
for the FAK-SRC complex in the disassembly of e-cadherin at tight junctions during EMT 
(Schaller 2010).   Cell spreading and focal adhesion turnover and maturation are also known 
to be affected by substrate stiffness (Plotnikov et al. 2012, Schaller 2010, Wehrle-Haller 
2012) as is the expression of vimentin within migrating cells (Mendez et al. 2010, Murray et 
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al. 2014).  Vimentin and keratin expression of cancer cells in different 3D contexts in the 
absence or presence of FAK or SRC inhibitors could therefore help to elucidate cellular 
responses to different niche environments.  
This chapter describes the investigation of vimentin and keratin expression with and without 
FAK and SRC inhibitors, using two different cell lines and three different 3D matrix 
environments developed within this project.    
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6.2. Materials and methods 
6.2.1. Inverted invasion assay 
Cells were trypsinized then seeded into 3.5cm2 microscope dishes (ibitreat – Thistle) and left 
for 1-2 days until cells were 70-80% confluent.  2mg/ml collagen solution was made using 
10X DMEM and 0.5M NaOH to bring to a pH or 7-7.5.  Whole growth medium was used to 
make up the full volume with SRC Kinase 1 inhibitor (Merck Millipore, used at 1µM) or FAK 
inhibitors (Tocris, used at 1µM) added as appropriate. The concentration for the inhibitors 
was chosen based on previous work within the lab which investigated the inhibition of 
invadosome formation in HT1080 cells (Patel 2012).  Growth medium was aspirated and 
collagen was layered over the top of the adherent cells and left to set in a humidified 
incubator at 37oC, 5% CO2.  Whole medium with/without inhibitors was added to each dish 
and these were placed in the incubator for either 1 or 2 days depending on the cell line 
seeded.  Cells were then fixed with 4% PFA/PBS, washed with PBS, permebalized with 0.2% 
TX-100/PBS then stained with phalloidin atto 565 (1:250) and DAPI (1µg/ml) using the 
protocol described in section 2.4.  Confocal images were taken using a Nikon A1 Plus 
microscope and images rendered and measurements taken using NIS Elements software.  
ImageJ software was then used to quantify fluorescence by first summating the protein 
expression for all slices in the Z stack, defining a specific region of interest (ROI) around a cell 
then taking the mean fluorescence for that cell.  For each image the mean fluorescence for a 
background sample was also measured and this value was deducted from the fluorescence 
mean for each cell to give a final corrected value.   
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6.2.2. SRC and FAK inhibited 2D/3D colonisation assay   
A 2D/3D assay (section 3.2.5) was set up by pipetting 2mg/ml collagen at the centre of each 
well of a 12-well tissue culture plate.  Collagen was set up both without inhibitors (control 
wells) or with FAK inhibitor or SRC Kinase 1 inhibitors added both at 1µM (experiment wells).  
Cells were trypsinized and re-suspended in normal growth medium with or without 
inhibitors and these were added to the 2D/3D assay to give a 20% initial confluence once 
cells had settled and adhered.  After 2 hours, time-lapse microscopy was set-up to monitor 
cell proliferation and migration using a Nikon TIE phase contrast microscope with moving 
stage and environmental chamber as described in section 2.5.   
6.2.3. Cell colonization on compressed collagen 
Compressed collagen discs were made according to the protocol described in section 3.2.4 
either without inhibitors (control) or with either FAK or SRC Kinase 1 inhibitors (both at 1µM 
concentration). Compressed collagen discs were first hydrated in medium (with/without 
inhibitors) to prepare them for cell seeding.  Cells from three cell lines were trypsinized from 
25cm2 flasks and re-suspended in medium either with or without inhibitors to give a 1:5 
concentration (where 1ml contains 1cm2 of cells ≈ 1.2 x 105 cells).  Re-suspended cells were 
then seeded onto compressed collagen: 200µl of HT1080 (around 2.4 x 104 cells) or 250µl 
(around 3 x 104 cells) of either MDA-MB-231 or MCF7 cells.  Cells were left to settle for 2 
hours then additional medium was added with/without inhibitors.  Colonization was 
monitored and medium changed every 2-3 days.  Cells/ compressed collagen were harvested 
5 days after seeding, fixed, permeabilized and stained with phalloidin, DAPI and with primary 
antibodies against specific proteins of interest, these being: vimentin (abcam RV202 ab8978, 
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1:250) and/or Ki67 (abcam 16667, 1:500) as described in section 5.2.7.  Alexafluor 647 was 
used as a secondary antibody for vimentin and Alexafluor 488 was used for Ki67.   
6.2.4. HT1080 colonization of dCAM 
dCAM was prepared for seeding as previously described (section 5.2.4).  Cells were 
trypsinized and re-suspended in medium with/without inhibitors.  Cells were seeded and left 
to settle as for the compressed collagen assay described above.  Additional medium 
with/without inhibitors was added and cells left to colonize the dCAM for the required 
number of days.  Medium was replaced every 2-3 days containing inhibitors as required and 
dCAM/cells were fixed, permeabilized and stained in the same way as for compressed 
collagen.   Primary antibodies were used against: vimentin (abcam RV202 ab8978, 1:250) 
and/or Ki67 (abcam 16667, 1:500) and keratin (abcam ab118817 1:200). Secondary 
antibodies used were Alexafluor 647 vimentin/keratin and Alexafluor 488 was used for Ki67. 
6.2.5. Statistics 
Graphpad Prism 6 was used for statistical analyses.  A normality test was conducted to 
determine whether data distribution fitted a Gaussian curve (normal distribution).  The 
statistical test to be used was then selected, either a One-way ANOVA if Gaussian or a 
Kruskal-Wallis test as an alternative non- parametric test.  Where an equal number of 
replicates for each condition was available a two-way ANOVA was conducted to take 
account of variation within each population when comparing replicates within each 
experiment/condition.  Pearson’s test for correlation was conducted to determine whether 
two variables might be correlated: cell aspect ratio and protein expression.  Outcomes of 
statistics are shown in the results section and full tables for each test are shown in Appendix 
E.   
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6.3. Results 
Cells respond and behave according to their surrounding environment and so research into 
cell behaviours is only relevant if it can replicate the environmental characteristics that drive 
the behaviours being studied (Bissell et al. 2003, Hynes 2009).  Providing an appropriate 
context for the study of cell behaviours is therefore important.  Due to the complexity and 
variation within live tissues, not to mention in different disease states and individual 
patients, it is difficult to determine a specific environment to be used.  This section presents 
the results obtained for three different contexts and two different cell lines. 
6.3.1. Cell colonisation and migration in the presence of FAK and SRC kinase 1 inhibitors 
The 2D/3D assay was used to determine the effect of FAK or SRC Kinase 1 inhibitors on cell 
adhesion, colonization and migration for three cell lines: MCF7, MDA-MB-231 and HT1080 
cells.  Time-lapse movies showed that cells adhered and started to colonize in all cases 
(Figure 6.1) but differences in the extent of colonization were difficult to detect due to the 
large area of seeding and difficulty in controlling seeding area so that it was directly 
comparable.  One approach for the comparison of proliferation was to count the number of 
cell divisions during the 22 hour time-lapse period.  However, when this was carried out for a 
sample of cells for each treatment, most cells divided once and the resulting data was 
insufficient for meaningful quantification, therefore this approach was not pursued (data not 
shown).  Whilst differences in cell migration could be quantified using cell  tracking, this 
would not necessarily provide data relating to colonization.  In order to better quantify 
invasion and colonization behaviours, the assay was modified to create an inverted invasion 
assay in which cells were seeded and grown until they were 70-80% confluent and then 
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collagen layered over the cells into which they could invade.  Quantification of invasion 
could then be specifically measured using z-depth analysis. 
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Figure 6.1, Cell colonization of a 2D/3D assay.  Cells from three different cell lines were 
seeded onto a 2D/3D collagen assay either with or without inhibitors for FAK or SRC Kinase 
1.  Cell migration and division were monitored for 22 hours via time-lapse microscopy using 
a Nikon TiE with moveable stage and environmental chamber.  Images shown are for the 
start and finish of the 22 hour period for each cell line.  A, B  MCF7 cells, C, D MDA-MB-231 
cells, E, F HT1080 cells.  Yellow arrows indicate cell groups which have expanded during the 
22 hour period.  Green arrows indicate areas now well populated after 22 hours. Red arrows 
indicate the 2D/3D border. Scale bars = 100µm. 
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6.3.2. Inverting the 2D/3D assay to quantify invasion – inverted invasion assay  
MCF7, MDA-MB-231 and HT1080 cells were seeded and allowed to proliferate on the 2D 
surface until they were at least 70% confluent before layering collagen over the cells and 
allowing them to invade into it.  Invasion into the collagen was then quantified by measuring 
the height of the top of the nucleus from the base of the dish for each cell type both without 
inhibitors (controls) and with either FAK or SRC inhibitors.  Results for MCF7 cells (Figure 6.2) 
showed that the height of the top of the nucleus from the base did vary between controls 
and the experiments with FAK and SRC inhibitors after 2 days, with mean values for 30 cells 
for each of 3 repeats suggesting that nuclei from inhibited cells had pushed up into the 
collagen around 1.5µm further from the dish base than had controls (control = 10.51µm, FAK 
inhibited = 12.03µm, SRC inhibited = 12.08µm). However, the measurements and images 
show that the majority of the cell nuclei were still in touch with the base of the plate and 
therefore could not be deemed to have migrated.  In Figure 6.2 A, nuclei (blue) appear oval 
and grouped, the phalloidin staining showing cytoskeletal protrusions reaching upwards into 
the collagen as well as laterally within the cell layer.  Figure 6.2 B, shows the confluence of a 
typical experiment indicating that cells would have little opportunity to move or proliferate 
in the horizontal plane due to their confluence.   For MDA-MB-231 cells (Figure 6.3) 
measurements of cell nuclei from the baseline for cells invading up into the collagen layer 
indicated that where SRC inhibitor was present, nuclei and therefore cells were more mobile 
and had started to invade into the overlying collagen significantly further than control cells 
(32 cells for each condition were counted and this repeated 3 times, statistical tests giving 
mean distances: control = 7.95, FAK inhibited = 9.12, SRC inhibited = 10.52). However there 
was no significant difference seen between control cells measured and cells with FAK 
inhibitors present in these experiments.  
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Figure 6.2, MCF7 cell invasion into collagen using an inverted invasion assay.  Collagen was 
layered over growing MCF7 cells.  After 2 days, cells were fixed and stained with phalloidin 
and DAPI and confocal images taken with a Nikon A1 plus microscope with a z-stack totalling 
40µm (0.4 µm slices).  NIS elements software was used to render images and measurements 
of height from base were taken for 30 cells per treatment type for each of 3 separate 
experiments (n=3).  A, 3D rendered image showing nuclei stained with DAPI (blue) and the 
actin cytoskeleton stained with phalloidin (red).  Green arrows indicate the base and the 
measurement of nucleus height from base.  B, maximum projection image of cells shows 
that cells formed a layer at the base of the plate.  C, The height of the nucleus for each of 30 
cells for each treatment was measured for each of three experiments.  Graphpad Prism 6 
was used to generate a two-way ANOVA with Dunn’s multiple comparisons test.  
Significance shown:  ** p≤0.01.  Each cell is represented by a point.  Error bars show 
standard error of the mean (SEM).  Scale bar in B = 25µm.   
192 
 
Figure 6.3, MDA-MB-231 cell invasion into collagen measured using an inverted invasion 
assay. Collagen was layered over growing cells.  After 2 days, cells were fixed and stained 
with phalloidin and DAPI and confocal images taken with a Nikon A1 plus microscope with a 
z-stack totalling 40µm (0.4 µm slices).  NIS elements software was used to render images and 
measurements of height of the nucleus from the base were taken for 32 cells per treatment 
type for each of 3 separate experiments (n=3).  A 3D rendered image using z-depth coding to 
show the invasion of nuclei upwards into the collagen layer. White arrows show nuclei that 
have moved 20-30 µm up into the collagen.  B 3D rendered image showing nuclei stained 
with DAPI (blue) and the actin cytoskeleton stained with phalloidin (red).  White arrows 
indicate nuclei which have moved away from the base and up into the collagen layer.  C 
Graph to show the height of the nucleus for each cell for each treatment was measured for 
each of three experiments. Each data point represents one cell.  Graphpad Prism 6 was used 
to generate a two-way ANOVA with Dunn’s multiple comparisons test.  Significance shown:  
** p≤0.01.  Error bars show standard error of the mean. 
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When the inverted invasion assay was used to compare the invasion of HT1080 cells into 
collagen in the absence or presence of FAK or SRC Kinase 1 inhibitors, cell invasion was 
prolific after 2 days and it was therefore difficult to differentiate between individual nuclei 
so cell invasion was measured after just one day.  The z-depth colour coded image shown in 
Figure 6.4 A, shows the extent of cell migration up into the collagen and blue arrows in 
Figure 6.4 B, show examples of DAPI stained nuclei and phalloidin stained cytoskeleton for 
some of these migrating cells.  The height of the top of cell nuclei from the baseline was 
measured for 30 cells for each of three independent experiments.  The graph at Figure 6.4 C, 
shows the results of obtained which suggested that there was a significant difference 
between control and cell invasion with FAK inhibitors, the nuclei of control cells moving 
further up into the collagen than those of cells with FAK inhibitors present (means: control = 
10.70µm, FAK inhibited = 7.11µm, SRC inhibited 11.51µm).  However, when cell nuclei for 
the control cells and cells with SRC inhibitors present were compared the height of nuclei 
from base showed a similar pattern of distribution and the difference was not found to be 
significant.  
Investigation into the effects on these cell lines of the FAK and SRC inhibitors was taken 
further by extending the investigation into the compressed collagen environment. 
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Figure 6.4, HT1080 cell invasion into collagen measured using an inverted invasion assay. 
Collagen was layered over growing cells.  After 1 day, cells were fixed and stained with 
phalloidin and DAPI and confocal images taken with a Nikon A1 plus microscope with a  
z-stack totalling 40µm (0.4 µm slices).  NIS elements software was used to render images and 
measurements of height from base were taken for 32 cells per treatment type for each of 3 
separate experiments (n=3).  A, 3D rendered image using z-depth coding to show the 
invasion of nuclei upwards into the collagen layer. White arrows show nuclei that have 
invaded at least 20µm into the collagen layer.  B, Image shows a slice through a z-stack 
showing nuclei stained with DAPI (blue) and the actin cytoskeleton stained with phalloidin 
(red).  Blue arrows indicate nuclei which have invaded right up into the collagen layer.   
C, The height of the nucleus for each cell for each treatment was measured for each of three 
experiments.  Graphpad Prism 6 was used to generate a two-way ANOVA with Dunn’s 
multiple comparisons test.  Each cell is represented by one data point. Significance shown:  
** p≤0.01 and **** p≤0.0001.  Errors bars show standard error of the mean.   
Scale bar in B = 25µm. 
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6.3.3. Using the compressed collagen 3D environment to investigate vimentin expression in 
the absence and presence of FAK and SRC kinase 1 inhibitors 
The compressed collagen assay, developed as a novel approach to the investigation of cell 
behaviour in the 3D environment, was explored further as a 3D in vitro assay to investigate 
the expression of the intermediate filament vimentin in the absence and presence of FAK 
and SRC kinase 1 inhibitors, these kinases being known to affect cell adhesion, migration and 
invasion.  MDA-MB-231 cells were seeded and allowed to proliferate on compressed 
collagen discs and the level of expression of vimentin quantified after 5 days (Figure 6.5).  
Compared to control cells, vimentin expression levels appeared to be higher in the presence 
of FAK inhibitor (mean and SD values: control: mean, 1994, SD, 1090; FAK: mean, 5168, SD, 
3553 Grays) whereas the standard deviation and population  distribution for control cells 
compared to cells in the presence of SRC inhibitor were similar (SRC: mean, 2882, SD, 2215).  
Cells showed a varied morphology with many rounded cells forming a pavement type 
arrangement on flat areas of the compressed collagen (blue arrows in Figure 6.5, A-C) and 
elongated cells stretched out along edges and in between groups of rounded cells (white 
arrows Figure 6.5, A-C).  For comparison, HT1080 cells were also seeded on compressed 
collagen and results for controls compared with cells with SRC inhibitor present, are shown 
in Figure 6.6 for two independent experiments (n=2).  For the first experiment the mean 
values and data distribution for vimentin expression were similar between the control and 
cells in the presence of SRC inhibitor (Con1 mean: 1310 Grays, SD, 596; SRC1 mean: 1241, 
SD, 360 Grays).  In the second experiment, the mean for the vimentin expression in control 
cells was higher than in the first experiment (Con1: mean: 1310, SD, 596 Grays and Con2 
mean, 2034, SD, 850 Grays) and the cells showed a greater variation in vimentin expression.   
SRC inhibited cells in the second experiment also showed a greater range of vimentin 
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expression and the mean value suggested that there might be a difference between the 
control and cells with SRC inhibitor for this experiment (Con2 mean: 2034, SD, 850 Grays; 
SRC2, mean: 3457, SD, 1762 Grays).   In comparison to MDA-MB-231 cells, HT1080 cells 
appeared to be mainly elongated in regions where they had colonized the compressed 
collagen surface.   
Differential expression of vimentin was further investigated in dCAM colonization 
experiments to enable the comparison of expression across three different culture 
environments: 2D tissue culture plastic, compressed collagen and decellularized tissue 
(dCAM).  
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Figure 6.5, Vimentin expression of MDA-MB-231 (MDA) cells on compressed collagen 
with/without inhibitors for FAK or SRC kinase 1.  Cells were seeded onto compressed 
collagen with/without inhibitors present and allowed to proliferate and colonize the collagen 
for 5 days. Cells and collagen were fixed, stained with phalloidin (red), DAPI (blue) and for 
vimentin (yellow). A Nikon A1 confocal plus was used to acquire image stacks. A 3D rendered 
image showing MDA cells colonizing compressed collagen (green due to reflectance at 
around 500nm).  Cells can be seen to adopt both elongated (white arrows) and rounded 
(blue arrows) morphologies on control samples.  B The z-stack for each image set was 
summated using ImageJ so that vimentin fluorescence could be quantified.  Cells of rounded 
(blue arrows) and elongated (white) morphologies are indicated.  C a region of interest was 
drawn around each vimentin expressing area for a cell (green arows indicate green ROIs) and 
a figure for mean fluorescence was obtained.  A background area was selected and the mean 
fluorescence from this area was deducted for all cells from that image. D Fluorescence for 30 
cells for each treatment for 1 experiment (n=1) was quantified and the mean and standard 
deviation (error bars) for each population calculated. Cells with FAK inhibitor showed higher 
fluorescence than control cells.  Fluorescence is measured based on summated pixel 
intensity in grays (y-axis).  Scale bars = 25µm.  
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Figure 6.6, HT1080 cell colonization of compressed collagen with/without SRC kinase 1 
inhibitor.  Cells were left to colonize compressed collagen for 5 days then fixed and stained 
with phalloidin (red - cytoskeleton) DAPI (blue - nuclei) and vimentin (yellow).  Images were 
taken using a Nikon A1 plus confocal microscope.  Vimentin expression was quantified using 
ImageJ based regions of interest drawn around cells on a summated z-stack for the far red 
channel. A 3D rendered image showing cell colonization – cells were mostly of elongated 
morphology (white arrows A and B). B combined DAPI and vimentin compressed z-stack 
image.  C vimentin only compressed image with ROI drawn around cells (green arrows and 
ROI).  Red arrow indicates the control area used to calculate background fluorescence which 
was then deducted. D Graph showing data from two separate experiments (n=2), each with 
a control and a colonized compressed collagen with SRC inhibitor.  Con = Control, SRC = SRC 
inhibited. Error bars show standard deviation.  Fluorescence is measured based on 
summated pixel intensity in grays (y-axis). Scale bars = 25µm. 
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6.3.4. Vimentin expression using dCAM as a 3D matrix 
Decellularized tissue was proposed as a second novel biomaterial for the culture and 
exploration of cell behaviour in Chapter 5.    dCAM was used here as a comparative 3D 
matrix for the exploration of vimentin expression levels in comparison with the compressed 
collagen assay.  Figure 6.7 shows results for the comparison of vimentin expression for cells 
in 2D, compressed collagen (CC) and on dCAM after deduction for background fluorescence.  
At least 37 cells were sampled for each environment and mean values and standard 
deviation (SD) in Grays were as follows: 2D: mean, 3143, SD 2006; CC: mean, 2034, SD, 
843.6; dCAM: mean, 7372, SD, 7851.  These results suggest that vimentin expression may be 
increased in the 3D dCAM environment for HT1080 cells. 
The response of HT1080 cells to dCAM was further investigated in the absence and presence 
of the SRC Kinase 1 inhibitor.  Figure 6.8 shows results for three independent SRC inhibited 
experiments in which HT1080 cells were seeded and cultured on dCAM in the presence of 
1µM of SRC kinase 1 inhibitor for 5 days.  A control sample from n3 is included for 
comparison against all samples.  Results for vimentin expression indicated that there was a 
significant difference between cells measured for the control sample compared to two of 
the three inhibited samples. Mean values and standard deviation (SD) in Grays were: 
Control: mean, 7372, SD, 7851; SRC n1, mean, 21825, SD, 9372; SRC n2: mean, 3835, SD, 
1551; SRC n3: mean, 14802, SD, 7151. The 3D image (Figure 6.8 A) suggests differential 
expression of vimentin across the dCAM with some cells expressing high quantities of 
vimentin (white arrows) and others barely expressing vimentin at all (green arrows). 
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Figure 6.7, Comparison of HT1080 vimentin expression on 2D plastic (2D), compressed 
collagen (CC) and decellularized chick chorioallantoic membrane (dCAM).  Cells were left to 
colonize CC and dCAM for 5 days then harvested and stained with phalloidin (actin - red), 
DAPI (nuclei - blue) and vimentin (yellow). 2D cells were fixed and stained 1 day after 
seeding directly onto plastic microscopy dishes (ibitreat).  White arrows indicate examples of 
cells expressing vimentin in each of A-C. A Cells dividing in 2D express vimentin.  B cells on 
CC have divided and colonized well and mostly show an elongated cell morphology in this 
summated z-stack image. C cells colonizing dCAM show varied vimentin expression in this 
summated z-stack image. D Graph showing differences in vimentin expression between 2D, 
CC and dCAM.  At least 37 data points are shown for each condition.  The results from 2 
independent experiments were summated for CC.  2D results were taken from 3 technical 
replicates from one experiment and dCAM results were taken by sampling several areas of a 
colonized dCAM from one experiment. Fluorescence is measured based on summated pixel 
intensity in grays (y-axis). Error bars show standard deviation.  Scale bars A-C, 25µm. 
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Figure 6.8, HT1080 expression of vimentin on dCAM in the absence and presence of SRC 
kinase 1 inhibitor.  Cells were seeded on prepared dCAM in the absence and presence of 
SRC Kinase 1 and left to colonize the matrix for 5 days.  Harvested samples were stained with 
phalloidin (actin – red), DAPI (nuclei – blue) and for vimentin (yellow).  Image stacks were 
taken using a Nikon A1 Plus confocal microscope.  ImageJ was used to summate the z-stacks 
and quantify fluorescence.  Three independent experiments were conducted (n1-3) and are 
shown for SRC inhibited samples along with one control sample from experiment 3.  The 
fluorescence for at least 31 cells was quantified for each condition.  Error bars show 
standard deviation. Fluorescence is measured based on summated pixel intensity in grays (y-
axis). 
Figure 6.9 presents a comparison of results for vimentin expression both with and without 
SRC across the three different environments: 2D, CC and dCAM in the absence and presence 
of SRC kinase 1 inhibitor.  The mean values and distribution of the data suggest that in the 
presence of SRC kinase 1 inhibitor, vimentin expression was different when compared across 
the two 3D environments, CC and dCAM (mean and standard deviation (SD) values in Grays: 
2D: mean, 3143, SD, 2006; CC Con: mean, 2034, SD, 843; CC SRC: mean, 2485, SD, 1733; d 
Con: mean, 7372, SD, 7851; d SRC: mean, 13780, SD, 10081). 
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Figure 6.9, Comparison of HT1080 vimentin expression between 2D and 3D environments 
with and without SRC kinase 1 inhibitor.  Vimentin expression for cells seeded on 2D plastic 
microscope dishes (Ibitreat) are shown as a control ‘2D’.  Controls, with no inhibitors, are 
shown for both compressed collagen (CC Con) and dCAM (d Con).  Cells with SRC inhibitor 
are shown for both CC (CC SRC) and dCAM (d SRC).  (Cell numbers for each condition were: 
2D, 82 cells from 3 technical replicates; CC Control, 62 cells and CC SRC 57 cells for 2 
independent replicates; d Con, 37 cells for one experiment; d SRC,  99 cells from 3 
independent replicates.)  Error bars show standard deviation.  
To explore the possibility that vimentin expression might reduce over time, a timeline study 
was conducted for vimentin expression on dCAM.  Figure 6.10 shows the vimentin 
expression results for 4 separate 7 day experiments, compared to one experiment for each a 
1 day and 3 day time point.  These results are compared to 2D vimentin expression.  The 
difference in mean and population spread suggested that there might be a difference in 
vimentin expression seen between 2D and day 1 on dCAM and between Day 1 results and 
results at Day 3 and each result at Day 7 (mean and SD values in Grays: 2D, 2611; Day1, 
6944; Day 3, 2550; Day7 n1, 5727, n2 1309, n3 4381, n4 2207 in Grays). 
203 
 
Figure 6.10, Timeline of vimentin expression for HT1080 cells seeded onto dCAM.  Cells 
were seeded and allowed to proliferate on dCAM for either 1 day, 3 days or 7 days (n1-4).  
Cells and matrix were harvested, stained with DAPI (nuclei-blue), phalloidin (actin-red) and 
vimentin (yellow) and confocal images taken using a Nikon A1 plus microscope.  ImageJ was 
used to summate the z-stacks and quantify fluorescence based on pixel intensity levels 
(grays).  A An example of a summated composite image showing DAPI and vimentin stained 
cells.  White arrows indicate elongated cells expressing vimentin which are defined and 
quantified at C.  B 3D rendered RGB image showing vimentin in the green channel.   
C Summated z-stack image for vimentin only shows defined regions of interest which were 
quantified for this image.  Background fluorescence was deducted based on a sample taken 
which is indicated by the blue arrow. D Graphpad6 was used to generate mean and standard 
deviation values for each experiment (at least 26 cells per experiment). Cells seeded on 2D 
plastic were used as a control for comparison.   Error bars show standard deviation.  Scale 
bars A, C, 25µm. 
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6.3.4.1. Is vimentin expression related to cell morphology? 
The cell morphology of cells inhabiting the different matrix models can be compared with a 
view to characterisation and identification of differential cell behaviours in each context.  
Cell morphology was quantified for cells on dCAM expressing vimentin.  Aspect ratio was 
calculated for each cell and the mean fluorescence level, indicating vimentin expression, 
calculated using ImageJ as shown in Figure 6.10.  This was carried out for three independent 
experiments (n1-3, for 30-33 cells per experiment). The aspect ratio for each cell was plotted 
against its mean fluorescence value for each experiment and these values plotted as a 
scatter plot (Figure 6.11).  A Pearson’s test for correlation was conducted for each cell 
population to determine whether the aspect ratio and vimentin expression levels might be 
related.  The results suggested that for the cells measured for these experiments that there 
was no correlation between aspect ratio and vimentin expression level for any of the three 
populations tested (statistics and confidence intervals (CI) obtained were: n1,  
Pearson r = -0.1414, 95% CI -0.4623 to 0.2122; n2, Pearson r = -0.007052, 95% CI -0.3664 to 
0.3541; n3, Pearson r = -0.1355, 95% CI -0.4727 to 0.2363.  Results tables are given in 
Apendix E.)   
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Figure 6.11, Is vimentin expression related to cell morphology?  The aspect ratio and 
vimentin expression level for at least thirty HT1080 cells cultured on dCAM for 7 days was 
plotted for three independent expeiments.  A n1; B n2; C n3, D n1-3.  Each cell is 
represented by a dot on the scatter plot.  There was no correlation found between aspect 
ratio and mean fluorescence for the populations.  Pearson’s test for correlation was 
conducted using Graphpad Prism 6.  
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6.3.5. Keratin expression in cells seeded on dCAM 
As intermediate filament expression is important in many cellular functions relating to cell-
cell adhesion and cell migration, the differential expression of keratin was also examined.  
Keratin expression was compared for cells seeded onto 2D plastic with the 3D, dCAM 
environment, using one day and seven day time points, Figure 6.12.  Images suggested 
variable expression on dCAM, for example, Figure 6.10 C, and mean and standard deviation 
statistics suggested that there might be a difference between keratin expression at the one 
Day time point when compared to three out of four of the seven day experiments (mean and 
SD values in Grays, 2D: mean, 1896, SD, 1050; 1 Day: mean, 5019, SD, 3506; 7 day n1: mean, 
1789, SD, 1166; 7 Day n2: mean, 2971, SD, 3018; 7 Day n3: mean, 925, SD, 732; 7 Day n3: 
mean, 5489, SD, 4346).  Interestingly, two of the day seven experiments showed populations 
of cells which were generally similarly low in keratin expression (n1, n3) whereas the other 
two showed a much greater range of keratin expression in cells (n2, n4).  Further replicates 
and time point samples would be needed to establish whether there is indeed a significant 
difference in expression over time. 
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Figure 6.12, Keratin expression in HT1080 cells seeded on dCAM at 1 and 7 days. Cells were 
seeded and allowed to proliferate on dCAM for either 1 day, or 7 days (n1-4).  Cells and 
matrix were harvested, stained with DAPI (nuclei-blue), phalloidin (actin-red) and keratin 
(yellow) and confocal images taken using a Nikon A1 plus microscope.  ImageJ was used to 
summate the z-stacks and quantify fluorescence based on pixel intensity levels (grays).  A 
Cells seeded in 2D as a control – keratin expression is indicated in cells by blue arrows. B  An 
example of a summated z-stack image for cells on dCAM. Blue arrows indicate the region of 
interest drawn around cells which was then used for quantifcation of fluorescence for 
keratin expression levels. C 3D rendered image showing keratin expression in some cells 
(blue arrows).  D Graphpad prism 6 was used to determine the means and standard 
deviation for each cell group. 30 cells per experiment and 60 cells for 2D control taken from 
2 technical replicates.  A difference was suggested between Day 1 samples and all except 
one of the Day 7 samples at varying levels of significance.  There was also a significant 
difference between 2D and Day 1 experiments.  Error bars show standard deviation.  Scale 
bars A, B, 25µm.   
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6.4. Discussion 
Cancer metastasis is a complex process involving the escape, transit and colonization of cells 
at new locations away from the primary site.  Metastasizing cells must move through and 
interact with a number of different and varied contexts.  Modelling appropriate conditions in 
which to study metastasis is therefore challenging as tissue contexts and locations will vary 
with each cancer and for each patient.  However, studying metastasis in a biologically 
relevant environment which at least represents the three dimensional extracellular matrix 
structure surrounding cells in tissue, provides a good starting point.  The assays developed 
within this project, three of which are used within this chapter, use ECM materials in 
different ways to recreate a 3D environment in which to study cell invasion, migration and 
colonization. 
The simple 2D/3D in vitro assay was used initially to explore the effects of FAK and SRC 
inhibitors on three different cell lines: MCF7 and MDA-MB-231 breast cancer cell lines (both 
samples originating from metastatic sites) and HT1080 fibrosarcoma cells (originating from a 
primary site).  Both FAK and SRC kinase 1 inhibitors from the same source had been titrated 
and used for cell migration and invasion as part of experiments conducted within the Dash 
laboratory and so were used here at the concentrations previously determined (Patel 2012).  
Ideally a fresh titration would have been conducted as part of this work for each cell line, 
conducted for cells seeded onto and adhering to a thin layer of collagen/fibronectin where 
focal adhesion turnover would be evident and FAK and SRC would be actively expressed in 
migrating cells.  The effectiveness of the FAK and SRC inhibitors could then have been 
assessed using western blotting with antibodies used to determine levels of phosphorylation 
of FAK and SRC in the absence and presence of the inhibitors.  
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In this work, using the previously determined concentrations of each inhibitor, the aim was 
to investigate differences in colonization in the absence and presence of FAK or SRC 
inhibitors, as a means of demonstrating the use of this matrix model in this scenario, by 
seeding cells on and around collagen and monitoring the progression of colonization.  
However, whilst time-lapse microscopy provided data for the analysis and comparison of cell 
migration, it was clear that to monitor colonization required imaging over extensive time 
periods.  Identifying and tracking cells in time-lapse movies as they proliferated to fill the 
visual field, would make correct identification over these timescales challenging.  To enable 
better quantification of cell behaviour, the assay was inverted, providing a more controlled 
environment in which cell invasion could be quantified for each condition.  This approach is 
similar in concept to that described by Artym and Matsumoto in which they s andwiched cells 
between collagen layers creating an enclosed environment in which to observe cell 
behaviour (Artym and Matsumoto 2010). 
The three different cell lines used within this assay showed different invasion characteristics.  
MCF7 cells which do not typically migrate individually, generally remaining in groups when 
they proliferate, showed some indication of early invasion, with nuclei pushing upwards into 
the collagen matrix along with actin protrusions.  Nuclear translocation was not evident for 
cells regardless of the presence or absence of inhibitors, with most cells remaining in contact 
with the base of the plate.  However as these cells are generally invasive rather than 
migratory and may retain their cell-cell junctions as they move collectively, a longer time 
point or a timeline would be necessary to investigate invasive behaviour further (Cheung et 
al. 2013, Friedl and Gilmour 2009).  The nuclei of MDA-MB-231 (MDA) cells on the other 
hand showed evidence of translocation into the overlying collagen layer.  MDA cells do not 
typically form cell-cell junctions however and migrate individually when they interact with a 
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3D collagen context in comparison with MCF7 cells.  Whilst the introduction of both the FAK 
and SRC inhibitors seemed to encourage a slightly greater thrust of nuclei upwards into the 
collagen layer for MCF7 cells, a somewhat different response was evident in the MDA cells.  
In the presence of the SRC inhibitor, MDA cells appeared to commence invasion and 
migration into the overlying collagen to a greater extent than the control cells, however the 
introduction of the FAK inhibitor seemed to make no difference to cell migration.  As FAK 
and SRC are known to form a complex which drives cell motility and focal adhesion turnover, 
one would expect that cell migration might be reduced where both these were inhibited, 
assuming that these inhibitors were acting on their intended targets in these experiments .  
However it is possible that whilst still expressed within MDA cells, focal adhesion proteins 
may not complex to form focal adhesions in the same way as seen on a 2D surface where 
these proteins are inhibited (Fraley et al. 2010).  If the FAK and SRC inhibitors were effective 
and on target in this assay, then it is possible then that the FAK-SRC complex was not the 
driving force for cell migration and invasion in this context and that other drivers of cell 
migration in 3D may counter the effect of inhibition of either FAK or SRC in this environment.  
In contrast to the results for the breast cancer cell lines in this assay, nuclei for HT1080 cells 
with and without SRC inhibitors started to translocate into the overlying collagen layer.  On 
the other hand, where the FAK inhibitor was present cells seemed to be much less mobile 
suggesting a possible role for FAK in the interaction of HT1080 cells with collagen (Menke et 
al. 2001, Zhao et al. 2016).   
Whilst using the FAK and SRC inhibitors did allow the approach to compound testing using 
this model to be demonstrated, without a fresh titration and evidence to show that each 
inhibitor was successfully acting on its target protein, any effects seen cannot be attributed 
to the inhibition of FAK and SRC in these scenarios but only to their presence. 
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This model provided a useful means of comparing cell migration and invasion into collagen 
and it could also be used to quantify cell morphology by measuring the length and width of 
cells and calculating the aspect ratio.  To avoid introducing the confounding factor of cell 
proliferation, the assay could be limited to a maximum of 24 hours.  Cells could also have 
been seeded onto a thin coating of collagen so that they had adapted to the collagen prior to 
layering the thick collagen over the top (Sanz-Moreno et al. 2011). 
Vimentin, a marker for EMT and a protein frequently upregulated in invasive and metastatic 
cells, was used as a reporter for metastatic cell behaviour in the compressed collagen and 
dCAM 3D matrix assays developed within this project.  Vimentin expression for MDA cells 
was similar for control and samples where the SRC inhibitor was present but increased when 
the FAK inhibitor was introduced.  Many of the cells quantified for the MDA control samples 
had adopted a more rounded morphology and although vimentin still appeared to be 
filamentous, the filament network seemed to be more compact and focussed around the 
nucleus. Cells within the samples where the FAK and SRC inhibitors were present had a more 
mixed morphology and this variation could have affected the fluorescence measurements 
made.  Further work to investigate vimentin expression in these conditions with respect to 
aspect ratio would help to clarify this relationship.  The rounded morphology and close 
association of cells in a cobbled arrangement suggests that  MDA cells could have been 
settling  and beginning to differentiate, undergoing Mesenchymal-epithelial transition (MET) 
in response to their 3D environment (Kalluri and Weinberg 2009, Radisky 2005).   The 
rounded cell morphology (Figure 6.4) could indicate an intermediate stage in the MET 
process for these cells, in which the extended filamentous vimentin network characteristic in 
an elongated migrating cell is broken down into shorter fragments and particulate vimentin 
(Lowery et al. 2015).   When HT1080 cells were allowed to colonize compressed collagen 
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they adopted the characteristic elongated, mesenchymal morphology typical of fibroblasts.  
In the presence of the SRC inhibitor, vimentin expression was elevated in the second 
experiment and there was greater variation of expression in both control and SRC inhibitor 
experiments for this pair in comparison to the first experiment pair.  Whilst further 
replicates would help to establish the pattern of vimentin expression in this context, it is 
clear that there was differential vimentin expression even within each context showing 
variation in intermediate filament dynamics in HT1080 cells as cells responded to their 3D 
context.   
Vimentin expression in HT1080 cells for cells in 2D was much lower compared to cells in the 
3D compressed collagen.  Cells seeded in 2D were harvested after 1 day and the HT1080 
cells were still proliferating, were more rounded than on CC and had in general not 
developed the elongated and extensive filamentous network evident in these cells on the 
CC.  It has been demonstrated that the form in which vimentin is expressed: particulate, 
short filaments, long filaments, indicates cell migration behaviour and polarity, particulate 
vimentin occurring at the leading edge of a migrating cell, smaller filaments close to the 
nucleus and the elongated fibrous network extending towards the tail of the elongated cell 
(Lowery et al. 2015).  It has recently been discovered that the solubility of vimentin is 
affected by substrate stiffness and so these two pieces of evidence together suggest that 
variation in vimentin expression seen here is likely to be directly affected by the interaction 
of the HT1080 cells with their 3D context.  As vimentin filaments directly associate with focal 
adhesions and focal adhesions vary in response to substrate stiffness, it is likely that both 
FAK and SRC expression would affect the vimentin expression response in different 
durotactic conditions (Doyle et al. 2015, Fraley et al. 2010, Leube et al. 2015, Murray et al. 
2014, Plotnikov et al. 2012). 
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On dCAM HT1080 cells showed a range of morphologies and vimentin expression levels.   
In the presence of the SRC inhibitor on dCAM, HT1080 cells again displayed differential 
vimentin expression, with two of the three samples showing a greater range and in general 
higher vimentin expression level than the control sample.  An initial analysis of cell 
morphology compared with vimentin expression for HT1080 cells suggested that there was 
no correlation between vimentin expression and aspect ratio, however, there was a great 
deal of variation for both variables and so a much larger sample size would be needed to 
clarify this further.  Whilst decellularized material used was processed in a similar way it is 
possible that some variation existed in the % of components present within the matrix both 
between and with particular samples.  Staining for structural components or proteomic 
analysis would help to quantify this variation and clarify this potential variation further.  As 
variation in component content is inherent within both healthy and diseased ECM (Nelson 
and Bissell 2006), the dCAM is likely to be more biologically relevant as a context in this 
respect.  However, understanding and controlling for this variation is  an important 
consideration when using the 3D matrix in a culture system. 
 It is clear from these results however that cells responded in different ways to their 3D 
matrix context both within and between experimental samples.  With a heterogeneous mix 
of cells seeded at any one time derived from cancer cell lines harbouring a multitude of 
mutations, cell response to context is likely to vary, just as it would for cells escaping a 
tumour.   
Differences evident from the comparison of HT1080 cell behaviour in the three contexts: 2D, 
CC and dCAM – in the presence and absence of the SRC inhibitor, provided a clear example 
of the importance of using different contexts to explore cell behaviour and metastatic 
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mechanisms in context.  Determining a timeline for behaviour for vimentin expression gave 
an early indication that cells may respond differently to their environment over time and 
that the CC and dCAM provided a new opportunity for longer studies into expression and 
inhibition.   
The timeline for the expression of the intermediate filament keratin showed some 
similarities to the pattern seen for vimentin, with an initially elevated expression shown 1 
day after seeding followed by downregulation of keratin in some samples.  Keratin 
expression in epithelial cells is generally diffuse and surrounds the nucleus, except where it 
is involved in desmosomes at cell-cell junctions (Lowery et al. 2015).  In fibroblasts however 
keratin has been shown to exhibit a pattern of expression similar to that of vimentin with a 
fibrous filamental structure extending behind the nucleus towards the back of the moving 
cell and particulate keratin at the leading edge (Lowery et al. 2015).  Keratin and vimentin 
have both been identified together within focal adhesions at the leading edge of keratocytes 
(Velez-delValle et al. 2016) and variable expression of keratin and vimentin within circulating 
tumour cells has been identified as a reporter of EMT status which may be useful for 
prognostic testing (Polioudaki et al. 2015). 
The results from each of the three assays tested here demonstrate that cell behaviour not 
only varies between 2D and 3D contexts but that different 3D contexts can trigger the same 
cell lines to behave differently under similar conditions.  The collagen based inverted 
invasion assay and compressed collagen assay are both similarly homogeneous in content, 
however the elasticity/rigidity of the CC is known to be closer to that of ECM than that of the 
soft collagen used in the inverted invasion assay.   Both of these matrices however lack the 
complexity of ECM and in their simplicity are missing many of the binding sites involved in 
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focal adhesion and integrin binding.  dCAM on the other hand is more complex in both its 
structure and content, with many of the structural components still available for binding (the 
exact content and percentage remaining needing further quantification via proteomic 
analysis).  Whilst the results shown here for CC and dCAM comprise just a few experiments 
to demonstrate proof of principle, there is clearly great opportunity to explore protein 
expression over time within these two assays, allowing as they do for cell culture and 
colonization over protracted periods on the bioengineered 3D matrices . 
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7. Discussion 
7.1. Background 
The mechanisms and progression of cancer metastasis are multi-factorial and complex, 
taking place within a host over months and years.  Given its spontaneity and the temporal 
nature of the process, metastasis is difficult to investigate, observe and model, occurring as 
it does within host tissues long before it is usually detected.   
7.2. Comparable and compatible models of metastasis 
Models of metastasis need to be representative of both the host environment and of the 
cellular changes which initiate and drive the metastatic process.  
This project has sought to develop an approach to modelling metastatic mechanisms in 
three dimensions in vitro using the basic components of the extracellular matrix to create a 
biologically relevant context as a research tool.  In particular the main focus has been on 
modelling of the primary tumour microenvironment and of the metastatic niche.  A unifying 
pipeline of the models discussed and presented in this thesis is given in Figure 7.1, which 
aims to show the main structural features of each model along with its suitability for culture 
and experimentation in order of increasing complexity.  A summary of the properties and 
considerations relating to each level in the diagram is discussed below.   
Starting with simple in vitro experiments based on ECM extracts, the extent to which 
metastatic behaviours seen in vivo could be represented was explored within these models.  
In recent research, simple gel like substrates have been used to either encapsulate cancer 
cells or as a substrate for invasion (Kramer et al. 2013, Sung et al. 2009, Wolf et al. 2009).  
Whilst the components of these gels have been broadly relevant; collagen, fibronectin and 
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laminin all being important components of the ECM; the construction of the 3D context has 
resulted in a soft, unstructured environment.  The initial model explored was based on the 
simple collagen gel invasion assays used by many researchers to explore migration (Kramer 
et al. 2013, Wolf et al. 2009).  By setting ECM components such as collagen or collagen with 
fibronectin in such a way that cells could be observed from multiple perspectives, invasion 
and migration could be explored and quantified at several different levels within the same 
assay: 2D, 3D, 2D to 3D, 3D to 2D and at border zones between the two environments.   
Figure 7.1, A pipeline approach to the experimental modelling of metastasis.  Models are 
presented in increasing complexity: 2D, two dimensional cell migration assay; 3D, three 
dimensional cell migration assay; 2D/3D assay; CC, compressed collagen assay; dCAM, 
decellularized chorioallantoic membrane assay; CAM, chorioallantoic membrane assay.  The 
structural features are listed along with the type of study that the model is suitable for and 
the time frame for its use.  The models can either be selected individually or used to 
compare and contrast cell behaviours accordingly.  
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Border zones are of great interest when exploring metastatic behaviour as cells invading and 
migrating out from a primary tumour must emerge and cross through borders into areas of 
different context and composition.  In vivo, ECM remodelling in the tumour 
microenvironment has resulted in a stiffened matrix and the formation of collagen bundles 
which cells have been seen to use as conduits for escape (Wang et al. 2002).  Epithelial-
mesenchymal transition results in the upregulation of integrin binding and other adhesion 
proteins with which cells can attach at collagen binding sites.  Bundles of collagen fibres thus 
provide tracks which cells can attach to and move along as they migrate away from a tumour 
(Friedl and Wolf 2003).   
The compressed collagen assay adapted in this project for the exploration of metastasis, 
provided a stiffer more complex in vitro model as well as a context in which to explore cell 
behaviours at border zones.  In this assay, cells could be observed as they transitioned 
between regions of different stiffness and context.  A variety of cell morphologies was 
observed ranging from elongated mesenchymal cells to rounded amoeboid morphologies, 
spanning the range described by Friedl and Wolf in their multiscale tuning model of cell 
migration (Friedl and Wolf 2009a).  Whilst homogeneous in components, the compressed 
collagen provided a more compact and structured context with a more biologically relevant 
elasticity and deformability to that of soft uncompressed collagen gels (Artym et al. 2015, 
Jones et al. 2012).  Both the 2D/3D and compressed collagen assay provide a simple highly 
replicable environment which can be manipulated easily for experimental purposes.  
However they both lack the deposited structural component of a 3D matrix constructed by 
cells themselves. 
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The chick CAM assay, well characterized and explored by many researchers, was explored as 
a potential in vivo assay in which to observe and explore the interaction of cells with ECM as 
they escaped their encapsulated collagen patch and migrated away, over and into the CAM 
tissue (Kain et al. 2014, Ribatti 2014).  As cell division and colonization at areas within the 
CAM was observed, mechanisms of colonization relating to a metastatic niche could also be 
investigated.  Whilst this assay had great potential as a tool for investigating the mechanisms 
of metastasis, there were a number of draw backs.  The short development cycle of the chick 
meant that once cells had seeded there was a period of only 6 days in which to allow cell 
dissemination and colonization before harvesting.  Whilst samples could be harvested and 
probed, tissue autofluorescence and a lack of human specific antibodies limited the amount 
of information that could be gleaned directly from this contextual environment. However, 
taking a tissue engineering approach to extract the cells from the CAM ECM and provide a 
cell free structure for colonization and study, allowed the study of metastasis in a relevant 
structural context to be explored for longer periods with better options for visualization and 
staining. 
The use of decellularized tissue for reconstructive surgery and organ replacement has been 
developed and expanded over recent years due to its natural and biologically relevant 
structure and reduced immunogenicity (Cheng et al. 2014, Macchiarini et al. 2014, 
Theodoridis et al. 2015).  As a biologically relevant structure to support 3D cell culture it is in 
many ways ideal, providing it can be decellularized without undue damage and loss of the 
important matrix components and properties (Balestrini et al. 2015, Crapo et al. 2011).  A 
number of different tissues have been decellularized and used in the medical arena and 
some researchers have sought to exploit its structure as a scaffold for the investigation of 
cellular mechanisms and disease conditions (Gonzalez-Andrades et al. 2011, Guyette et al. 
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2014, Hoshiba et al. 2016, Xiong et al. 2015).  Whilst whole organ decellularization allows 
tissue compartments within to support each other and remain intact, small tissue sections 
are more vulnerable to abrasive damage as they are processed (Crapo et al. 2011, Guyette et 
al. 2014).  Decellularization of the CAM ECM required a delicate approach but yielded a 
useful and interesting scaffold for 3D cell culture.  The morphological response of cells in this 
environment was mixed, with both elongated and rounded amoeboid cells observed and 
from a temporal point of view cell culture of more than 7 days could easily be supported.  
The material was easy to set up and manipulate and could be used in a similar way to either 
the compressed collagen or an artificial product such as Alvetex.  However, as a naturally 
derived and highly structured product, the decellularized CAM provides a superior context to 
the more homogenous compressed collagen or the artificial membrane.  Whilst cell 
colonization seemed to take place primarily at the dCAM surface, full colonization was not 
observed for the duration of the experiments conducted.  Further experiments to establish a 
timeline for colonization and invasion would help to determine cell colonization behaviours 
in more detail.  Probing for invasive mechanisms and matrix degradation during colonization 
could help determine how and to what extent migration and invasion is employed by cells as 
they proliferate and take up residence within the decellularized tissue. 
Whilst the elasticity and deformability of the dCAM was not specifically measured as part of 
this project, from other relevant research it is clear that both the stiffness and elasticity of 
the matrix is somewhat reduced (Badylak and Gilbert 2008, Crapo et al. 2011).  Steric 
hindrance may also be an issue with nuclear translocation having been identified as a 
limitation for cells migrating in a constricted environment such as a dense fibrillar collagen 
network (Lange and Fabry 2013, Wolf et al. 2013).  Taking the tissue engineering approach to 
re-population could provide an excellent basis for co-culture experiments using 
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decellularized tissue as the platform and seeding with cells of interest to form a tissue 
section.  This approach could potentially restore the elastic and dynamic properties of the 
ECM allowing it to function as a more relevant biological niche as was recently demonstrated 
in the repopulation of arterial conduits, heart valves and ECM for cardiovascular tissue 
engineering (Moroni and Mirabella 2014, Quint et al. 2011).   
Whilst the use of stably expressing fluorescent cell lines was important when working in 
vivo, allowing the differentiation between CAM and human cells, this was not a necessity 
when working with decellularized CAM tissue.  Where a co-culture model was set up using a 
relevant non-fluorescent cell type for repopulation of the matrix, fluorescently labelled cells 
of interest could be introduced, based on the approaches tested in this project and 
interactions with the re-populated dCAM could be monitored as a timeline experiment over 
periods of days and potentially weeks. 
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7.3. Technical issues and mitigation 
A number of technical issues were experienced during the course of the project.  Those 
issues considered to have had a broader impact are discussed here along with their 
mitigation. 
7.3.1. Mycoplasma  
A mycoplasma infection was identified in the shared tissue culture facilities in the Hopkins 
building at University of Reading during the final months of the project during which some 
experiments were being conducted.   
Mycoplasma is a prokaryote and member of the Mollicutes which infects human cells and 
may be either extra-cellular or intra-cellular, the intracellular phase allowing the bacteria to 
evade both detection and therapies (Drexler and Uphoff 2002).  Mycoplasma does not have 
a cell wall and penicillin is therefore ineffective (Taylor-Robinson and Bebear 1997). 
Resistance to other antibiotics is high and whilst treatment may be possible, cells in culture 
may be adversely affected to the point that they would no longer be viable for experimental 
purposes (Drexler and Uphoff 2002, Stanbridge 1971).  Infection can go undetected during 
tissue culture as the organisms are small and not readily seen when checking cell cultures 
under low magnification.  Continuously cultured cell lines are more at risk due to protracted 
culture and the many opportunities for infection to be introduced during the cell passaging 
process (Freshney 2010, Stanbridge 1971).  Usually introduced into incubators and culture 
hoods via contaminated sources or human exposure, once established mycoplasma infection 
is very difficult to remove and can easily be transferred from one culture to another (Drexler 
and Uphoff 2002, Freshney 2010).  Where facilities and tissue culture equipment is shared 
this can be problematic and the infection can spread quickly. 
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Whilst all infected and potentially infected samples and materials were destroyed, it is 
possible that some of the work conducted in the preceding 2-3 months could have been 
contaminated.  As the infection is largely silent and difficult to qualify without a specific test 
it is uncertain which experiments were affected and it was not possible to repeat all work for 
this period during the timescales available.  Possible evidence of infection was spotted 
during time-lapse quantification of in vitro cell migration experiments for the period in 
question, however cells still proliferated and migrated in a similar way to samples from 12 
month earlier.  To determine the effect a mycoplasma infection may have had on cell 
migration, cell tracking and quantification was carried out and compared for MDA-MB-231 
cells and HT1080 cells.  A set of control samples (30 cells each) for each cell line was tracked 
from much earlier in the project and these compared with the data from three replicates of 
30 cells each conducted in the questionable period before the infection was identified.  No 
significant difference was seen when experiments were compared with controls for either 
cell line for either speed of migration or for distance from start after 8 hours. (Graphs are 
shown in Appendix F.) 
7.3.2. Microscopy 
When observing cell behaviours in context, the properties of the context have an impact on 
the data acquisition and quantification methods used.  Tissue autofluorescence and light 
scattering were both issues encountered during bright field, phase contrast and confocal 
microscopy when working with samples and experiments in three dimensions. 
Tissue autofluorescence arises from the intrinsic properties of tissues and their bi-products 
and can be a confounding factor when trying to use fluorophores as markers to identify 
specific structures and interactions at a cellular and molecular level (Monici 2005).  
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Autofluorescence can also be increased in some samples dependent on the fixation method 
used (Williams et al. 2008).  When working with densely populated tissues such as the chick 
chorioallantoic membrane, components of the extracellular matrix as well as the cells 
contribute to the intrinsic autofluorescence of the tissue.  Autofluorescence from collagen 
and elastin fibres results from light excitation in the 440-480nm range with emission 
detected in the 470-520nm range which conflicts mainly with the emission spectral profile 
for enhanced GFP (eGFP - main emission peak at 509nm) (Billinton and Knight 2001).  eGFP 
(adapted from the wild type GFP for excitation at 490nm) was used within this project as a 
marker to identify either the specific cell type or for the expression of a protein of interest.  
Due to the high content of collagen in the extracellular matrix or collagen substrates used, 
autofluorescence of collagen could mean that differentiating cells against background 
fluorescence was an issue.  Approaches used to mitigate this included confocal imaging in a 
linear rather than parallel fashion for multiple fluorophores, the use of spectral unmixing 
confocal microscopy and reflectance microscopy.   Taking images for each fluorophore using 
laser channels in turn provided a means of capture of all light emitted for the excitation 
range for that laser channel, an image being produced for analysis for each channel in 
question.  This method also eliminated the issue of cross talk between channels which can 
occur when multiple fluorophores are imaged simultaneously. Whilst autofluorescence 
could occur across all channels, the emission spectra for each fluorophore of interest could 
be extracted above the background in most cases.  Spectral unmixing using Nikon A1 Plus 
confocal microscopes also enabled specific emission profiles to be extracted.  In addition, 
the emission spectrum for a control tissue sample could be used to determine the peaks in 
autofluorescence so that they could be deducted or at least considered when analysing data.   
Reflectance microscopy is a way of specifically detecting and creating an image based on 
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reflectance or the back scatter of light from tissues and their structures and it could be used 
to specifically identify components such as collagen to help set cells in context (Artym and 
Matsumoto 2010).  Two different methods of confocal imaging (4 laser channels: blue, 
green, red, far red) using fluorophores in combination with reflectance enabled cells to be 
set in context with up to two fluorophores, using the 488nm excitation laser for reflectance 
rather than to excite fluorophores, thus minimizing background for the 488/green channel.  
Sample harvesting protocols could also be further optimized to reduce autofluorescence, 
given that paraformaldehyde can increase autofluorescence in some tissues and cells; for 
example, alternatives such as a mix of ethanol and methanol could be used for fixation 
(Aubin 1979, Williams et al. 2008). 
When taking images using bright field and phase contrast imaging using an inverted 
microscope, the appropriate phase ring was employed and settings for light levels, gain and 
exposure were adjusted to give the best image possible at the focal point selected.  With the 
light source above the matrix and lens inverted, this meant that cells closest to the lens 
could be seen most clearly however, cells further away from optics and located within the 
3D matrix were more difficult to see and light scatter could hinder the collection of cell 
images with good definition. 
7.3.3. Quantification of 3D assays using 2D analytical methods 
Throughout the work presented here, the quantification methods used have entailed taking 
a two dimensional approach to analysis. 
Where cell tracking has been conducted, tracking has been measured based on movement in 
the x,y plane only, so no account has been taken of fluctuations in z-depth.  Where cells have 
moved so far in the z-plane that they could no longer be differentiated from their context 
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then tracking ceased or they were excluded.  This means if anything that cell migration 
distances have been under reported, however this was consistent throughout the analyses. 
For confocal microscopy where a z-stack image set was collected and a 3D rendered image 
obtained, measurement was taken from base to maximum height.  Measurements of travel 
for cells towards the front of a 3D rendered image will therefore be more accurate than for 
cells towards the rear whose migration distances will be under reported.  When quantifying 
images, mainly cells towards the front of the image were measured for this reason.  
Issues relating to the production and quantification of images for cell migration have been 
highlighted in a recently published review which identifies key considerations for 
experimental design when seeking the correct means of obtaining images and quantifying 
events in a 3D environment (Driscoll and Danuser 2015).  Certainly as technology to obtain 
complex 3D data improves, so too should the means to quantify the data in an appropriate 
manner and these inconsistencies can be removed. 
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7.4. Further work and potential application of methods 
This project allowed the development and novel application of three in vitro 3D matrices 
which have the potential to be used for the exploration and manipulation of cell behaviours 
in a number of different ways.  As demonstrated in Chapter 6, the 2D/3D assay can be used 
innovatively to investigate cell invasion, migration and proliferation.  The compressed 
collagen assay, a more complex and stiffer substrate, could also be used with an inverted 
invasion assay approach.  Both compressed collagen and decellularized tissue could be used 
to culture cells as free floating tissue organoids as described here or they could be used as 
well inserts in a similar way to a Boyden chamber assay.  Decellularized tissue could also be 
anchored into a substrate such as a collagen substrate in a similar way to the approach used 
to anchor compressed collagen.  Flexible arrangements and transfer of set-up attributes 
between these assays would allow the flexible study of different aspects of cell invasion, 
migration and colonization relevant to cancer metastasis and other diseases.  Population and 
seeding with different cell lines, including primary cell lines or new tumour samples would 
enable these matrices to be investigated further as relevant 3D bio-matrices and to glean 
new insights into the behaviours of cells when interacting in these environments. 
The proteomic content and detailed staining of decellularized tissues produced from further 
optimized protocols, would allow both the tissue composition to be determined and 
quantified as well as the damage and changes from the decellularization process to be 
assessed.  A first attempt at solubilizing decellularized CAM using the Medberry protocol for 
hydrogel production (Medberry et al. 2013) yielded partial information of protein content, 
probably due to problems with protein precipitation encountered when trying to solubilize 
the dCAM.  However other recently published research offers new protocols which could be 
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explored and optimized to take this work further (Aguado et al. 2016, de Castro Bras et al. 
2013). 
The assays developed and presented in this work offer the opportunity to take a flexible and 
integrative approach to the study of cell behaviours in 3D with specific pertinence to the 
metastatic process, based as they are on the ECM environment, a tissue environment 
relevant as both a tumour microenvironment and a metastatic niche.  The collagen based 
matrices and the decellularized chorioallantoic chick membrane can all be replicated using 
simple protocols and readily available materials at relatively low cost or could be adapted to 
use alternatives as necessary.  With the option to select and adapt each assay according to 
the exact requirement to be tested, a suite of assays can thus be designed to investigate a 
specific target of interest.  For example other ECM materials can be introduced to the 
compressed collagen and inverted invasion assays at specific percentages to reflect those 
found through proteomic analysis of dCAM.  By manipulating components and content of 
each assay in the context of metastasis, contextual drivers of cell behaviours could be 
explored.   
Batch processing could allow the use of these assays to be scaled up and potentially 
automated for use as a pipeline for probing multiple targets of interest or for testing drugs 
on different combinations of cells in 3D.  Once a protocol for production of a dCAM hydrogel 
was optimized this could be used as either a tissue culture coating (2D or 3D environments) 
or as a base for the anchorage of whole dCAM to allow further development of the use of 
whole dCAM sections for longer timescales for the generation of artificial tissue 
(Decaestecker et al. 2007, Dunne et al. 2014, Edmondson et al. 2014, Loessner et al. 2010).  
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Appendix A 
A1. DMEM constituents (DMEM, low glucose with pyruvate – 31885 Thermo 
Fisher) 
Components Molecular Weight Concentration (mg/L) mM 
Amino Acids 
Glycine 75.0 30.0 0.4 
L-Arginine hydrochloride 211.0 84.0 0.39810428 
L-Cystine 2HCl 313.0 63.0 0.20127796 
L-Glutamine 146.0 580.0 3.9726028 
L-Histidine hydrochloride-H2O 210.0 42.0 0.2 
L-Isoleucine 131.0 105.0 0.8015267 
L-Leucine 131.0 105.0 0.8015267 
L-Lysine hydrochloride 183.0 146.0 0.7978142 
L-Methionine 149.0 30.0 0.20134228 
L-Phenylalanine 165.0 66.0 0.4 
L-Serine 105.0 42.0 0.4 
L-Threonine 119.0 95.0 0.79831934 
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Components Molecular Weight Concentration (mg/L) mM 
L-Tryptophan 204.0 16.0 0.078431375 
L-Tyrosine 181.0 72.0 0.39779004 
L-Valine 117.0 94.0 0.8034188 
 
Vitamins 
Choline chloride 140.0 4.0 0.028571429 
D-Calcium pantothenate 477.0 4.0 0.008385744 
Folic Acid 441.0 4.0 0.009070295 
Niacinamide 122.0 4.0 0.032786883 
Pyridoxine hydrochloride 206.0 4.0 0.019417476 
Riboflavin 376.0 0.4 0.0010638298 
Thiamine hydrochloride 337.0 4.0 0.011869436 
i-Inositol 180.0 7.2 0.04 
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Inorganic Salts 
Calcium Chloride (CaCl2-2H2O) 147.0 264.0 1.7959183 
Ferric Nitrate (Fe(NO3)3"9H2O) 404.0 0.1 2.4752476E-4 
Magnesium Sulfate (MgSO4-7H2O) 246.0 200.0 0.8130081 
Potassium Chloride (KCl) 75.0 400.0 5.3333335 
Sodium Bicarbonate (NaHCO3) 84.0 3700.0 44.04762 
Sodium Chloride (NaCl) 58.0 6400.0 110.344826 
Sodium Phosphate monobasic (NaH2PO4-2H2O) 154.0 141.0 0.91558444 
Other Components 
D-Glucose (Dextrose) 180.0 1000.0 5.5555553 
Phenol Red 376.4 15.0 0.039851222 
Sodium Pyruvate 110.0 110.0 1.0 
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A2. Qiagen mini-prep and giga-prep kits 
Qiagen mini-prep kit used: QIAprep Spin Miniprep Kit  
The miniprep kit was used according to manufatureres instructions fol lowing the Qiagen 
Qiaprep Miniprep Handbook 2012. 
Briefly: 
1. Overnight cultures were harvested and the pellet resuspended in resuspension buffer 
P1. 
2. Lysis buffer P2 was added and mixed gently to produce a viscous solution.  
3. Precipitation buffer N3 was added and mixed gently but thoroughly. 
4. The precipitate solution was centrifuged for 10 minutes at 3000 x g in a spin column 
and collection tube.  This was conducted to pellet separate genomic DNA and cell 
debris from plasmid DNA. 
5. The bound plasmid DNA was washed in the spin tube. 
6. The plasmid was eluted from the spin column using double distilled water and stored 
at -80oC. 
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Plasmid Giga Kit (12191) 
The kit was used according to the manufacturer’s instructions contained in the EndoFree 
Plasmid Purification Handbook provided with the kit (2013). 
Briefly: 
1. An overnight bacterial culture was harvested by pelleting at 6000 x g for 15 minutes 
at 4oC. 
2. The bacterial pellet was resuspended in buffer P1. 
3. Buffer P1 and P2 were mixed in equal quantities at room temperature for 5 minutes 
to lyse the bacteria. (LyseBlue was added as an indicator to show lysis.) 
4. Buffer P3 was used to precipitate the plasmid DNA.  It was added, mixed and left to 
incubate for 30 minutes. 
5. The precipitate mix was then filtered to remove cell debris, genomic DNA and other 
extraneous material.  It was added to a filter cartridge, left to incubate for 10 minutes 
then filtration achieved with the aid of a vacuum pump. 
6. The eluent was treated with an endotoxin removal buffer and incubated on ice for 30 
minutes. 
7. The Qiagen tip was equilibrated with buffer QBT. 
8. The supernatant containing plasmid was added to the Qiagen tip and left to bind to 
the column for 10 minutes. 
9. The Qiagen tip and its contents were washed with a wash buffer and then plasmid 
DNA eluted using an eluting buffer and a vacuum pump. 
10. The DNA was precipitated from the eluent using isopropanol followed by 
centrifugation for 30 minutes at 15,000 x g at 40C. 
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11. The supernatant was removed, the pellet washed with 70% ethanol then the pellet 
air dried. 
12. The pellet was re-suspended in TE buffer, aliquoted and frozen at -80oC. 
 
Buffers Used: 
P1 – Resuspension Buffer – 50mM Tris-Cl, pH 8.0; 10mM EDTA; 100µg/ml RNase A 
P2 – Lysis Buffer – 200mM NaOH, 1% SDS (w/v) 
P3 – Neutralization Buffer – 3.0M potassium acetate, pH5.5 
Filter Wash Buffer – 1M Potassium acetate pH 5.0 
Tip Equilibration Buffer – 750mM NaCl; 50mM MOPS pH 7.0; 15% isopropanol (v/v); 0.15% 
Triton X-100 (v/v) 
Tip Wash Buffer – 1.0M NaCl; 50mM MOPS pH 7.0; 15% isopropanol (v/v). 
Tip Elution buffer – 1.25M NaCl; 50mM TrisCl, pH 8.5; 15% isopropanol (v/v). 
TE Buffer – 10mM Tris-Cl, pH 8.0; 1mM EDTA. 
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Appendix B  
B1. 2D coatings 
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B2. 3D collagen 
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B3. Collagen/fibronectin (MDA-MB-231) 
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B4. 2D/3D assay 
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B5. 2D coatings: fibronectin/collagen/Matrigel 
MDA-MB-231 Cells – Distance to Start 
Table Analyzed D2S all     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary 
Signif icant
?  
Interaction 28.17 0.0409 * Yes  
Cells 8.220 0.7080 ns No  
Coating 7.688 < 0.0001 **** Yes  
ANOVA table SS DF MS 
F (DFn, 
DFd) P value 
Interaction 177157 58 3054 
F (58, 165) 
= 1.432 P = 0.0409 
Cells 51693 29 1783 
F (29, 165) 
= 0.8359 P = 0.7080 
Coating 48350 2 24175 
F (2, 165) 
= 11.34 P < 0.0001 
Residual 351852 165 2132   
Number of missing values 15     
Compare column means (main column 
effect)     
Number of families 1    
Number of comparisons per family 3    
Alpha 0.05    
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. 
Signif icant
? Summary 
Fibronectin vs. Collagen  28.67 11.71 to 45.62 Yes *** 
Fibronectin vs. Matrigel 29.17 13.00 to 45.33 Yes **** 
Collagen vs. Matrigel 0.4985 -16.46 to 17.46 No ns 
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen  79.60 50.94 28.67 7.191     
Fibronectin vs. Matrigel 79.60 50.44 29.17 6.857 90 90 4.745 180 
Collagen vs. Matrigel 50.94 50.44 0.4985 7.191 90 90 6.531 180 
     90 90 1.786 180 
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MDA-MB-231 cells - speed 
 
Table Analyzed Speed     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Signif icant?  
Interaction 6.304 < 0.0001 **** Yes  
Cells 0.9150 0.1285 ns No  
Coating 38.39 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 0.5086 4 0.1272 F (4, 246) = 7.128 
P < 
0.0001 
Cells 0.07383 2 0.03691 F (2, 246) = 2.069 
P = 
0.1285 
Coating 3.098 2 1.549 F (2, 246) = 86.82 
P < 
0.0001 
Residual 4.388 246 0.01784   
Number of missing values 15     
Compare column means (main 
column effect)     
Number of families 1    
Number of comparisons per 
family 3    
Alpha 0.05    
Tukey's multiple comparisons 
test Mean Diff. 95% CI of diff. Signif icant? Summary 
Fibronectin vs. Collagen  0.1947 0.1454 to 0.2439 Yes **** 
Fibronectin vs. Matrigel 0.2625 0.2156 to 0.3095 Yes **** 
Collagen vs. Matrigel 0.06788 
0.01865 to 
0.1171 Yes ** 
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen  0.4446 0.2499 0.1947 0.02088 90 90 8.799 180 
Fibronectin vs. Matrigel 0.4446 0.1820 0.2625 0.01991 90 90 11.50 180 
Collagen vs. Matrigel 0.2499 0.1820 0.06788 0.02088 90 90 2.697 180 
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MDA-MB-231 cells – aspect ratio 
Table Analyzed Aspect Ratio     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation 
P 
value P value summary Signif icant?  
Interaction 12.36 0.4411 ns No  
Cells 7.037 0.2683 ns No  
Coating 48.84 
< 
0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 95.12 58 1.640 F (58, 165) = 1.025 
P = 
0.4411 
Cells 54.17 29 1.868 F (29, 165) = 1.167 
P = 
0.2683 
Coating 376.0 2 188.0 F (2, 165) = 117.5 
P < 
0.0001 
Residual 264.0 165 1.600   
Number of missing values 15     
Compare column means (main column effect)       
Number of families 1        
Number of comparisons 
per family 3        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 95% CI of dif f . Signif icant? Summary     
Fibronectin vs. Collagen  -2.151 -2.619 to -1.683 Yes ****     
Fibronectin vs. Matrigel 0.7487 0.3027 to 1.195 Yes ***     
Collagen vs. Matrigel 2.900 2.432 to 3.367 Yes ****     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen  1.953 4.104 -2.151 0.1978 90 75 15.38 165 
Fibronectin vs. Matrigel 1.953 1.205 0.7487 0.1886 90 90 5.615 165 
Collagen vs. Matrigel 4.104 1.205 2.900 0.1978 75 90 20.73 165 
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HT1080 cells - distance to start 
Table Analyzed HT1080 D2S     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Signif icant?  
Interaction 20.51 0.3170 ns No  
Cells 14.18 0.0534 ns No  
Coating 7.338 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 83594 58 1441 F (58, 180) = 1.098 P = 0.3170 
Cells 57795 29 1993 F (29, 180) = 1.518 P = 0.0534 
Coating 29911 2 14956 F (2, 180) = 11.39 P < 0.0001 
Residual 236310 180 1313   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. Signif icant? Summary     
Fibronectin vs. Collagen 18.12 
5.357 to 
30.89 Yes **     
Fibronectin vs. Matrigel 24.94 
12.18 to 
37.71 Yes ****     
Collagen vs. Matrigel 6.820 
-5.944 to 
19.58 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen 64.62 46.50 18.12 5.401 90 90 4.745 180 
Fibronectin vs. Matrigel 64.62 39.68 24.94 5.401 90 90 6.531 180 
Collagen vs. Matrigel 46.50 39.68 6.820 5.401 90 90 1.786 180 
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HT1080 cells - speed 
Table Analyzed HT1080 Speed     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Signif icant?  
Interaction 10.98 0.9926 ns No  
Cells 5.673 0.9519 ns No  
Coating 23.88 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 0.6117 58 0.01055 F (58, 180) = 0.5730 P = 0.9926 
Cells 0.3161 29 0.01090 F (29, 180) = 0.5921 P = 0.9519 
Coating 1.331 2 0.6653 F (2, 180) = 36.14 P < 0.0001 
Residual 3.313 180 0.01841   
Number of missing values 0     
Compare column means (main column 
effect)         
         
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. Signif icant? Summary     
Fibronectin vs. Collagen 0.1258 
0.07804 to 
0.1736 Yes ****     
Fibronectin vs. Matrigel 0.1644 
0.1166 to 
0.2122 Yes ****     
Collagen vs. Matrigel 0.03857 
-0.009225 
to 0.08637 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen 0.3728 0.2470 0.1258 0.02022 90 90 8.799 180 
Fibronectin vs. Matrigel 0.3728 0.2084 0.1644 0.02022 90 90 11.50 180 
Collagen vs. Matrigel 0.2470 0.2084 0.03857 0.02022 90 90 2.697 180 
 
 
HT1080 cells - aspect ratio 
Table Analyzed HT1080 Aspect Ratio     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
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Source of Variation % of total variation P value 
P value 
summary Signif icant?  
Interaction 13.79 0.9043 ns No  
Cells 3.510 0.9985 ns No  
Coating 25.20 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 105.7 58 1.822 F (58, 180) = 0.7444 P = 0.9043 
Cells 26.89 29 0.9273 F (29, 180) = 0.3790 P = 0.9985 
Coating 193.1 2 96.55 F (2, 180) = 39.46 P < 0.0001 
Residual 440.5 180 2.447   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Signif icant? Summary     
Fibronectin vs. Collagen -1.883 -2.434 to -1.332 Yes ****     
Fibronectin vs. Matrigel -0.1942 -0.7453 to 0.3569 No ns     
Collagen vs. Matrigel 1.689 1.138 to 2.240 Yes ****     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Fibronectin vs. Collagen 1.663 3.546 -1.883 0.2332 90 90 11.42 180 
Fibronectin vs. Matrigel 1.663 1.857 -0.1942 0.2332 90 90 1.177 180 
Collagen vs. Matrigel 3.546 1.857 1.689 0.2332 90 90 10.24 180 
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HT1080 v MDA-MB-231 speed comparison 
Table Analyzed Speed Comparison HT and MDA 
Kruskal-Wallis test  
P value 0.0011 
Exact or approximate P value? Approximate 
P value summary ** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 16.10 
Data summary  
Number of treatments (columns) 4 
Number of values (total) 225 
Number of families 1      
Number of comparisons per family 2      
Alpha 0.05      
Dunn's multiple comparisons test 
Mean rank 
diff. Significant? Summary    
HT Control vs. HT N1-3 8.767 No ns  A-B  
MDA Control vs. MDA N1-3 16.71 No ns  C-D  
Test details Mean rank 1 
Mean rank 
2 
Mean rank 
diff. n1 n2  
HT Control vs. HT N1-3 104.2 95.47 8.767 30 90  
MDA Control vs. MDA N1-3 142.5 125.8 16.71 30 75  
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B6. 3D collagen assay for HT1080, MDA-MB-231 and MCF7 cells 
Cell length 
Table Analyzed  cell length n1-3     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value P value summary Signif icant?  
Interaction 13.10 0.4256 ns No  
Cells 4.220 0.0049 ** Yes  
Cell in Matrix 51.17 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 83464 245 340.7 F (245, 600) = 1.019 P = 0.4256 
Cells 26878 49 548.5 F (49, 600) = 1.640 P = 0.0049 
Cell in Matrix 325953 5 65191 F (5, 600) = 194.9 P < 0.0001 
Residual 200658 600 334.4   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 15        
Alpha 0.05        
Tukey's multiple comparisons test 
Mean 
Diff. 
95% CI of 
diff. Signif icant? Summary     
MCF7 1mg/ml vs. MCF7 2mg/ml  4.000 
-2.037 to 
10.04 No ns     
MCF7 1mg/ml vs. MDA 1mg/ml  -32.82 
-38.86 to -
26.78 Yes ****     
MCF7 1mg/ml vs. MDA 2mg/ml  -28.31 
-34.34 to -
22.27 Yes ****     
MCF7 1mg/ml vs. HT 1mg/ml  -45.86 
-51.90 to -
39.82 Yes ****     
MCF7 1mg/ml vs. HT 2mg/ml  -39.47 
-45.50 to -
33.43 Yes ****     
MCF7 2mg/ml vs. MDA 1mg/ml  -36.82 
-42.86 to -
30.78 Yes ****     
MCF7 2mg/ml vs. MDA 2mg/ml  -32.31 
-38.34 to -
26.27 Yes ****     
MCF7 2mg/ml vs. HT 1mg/ml  -49.86 
-55.90 to -
43.82 Yes ****     
Tukey's multiple comparisons test 
Mean 
Diff. 
95% CI of 
diff. Signif icant? Summary     
MCF7 2mg/ml vs. HT 2mg/ml  -43.47 
-49.50 to -
37.43 Yes ****     
MDA 1mg/ml vs. MDA 2mg/ml  4.513 
-1.524 to 
10.55 No ns     
MDA 1mg/ml vs. HT 1mg/ml  -13.04 
-19.08 to -
7.003 Yes ****     
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MDA 1mg/ml vs. HT 2mg/ml  -6.647 
-12.68 to -
0.6096 Yes *     
MDA 2mg/ml vs. HT 1mg/ml  -17.55 
-23.59 to -
11.52 Yes ****     
MDA 2mg/ml vs. HT 2mg/ml  -11.16 
-17.20 to -
5.123 Yes ****     
HT 1mg/ml vs. HT 2mg/ml  6.393 
0.3562 to 
12.43 Yes *     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
MCF7 1mg/ml vs. MCF7 2mg/ml  31.30 27.30 4.000 2.112 150 150 2.679 600 
MCF7 1mg/ml vs. MDA 1mg/ml  31.30 64.12 -32.82 2.112 150 150 21.98 600 
MCF7 1mg/ml vs. MDA 2mg/ml  31.30 59.61 -28.31 2.112 150 150 18.96 600 
MCF7 1mg/ml vs. HT 1mg/ml  31.30 77.16 -45.86 2.112 150 150 30.71 600 
MCF7 1mg/ml vs. HT 2mg/ml  31.30 70.77 -39.47 2.112 150 150 26.43 600 
MCF7 2mg/ml vs. MDA 1mg/ml  27.30 64.12 -36.82 2.112 150 150 24.66 600 
MCF7 2mg/ml vs. MDA 2mg/ml  27.30 59.61 -32.31 2.112 150 150 21.64 600 
MCF7 2mg/ml vs. HT 1mg/ml  27.30 77.16 -49.86 2.112 150 150 33.39 600 
MCF7 2mg/ml vs. HT 2mg/ml  27.30 70.77 -43.47 2.112 150 150 29.11 600 
MDA 1mg/ml vs. MDA 2mg/ml  64.12 59.61 4.513 2.112 150 150 3.023 600 
MDA 1mg/ml vs. HT 1mg/ml  64.12 77.16 -13.04 2.112 150 150 8.733 600 
MDA 1mg/ml vs. HT 2mg/ml  64.12 70.77 -6.647 2.112 150 150 4.451 600 
MDA 2mg/ml vs. HT 1mg/ml  59.61 77.16 -17.55 2.112 150 150 11.76 600 
MDA 2mg/ml vs. HT 2mg/ml  59.61 70.77 -11.16 2.112 150 150 7.474 600 
HT 1mg/ml vs. HT 2mg/ml  77.16 70.77 6.393 2.112 150 150 4.282 600 
 
 
 
 
 
Aspect ratio 
Table Analyzed aspect ratio n1-3     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Signif icant?  
Interaction 21.22 0.2457 ns No  
cell 6.017 0.0144 * Yes  
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Cell and matrix 24.42 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 1279 245 5.219 F (245, 600) = 1.075 P = 0.2457 
cell 362.6 49 7.401 F (49, 600) = 1.524 P = 0.0144 
Cell and matrix 1471 5 294.3 F (5, 600) = 60.59 P < 0.0001 
Residual 2914 600 4.857   
Number of missing 
values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per 
family 15        
Alpha 0.05        
Tukey's multiple comparisons 
test 
Mean 
Diff. 95% CI of diff. Signif icant? Summary     
MCF7 1mg/ml vs. MCF7 2mg/ml  0.1576 
-0.5699 to 
0.8851 No ns     
MCF7 1mg/ml vs. MDA 1mg/ml  -1.104 
-1.831 to -
0.3764 Yes ***     
MCF7 1mg/ml vs. MDA 2mg/ml  -1.780 -2.508 to -1.053 Yes ****     
MCF7 1mg/ml vs. HT 1mg/ml  -3.353 -4.081 to -2.626 Yes ****     
MCF7 1mg/ml vs. HT 2mg/ml  -2.578 -3.305 to -1.850 Yes ****     
MCF7 2mg/ml vs. MDA 1mg/ml  -1.261 
-1.989 to -
0.5340 Yes ****     
MCF7 2mg/ml vs. MDA 2mg/ml  -1.938 -2.665 to -1.210 Yes ****     
MCF7 2mg/ml vs. HT 1mg/ml  -3.511 -4.239 to -2.784 Yes ****     
MCF7 2mg/ml vs. HT 2mg/ml  -2.735 -3.463 to -2.008 Yes ****     
MDA 1mg/ml vs. MDA 2mg/ml  -0.6762 
-1.404 to 
0.05130 No ns     
MDA 1mg/ml vs. HT 1mg/ml  -2.250 
-2.977 to 
-1.522 Yes ****     
Tukey's multiple comparisons 
test 
Mean 
Diff. 
95% CI 
of diff. Signif icant? Summary     
MDA 1mg/ml vs. HT 2mg/ml  -1.474 
-2.201 to 
-0.7462 Yes ****     
MDA 2mg/ml vs. HT 1mg/ml  -1.573 
-2.301 to 
-0.8458 Yes ****     
MDA 2mg/ml vs. HT 2mg/ml  -0.7975 
-1.525 to 
-0.06992 Yes *     
HT 1mg/ml vs. HT 2mg/ml  0.7759 
0.04832 
to 1.503 Yes *     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
MCF7 1mg/ml vs. MCF7 2mg/ml  1.996 1.839 0.1576 0.2545 150 150 0.8759 600 
MCF7 1mg/ml vs. MDA 1mg/ml  1.996 3.100 -1.104 0.2545 150 150 6.135 600 
MCF7 1mg/ml vs. MDA 2mg/ml  1.996 3.776 -1.780 0.2545 150 150 9.893 600 
MCF7 1mg/ml vs. HT 1mg/ml  1.996 5.350 -3.353 0.2545 150 150 18.64 600 
MCF7 1mg/ml vs. HT 2mg/ml  1.996 4.574 -2.578 0.2545 150 150 14.32 600 
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MCF7 2mg/ml vs. MDA 1mg/ml  1.839 3.100 -1.261 0.2545 150 150 7.011 600 
MCF7 2mg/ml vs. MDA 2mg/ml  1.839 3.776 -1.938 0.2545 150 150 10.77 600 
MCF7 2mg/ml vs. HT 1mg/ml  1.839 5.350 -3.511 0.2545 150 150 19.51 600 
MCF7 2mg/ml vs. HT 2mg/ml  1.839 4.574 -2.735 0.2545 150 150 15.20 600 
MDA 1mg/ml vs. MDA 2mg/ml  3.100 3.776 -0.6762 0.2545 150 150 3.758 600 
MDA 1mg/ml vs. HT 1mg/ml  3.100 5.350 -2.250 0.2545 150 150 12.50 600 
MDA 1mg/ml vs. HT 2mg/ml  3.100 4.574 -1.474 0.2545 150 150 8.190 600 
MDA 2mg/ml vs. HT 1mg/ml  3.776 5.350 -1.573 0.2545 150 150 8.743 600 
MDA 2mg/ml vs. HT 2mg/ml  3.776 4.574 -0.7975 0.2545 150 150 4.432 600 
HT 1mg/ml vs. HT 2mg/ml  5.350 4.574 0.7759 0.2545 150 150 4.312 600 
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Speed 
Table Analyzed 
Speed All 
Summary 
Values     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Signif icant?  
Interaction 3.506 < 0.0001 **** Yes  
Cell and Matrix 56.88 < 0.0001 **** Yes  
Replicates 3.470 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 1.274 10 0.1274 
F (10, 1782) = 
17.29 P < 0.0001 
Cell and Matrix 20.66 5 4.133 F (5, 1782) = 560.9 P < 0.0001 
Replicates 1.261 2 0.6303 F (2, 1782) = 85.55 P < 0.0001 
Residual 13.13 1782 0.007368   
Number of missing values 0     
Compare row  means (main row  effect)      
Number of families 1     
Number of comparisons per family 15     
Alpha 0.05     
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. Signif icant? Summary  
MCF-7 1mg/ml vs. MCF-7 2mg/ml 0.02736 
0.007371 to 
0.04736 Yes **  
MCF-7 1mg/ml vs. MDA-MB-231 1mg/ml -0.1531 
-0.1731 to -
0.1331 Yes ****  
MCF-7 1mg/ml vs. MDA-MB-231 2mg/ml -0.09373 
-0.1137 to -
0.07373 Yes ****  
MCF-7 1mg/ml vs. HT1080 1mg/ml -0.2693 
-0.2893 to -
0.2493 Yes ****  
MCF-7 1mg/ml vs. HT1080 2mg/ml -0.2134 
-0.2334 to -
0.1934 Yes ****  
MCF-7 2mg/ml vs. MDA-MB-231 1mg/ml -0.1805 
-0.2005 to -
0.1605 Yes ****  
MCF-7 2mg/ml vs. MDA-MB-231 2mg/ml -0.1211 
-0.1411 to -
0.1011 Yes ****  
MCF-7 2mg/ml vs. HT1080 1mg/ml -0.2967 
-0.3167 to -
0.2767 Yes ****  
MCF-7 2mg/ml vs. HT1080 2mg/ml -0.2408 
-0.2608 to -
0.2208 Yes ****  
MDA-MB-231 1mg/ml vs. MDA-MB-231 
2mg/ml 0.0594 
0.03941 to 
0.07939 Yes ****  
MDA-MB-231 1mg/ml vs. HT1080 1mg/ml -0.1162 
-0.1362 to -
0.09622 Yes ****  
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. Signif icant? Summary  
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MDA-MB-231 1mg/ml vs. HT1080 2mg/ml -0.06028 
-0.08027 to -
0.04029 Yes ****  
MDA-MB-231 2mg/ml vs. HT1080 1mg/ml -0.1756 
-0.1956 to -
0.1556 Yes ****  
MDA-MB-231 2mg/ml vs. HT1080 2mg/ml -0.1197 
-0.1397 to -
0.09969 Yes ****  
HT1080 1mg/ml vs. HT1080 2mg/ml 0.05593 
0.03594 to 
0.07593 Yes ****  
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 
MCF-7 1mg/ml vs. MCF-7 2mg/ml 0.1113 0.08392 0.02736 0.007009 300 
MCF-7 1mg/ml vs. MDA-MB-231 1mg/ml 0.1113 0.2644 -0.1531 0.007009 300 
MCF-7 1mg/ml vs. MDA-MB-231 2mg/ml 0.1113 0.2050 -0.09373 0.007009 300 
MCF-7 1mg/ml vs. HT1080 1mg/ml 0.1113 0.3806 -0.2693 0.007009 300 
MCF-7 1mg/ml vs. HT1080 2mg/ml 0.1113 0.3247 -0.2134 0.007009 300 
MCF-7 2mg/ml vs. MDA-MB-231 1mg/ml 0.08392 0.2644 -0.1805 0.007009 300 
MCF-7 2mg/ml vs. MDA-MB-231 2mg/ml 0.08392 0.2050 -0.1211 0.007009 300 
MCF-7 2mg/ml vs. HT1080 1mg/ml 0.08392 0.3806 -0.2967 0.007009 300 
MCF-7 2mg/ml vs. HT1080 2mg/ml 0.08392 0.3247 -0.2408 0.007009 300 
MDA-MB-231 1mg/ml vs. MDA-MB-231 
2mg/ml 0.2644 0.2050 0.0594 0.007009 300 
MDA-MB-231 1mg/ml vs. HT1080 1mg/ml 0.2644 0.3806 -0.1162 0.007009 300 
MDA-MB-231 1mg/ml vs. HT1080 2mg/ml 0.2644 0.3247 -0.06028 0.007009 300 
MDA-MB-231 2mg/ml vs. HT1080 1mg/ml 0.2050 0.3806 -0.1756 0.007009 300 
MDA-MB-231 2mg/ml vs. HT1080 2mg/ml 0.2050 0.3247 -0.1197 0.007009 300 
HT1080 1mg/ml vs. HT1080 2mg/ml 0.3806 0.3247 0.05593 0.007009 300 
 
 
 
 
 
Distance to start 
Table Analyzed All  D2S n1-3     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation 
P 
value 
P value 
summary Signif icant?  
Interaction 17.48 0.5827 ns No  
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Cell 3.461 0.5551 ns No  
Cell and Matrix 35.96 
< 
0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 1.286e+006 495 2598 F (495, 1200) = 0.9835 P = 0.5827 
Cell 254595 99 2572 F (99, 1200) = 0.9736 P = 0.5551 
Cell and Matrix 2.645e+006 5 528971 F (5, 1200) = 200.3 P < 0.0001 
Residual 3.170e+006 1200 2641   
Number of missing values 0     
Number of comparisons per 
family 15        
Alpha 0.05        
Tukey's multiple comparisons 
test Mean Dif f. 95% CI of diff. Signif icant? 
Summar
y     
MCF7 1mg/ml vs. MCF7 
2mg/ml  7.461 -4.517 to 19.44 No ns     
MCF7 1mg/ml vs. MDA 
1mg/ml  -67.66 -79.64 to -55.68 Yes ****     
MCF7 1mg/ml vs. MDA 
2mg/ml  -35.96 -47.94 to -23.98 Yes ****     
MCF7 1mg/ml vs. HT 1mg/ml  -97.04 -109.0 to -85.06 Yes ****     
MCF7 1mg/ml vs. HT 2mg/ml  -72.19 -84.17 to -60.21 Yes ****     
MCF7 2mg/ml vs. MDA 
1mg/ml  -75.12 -87.10 to -63.14 Yes ****     
MCF7 2mg/ml vs. MDA 
2mg/ml  -43.42 -55.40 to -31.45 Yes ****     
MCF7 2mg/ml vs. HT 1mg/ml  -104.5 -116.5 to -92.52 Yes ****     
MCF7 2mg/ml vs. HT 2mg/ml  -79.65 -91.63 to -67.67 Yes ****     
MDA 1mg/ml vs. MDA 2mg/ml  31.70 19.72 to 43.67 Yes ****     
MDA 1mg/ml vs. HT 1mg/ml  -29.38 -41.36 to -17.40 Yes ****     
MDA 1mg/ml vs. HT 2mg/ml  -4.531 -16.51 to 7.446 No ns     
MDA 2mg/ml vs. HT 1mg/ml  -61.08 -73.05 to -49.10 Yes ****     
MDA 2mg/ml vs. HT 2mg/ml  -36.23 -48.21 to -24.25 Yes ****     
HT 1mg/ml vs. HT 2mg/ml  24.85 12.87 to 36.83 Yes ****     
         
         
         
         
         
Test details Mean 1 Mean 2 Mean Diff. 
SE of 
diff. N1 N2 q DF 
MCF7 1mg/ml vs. MCF7 
2mg/ml  19.49 12.02 7.461 4.196 300 300 2.515 1200 
MCF7 1mg/ml vs. MDA 
1mg/ml  19.49 87.14 -67.66 4.196 300 300 22.80 1200 
MCF7 1mg/ml vs. MDA 
2mg/ml  19.49 55.45 -35.96 4.196 300 300 12.12 1200 
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MCF7 1mg/ml vs. HT 1mg/ml  19.49 116.5 -97.04 4.196 300 300 32.70 1200 
MCF7 1mg/ml vs. HT 2mg/ml  19.49 91.68 -72.19 4.196 300 300 24.33 1200 
MCF7 2mg/ml vs. MDA 
1mg/ml  12.02 87.14 -75.12 4.196 300 300 25.32 1200 
MCF7 2mg/ml vs. MDA 
2mg/ml  12.02 55.45 -43.42 4.196 300 300 14.63 1200 
MCF7 2mg/ml vs. HT 1mg/ml  12.02 116.5 -104.5 4.196 300 300 35.22 1200 
MCF7 2mg/ml vs. HT 2mg/ml  12.02 91.68 -79.65 4.196 300 300 26.84 1200 
MDA 1mg/ml vs. MDA 2mg/ml  87.14 55.45 31.70 4.196 300 300 10.68 1200 
MDA 1mg/ml vs. HT 1mg/ml  87.14 116.5 -29.38 4.196 300 300 9.901 1200 
MDA 1mg/ml vs. HT 2mg/ml  87.14 91.68 -4.531 4.196 300 300 1.527 1200 
MDA 2mg/ml vs. HT 1mg/ml  55.45 116.5 -61.08 4.196 300 300 20.58 1200 
MDA 2mg/ml vs. HT 2mg/ml  55.45 91.68 -36.23 4.196 300 300 12.21 1200 
HT 1mg/ml vs. HT 2mg/ml  116.5 91.68 24.85 4.196 300 300 8.374 1200 
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B7. 3D collagen with fibronectin 
Distance to start 
Table Analyzed D2S     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value P value summary Signif icant?  
Interaction 19.69 0.9850 ns No  
Row  Factor 3.604 0.9045 ns No  
Column Factor 9.889 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 670609 145 4625 
F (145, 360) = 
0.7317 P = 0.9850 
Row  Factor 122738 29 4232 
F (29, 360) = 
0.6696 P = 0.9045 
Column Factor 336780 5 67356 
F (5, 360) = 
10.66 P < 0.0001 
Residual 2.275e+006 360 6320   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 15        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Signif icant? Summary     
Col 1mg vs. Col 1+5F 23.32 -10.64 to 57.27 No ns     
Col 1mg vs. Col 1+10F 21.75 -12.21 to 55.70 No ns     
Col 1mg vs. Col 2mg 66.74 32.79 to 100.7 Yes ****     
Col 1mg vs. Col 2+5F 59.96 26.00 to 93.91 Yes ****     
Col 1mg vs. Col 2+10F 60.66 26.70 to 94.61 Yes ****     
Col 1+5F vs. Col 1+10F -1.567 -35.52 to 32.39 No ns     
Col 1+5F vs. Col 2mg 43.43 9.470 to 77.38 Yes **     
Col 1+5F vs. Col 2+5F 36.64 2.688 to 70.60 Yes *     
Col 1+5F vs. Col 2+10F 37.34 3.384 to 71.29 Yes *     
Col 1+10F vs. Col 2mg 44.99 11.04 to 78.95 Yes **     
Col 1+10F vs. Col 2+5F 38.21 4.255 to 72.17 Yes *     
Col 1+10F vs. Col 2+10F 38.91 4.951 to 72.86 Yes *     
Col 2mg vs. Col 2+5F -6.783 -40.74 to 27.17 No ns     
Col 2mg vs. Col 2+10F -6.086 -40.04 to 27.87 No ns     
Col 2+5F vs. Col 2+10F 0.6963 -33.26 to 34.65 No ns     
Test details Mean 1 Mean 2 Mean Diff. 
SE of 
diff. N1 N2 q DF 
Col 1mg vs. Col 1+5F 128.4 105.1 23.32 11.85 90 90 2.782 360 
Col 1mg vs. Col 1+10F 128.4 106.6 21.75 11.85 90 90 2.595 360 
Col 1mg vs. Col 2mg 128.4 61.65 66.74 11.85 90 90 7.964 360 
Col 1mg vs. Col 2+5F 128.4 68.43 59.96 11.85 90 90 7.155 360 
Col 1mg vs. Col 2+10F 128.4 67.74 60.66 11.85 90 90 7.238 360 
Col 1+5F vs. Col 1+10F 105.1 106.6 -1.567 11.85 90 90 0.1870 360 
Col 1+5F vs. Col 2mg 105.1 61.65 43.43 11.85 90 90 5.182 360 
Col 1+5F vs. Col 2+5F 105.1 68.43 36.64 11.85 90 90 4.373 360 
Col 1+5F vs. Col 2+10F 105.1 67.74 37.34 11.85 90 90 4.456 360 
Col 1+10F vs. Col 2mg 106.6 61.65 44.99 11.85 90 90 5.369 360 
Col 1+10F vs. Col 2+5F 106.6 68.43 38.21 11.85 90 90 4.560 360 
Col 1+10F vs. Col 2+10F 106.6 67.74 38.91 11.85 90 90 4.643 360 
Col 2mg vs. Col 2+5F 61.65 68.43 -6.783 11.85 90 90 0.8094 360 
Col 2mg vs. Col 2+10F 61.65 67.74 -6.086 11.85 90 90 0.7263 360 
Col 2+5F vs. Col 2+10F 68.43 67.74 0.6963 11.85 90 90 0.08309 360 
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Speed 
Table Analyzed Speed     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value P value summary Signif icant?  
Interaction 12.10 > 0.9999 ns No  
Cell speed 1.445 > 0.9999 ns No  
Matrix 19.62 < 0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 2.044 145 0.01410 F (145, 360) = 0.4497 P > 0.9999 
Cell speed 0.2440 29 0.008412 F (29, 360) = 0.2684 P > 0.9999 
Matrix 3.313 5 0.6627 F (5, 360) = 21.14 P < 0.0001 
Residual 11.29 360 0.03135   
Number of missing values 0     
Number of comparisons per family 15        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Signif icant? Summary     
Col 1mg vs. Col 1+5F 0.07194 -0.003677 to 0.1476 No ns     
Col 1mg vs. Col 1+10F 0.03256 -0.04306 to 0.1082 No ns     
Col 1mg vs. Col 2mg 0.1973 0.1216 to 0.2729 Yes ****     
Col 1mg vs. Col 2+5F 0.1891 0.1135 to 0.2647 Yes ****     
Col 1mg vs. Col 2+10F 0.1683 0.09271 to 0.2439 Yes ****     
Col 1+5F vs. Col 1+10F -0.03938 -0.1150 to 0.03624 No ns     
Col 1+5F vs. Col 2mg 0.1253 0.04970 to 0.2009 Yes ****     
Col 1+5F vs. Col 2+5F 0.1171 0.04151 to 0.1928 Yes ***     
Col 1+5F vs. Col 2+10F 0.09638 0.02076 to 0.1720 Yes **     
Col 1+10F vs. Col 2mg 0.1647 0.08908 to 0.2403 Yes ****     
Col 1+10F vs. Col 2+5F 0.1565 0.08090 to 0.2321 Yes ****     
Col 1+10F vs. Col 2+10F 0.1358 0.06015 to 0.2114 Yes ****     
Col 2mg vs. Col 2+5F -0.008184 -0.08381 to 0.06744 No ns     
Col 2mg vs. Col 2+10F -0.02893 -0.1046 to 0.04669 No ns     
Col 2+5F vs. Col 2+10F -0.02075 -0.09637 to 0.05487 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Col 1mg vs. Col 1+5F 0.3998 0.3278 0.07194 0.02639 90 90 3.855 360 
Col 1mg vs. Col 1+10F 0.3998 0.3672 0.03256 0.02639 90 90 1.745 360 
Col 1mg vs. Col 2mg 0.3998 0.2025 0.1973 0.02639 90 90 10.57 360 
Col 1mg vs. Col 2+5F 0.3998 0.2107 0.1891 0.02639 90 90 10.13 360 
Col 1mg vs. Col 2+10F 0.3998 0.2314 0.1683 0.02639 90 90 9.019 360 
Col 1+5F vs. Col 1+10F 0.3278 0.3672 -0.03938 0.02639 90 90 2.110 360 
Col 1+5F vs. Col 2mg 0.3278 0.2025 0.1253 0.02639 90 90 6.715 360 
Col 1+5F vs. Col 2+5F 0.3278 0.2107 0.1171 0.02639 90 90 6.276 360 
Col 1+5F vs. Col 2+10F 0.3278 0.2314 0.09638 0.02639 90 90 5.164 360 
Col 1+10F vs. Col 2mg 0.3672 0.2025 0.1647 0.02639 90 90 8.825 360 
Col 1+10F vs. Col 2+5F 0.3672 0.2107 0.1565 0.02639 90 90 8.386 360 
Col 1+10F vs. Col 2+10F 0.3672 0.2314 0.1358 0.02639 90 90 7.275 360 
Col 2mg vs. Col 2+5F 0.2025 0.2107 -0.008184 0.02639 90 90 0.4385 360 
Col 2mg vs. Col 2+10F 0.2025 0.2314 -0.02893 0.02639 90 90 1.550 360 
Col 2+5F vs. Col 2+10F 0.2107 0.2314 -0.02075 0.02639 90 90 1.112 360 
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Track length 
Table Analyzed 
Distance 
Travelled     
Tw o-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value P value summary Signif icant?  
Interaction 12.10 > 0.9999 ns No  
Cell track 1.445 > 0.9999 ns No  
Matrix 19.62 < 0.0001 **** Yes  
ANOVA table SS DF MS 
F (DFn, 
DFd) P value 
Interaction 2.993e+006 145 20640 
F (145, 
360) = 
0.4497 P > 0.9999 
Cell track 357183 29 12317 
F (29, 360) 
= 0.2684 P > 0.9999 
Matrix 4.851e+006 5 970212 
F (5, 360) 
= 21.14 P < 0.0001 
Residual 1.652e+007 360 45896   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 15        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Signif icant? Summary     
Col 1mg vs. Col 1+5F 87.05 -4.450 to 178.6 No ns     
Col 1mg vs. Col 1+10F 39.40 -52.10 to 130.9 No ns     
Col 1mg vs. Col 2mg 238.7 147.2 to 330.2 Yes ****     
Col 1mg vs. Col 2+5F 228.8 137.3 to 320.3 Yes ****     
Col 1mg vs. Col 2+10F 203.7 112.2 to 295.2 Yes ****     
Col 1+5F vs. Col 1+10F -47.65 -139.2 to 43.85 No ns     
Col 1+5F vs. Col 2mg 151.6 60.13 to 243.1 Yes ****     
Col 1+5F vs. Col 2+5F 141.7 50.23 to 233.2 Yes ***     
Col 1+5F vs. Col 2+10F 116.6 25.12 to 208.1 Yes **     
Col 1+10F vs. Col 2mg 199.3 107.8 to 290.8 Yes ****     
Col 1+10F vs. Col 2+5F 189.4 97.88 to 280.9 Yes ****     
Col 1+10F vs. Col 2+10F 164.3 72.78 to 255.8 Yes ****     
Col 2mg vs. Col 2+5F -9.903 -101.4 to 81.60 No ns     
Col 2mg vs. Col 2+10F -35.01 -126.5 to 56.49 No ns     
Col 2+5F vs. Col 2+10F -25.10 -116.6 to 66.40 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Col 1mg vs. Col 1+5F 483.7 396.7 87.05 31.94 90 90 3.855 360 
Col 1mg vs. Col 1+10F 483.7 444.3 39.40 31.94 90 90 1.745 360 
Col 1mg vs. Col 2mg 483.7 245.0 238.7 31.94 90 90 10.57 360 
Col 1mg vs. Col 2+5F 483.7 254.9 228.8 31.94 90 90 10.13 360 
Col 1mg vs. Col 2+10F 483.7 280.0 203.7 31.94 90 90 9.019 360 
Col 1+5F vs. Col 1+10F 396.7 444.3 -47.65 31.94 90 90 2.110 360 
Col 1+5F vs. Col 2mg 396.7 245.0 151.6 31.94 90 90 6.715 360 
Col 1+5F vs. Col 2+5F 396.7 254.9 141.7 31.94 90 90 6.276 360 
Col 1+5F vs. Col 2+10F 396.7 280.0 116.6 31.94 90 90 5.164 360 
Col 1+10F vs. Col 2mg 444.3 245.0 199.3 31.94 90 90 8.825 360 
Col 1+10F vs. Col 2+5F 444.3 254.9 189.4 31.94 90 90 8.386 360 
Col 1+10F vs. Col 2+10F 444.3 280.0 164.3 31.94 90 90 7.275 360 
Col 2mg vs. Col 2+5F 245.0 254.9 -9.903 31.94 90 90 0.4385 360 
Col 2mg vs. Col 2+10F 245.0 280.0 -35.01 31.94 90 90 1.550 360 
Col 2+5F vs. Col 2+10F 254.9 280.0 -25.10 31.94 90 90 1.112 360 
 
Aspect ratio 
Table Analyzed Aspect Ratio     
Tw o-way ANOVA Ordinary     
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Alpha 0.05     
Source of Variation % of total variation P value P value summary Signif icant?  
Interaction 25.56 0.6356 ns No  
Cell 5.873 0.3440 ns No  
Matrix 1.778 0.0908 ns No  
ANOVA table SS DF MS F (DFn, DFd) 
P 
value 
Interaction 824.1 145 5.683 
F (145, 360) = 
0.9501 
P = 
0.6356 
Cell 189.4 29 6.530 
F (29, 360) = 
1.092 
P = 
0.3440 
Matrix 57.33 5 11.47 
F (5, 360) = 
1.917 
P = 
0.0908 
Residual 2154 360 5.982   
Number of missing 
values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons 
per family 15        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 95% CI of diff. Signif icant? Summary     
Col 1mg vs. Col 1+5F 0.4965 -0.5482 to 1.541 No ns     
Col 1mg vs. Col 1+10F -0.2691 -1.314 to 0.7755 No ns     
Col 1mg vs. Col 2mg 0.6132 -0.4314 to 1.658 No ns     
Col 1mg vs. Col 2+5F 0.5944 -0.4502 to 1.639 No ns     
Col 1mg vs. Col 2+10F 0.2620 -0.7826 to 1.307 No ns     
Col 1+5F vs. Col 1+10F -0.7656 -1.810 to 0.2791 No ns     
Col 1+5F vs. Col 2mg 0.1168 -0.9279 to 1.161 No ns     
Col 1+5F vs. Col 2+5F 0.09798 -0.9467 to 1.143 No ns     
Col 1+5F vs. Col 2+10F -0.2344 -1.279 to 0.8102 No ns     
Col 1+10F vs. Col 2mg 0.8824 -0.1623 to 1.927 No ns     
Col 1+10F vs. Col 2+5F 0.8636 -0.1811 to 1.908 No ns     
Col 1+10F vs. Col 2+10F 0.5311 -0.5135 to 1.576 No ns     
Col 2mg vs. Col 2+5F -0.01880 -1.063 to 1.026 No ns     
Col 2mg vs. Col 2+10F -0.3512 -1.396 to 0.6934 No ns     
Col 2+5F vs. Col 2+10F -0.3324 -1.377 to 0.7122 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Col 1mg vs. Col 1+5F 4.239 3.743 0.4965 0.3646 90 90 1.926 360 
Col 1mg vs. Col 1+10F 4.239 4.508 -0.2691 0.3646 90 90 1.044 360 
Col 1mg vs. Col 2mg 4.239 3.626 0.6132 0.3646 90 90 2.379 360 
Col 1mg vs. Col 2+5F 4.239 3.645 0.5944 0.3646 90 90 2.306 360 
Col 1mg vs. Col 2+10F 4.239 3.977 0.2620 0.3646 90 90 1.016 360 
Col 1+5F vs. Col 1+10F 3.743 4.508 -0.7656 0.3646 90 90 2.969 360 
Col 1+5F vs. Col 2mg 3.743 3.626 0.1168 0.3646 90 90 0.4529 360 
Col 1+5F vs. Col 2+5F 3.743 3.645 0.09798 0.3646 90 90 0.3800 360 
Col 1+5F vs. Col 2+10F 3.743 3.977 -0.2344 0.3646 90 90 0.9093 360 
Col 1+10F vs. Col 2mg 4.508 3.626 0.8824 0.3646 90 90 3.422 360 
Col 1+10F vs. Col 2+5F 4.508 3.645 0.8636 0.3646 90 90 3.349 360 
Col 1+10F vs. Col 2+10F 4.508 3.977 0.5311 0.3646 90 90 2.060 360 
Col 2mg vs. Col 2+5F 3.626 3.645 -0.01880 0.3646 90 90 0.07292 360 
Col 2mg vs. Col 2+10F 3.626 3.977 -0.3512 0.3646 90 90 1.362 360 
Col 2+5F vs. Col 2+10F 3.645 3.977 -0.3324 0.3646 90 90 1.289 360 
 
Cell length 
Table Analyzed Cell Length     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 24.46 0.7560 ns No  
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Cells 7.526 0.0894 ns No  
Matrix 0.9044 0.4359 ns No  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 79009 145 544.9 
F (145, 360) = 
0.9048 P = 0.7560 
Cells 24312 29 838.4 F (29, 360) = 1.392 P = 0.0894 
Matrix 2922 5 584.3 F (5, 360) = 0.9702 P = 0.4359 
Residual 216803 360 602.2   
Number of missing 
values 0     
Compare column 
means (main column 
effect)         
Number of families 1        
Number of comparisons 
per family 15        
Alpha 0.05        
Tukey's multiple 
comparisons test 
Mean 
Diff. 95% CI of diff. Significant? Summary     
Col 1mg vs. Col 1+5F 3.567 -6.915 to 14.05 No ns     
Col 1mg vs. Col 1+10F 7.422 -3.059 to 17.90 No ns     
Col 1mg vs. Col 2mg 2.856 -7.626 to 13.34 No ns     
Col 1mg vs. Col 2+5F 4.844 -5.637 to 15.33 No ns     
Col 1mg vs. Col 2+10F 1.878 -8.604 to 12.36 No ns     
Col 1+5F vs. Col 1+10F 3.856 -6.626 to 14.34 No ns     
Col 1+5F vs. Col 2mg -0.7111 -11.19 to 9.770 No ns     
Col 1+5F vs. Col 2+5F 1.278 -9.204 to 11.76 No ns     
Col 1+5F vs. Col 2+10F -1.689 -12.17 to 8.793 No ns     
Col 1+10F vs. Col 2mg -4.567 -15.05 to 5.915 No ns     
Col 1+10F vs. Col 2+5F -2.578 -13.06 to 7.904 No ns     
Col 1+10F vs. Col 
2+10F -5.544 -16.03 to 4.937 No ns     
Col 2mg vs. Col 2+5F 1.989 -8.493 to 12.47 No ns     
Col 2mg vs. Col 2+10F -0.9778 -11.46 to 9.504 No ns     
Col 2+5F vs. Col 2+10F -2.967 -13.45 to 7.515 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Col 1mg vs. Col 1+5F 59.89 56.32 3.567 3.658 90 90 1.379 360 
Col 1mg vs. Col 1+10F 59.89 52.47 7.422 3.658 90 90 2.869 360 
Col 1mg vs. Col 2mg 59.89 57.03 2.856 3.658 90 90 1.104 360 
Col 1mg vs. Col 2+5F 59.89 55.04 4.844 3.658 90 90 1.873 360 
Col 1mg vs. Col 2+10F 59.89 58.01 1.878 3.658 90 90 0.7259 360 
Col 1+5F vs. Col 1+10F 56.32 52.47 3.856 3.658 90 90 1.490 360 
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Col 1+5F vs. Col 2mg 56.32 57.03 -0.7111 3.658 90 90 0.2749 360 
Col 1+5F vs. Col 2+5F 56.32 55.04 1.278 3.658 90 90 0.4940 360 
Col 1+5F vs. Col 2+10F 56.32 58.01 -1.689 3.658 90 90 0.6529 360 
Col 1+10F vs. Col 2mg 52.47 57.03 -4.567 3.658 90 90 1.765 360 
Col 1+10F vs. Col 2+5F 52.47 55.04 -2.578 3.658 90 90 0.9965 360 
Col 1+10F vs. Col 
2+10F 52.47 58.01 -5.544 3.658 90 90 2.143 360 
Col 2mg vs. Col 2+5F 57.03 55.04 1.989 3.658 90 90 0.7689 360 
Col 2mg vs. Col 2+10F 57.03 58.01 -0.9778 3.658 90 90 0.3780 360 
Col 2+5F vs. Col 2+10F 55.04 58.01 -2.967 3.658 90 90 1.147 360 
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HT1080 aspect ratio 
Table Analyzed Aspect Ratio HT1080 n1 
Kruskal-Wallis test  
P value 0.1732 
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 6 
Kruskal-Wallis statistic 7.707 
Data summary  
Number of treatments (columns) 6 
Number of values (total) 180 
Number of families 1     
Number of comparisons per family 15     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
Col 1mg vs. Col 1+5F 10.48 No ns  A-B 
Col 1mg vs. Col1+10F -7.183 No ns  A-C 
Col 1mg vs. Col 2mg 27.25 No ns  A-D 
Col 1mg vs. Col 2+5F 7.500 No ns  A-E 
Col 1mg vs. Col2+10F 1.950 No ns  A-F 
Col 1+5F vs. Col1+10F -17.67 No ns  B-C 
Col 1+5F vs. Col 2mg 16.77 No ns  B-D 
Col 1+5F vs. Col 2+5F -2.983 No ns  B-E 
Col 1+5F vs. Col2+10F -8.533 No ns  B-F 
Col1+10F vs. Col 2mg 34.43 No ns  C-D 
Col1+10F vs. Col 2+5F 14.68 No ns  C-E 
Col1+10F vs. Col2+10F 9.133 No ns  C-F 
Col 2mg vs. Col 2+5F -19.75 No ns  D-E 
Col 2mg vs. Col2+10F -25.30 No ns  D-F 
Col 2+5F vs. Col2+10F -5.550 No ns  E-F 
Test details Mean rank 1 Mean rank 2 
Mean rank 
diff. n1 n2 
Col 1mg vs. Col 1+5F 97.17 86.68 10.48 30 30 
Col 1mg vs. Col1+10F 97.17 104.4 -7.183 30 30 
Col 1mg vs. Col 2mg 97.17 69.92 27.25 30 30 
Col 1mg vs. Col 2+5F 97.17 89.67 7.500 30 30 
Col 1mg vs. Col2+10F 97.17 95.22 1.950 30 30 
Col 1+5F vs. Col1+10F 86.68 104.4 -17.67 30 30 
Col 1+5F vs. Col 2mg 86.68 69.92 16.77 30 30 
Col 1+5F vs. Col 2+5F 86.68 89.67 -2.983 30 30 
Col 1+5F vs. Col2+10F 86.68 95.22 -8.533 30 30 
Col1+10F vs. Col 2mg 104.4 69.92 34.43 30 30 
Col1+10F vs. Col 2+5F 104.4 89.67 14.68 30 30 
Col1+10F vs. Col2+10F 104.4 95.22 9.133 30 30 
Col 2mg vs. Col 2+5F 69.92 89.67 -19.75 30 30 
Col 2mg vs. Col2+10F 69.92 95.22 -25.30 30 30 
Col 2+5F vs. Col2+10F 89.67 95.22 -5.550 30 30 
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HT1080 cell length 
Table Analyzed Cell Length HT1080 n1 
Kruskal-Wallis test  
P value < 0.0001 
Exact or approximate P value? Approximate 
P value summary **** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 6 
Kruskal-Wallis statistic 32.68 
Data summary  
Number of treatments (columns) 6 
Number of values (total) 180 
Number of families 1     
Number of comparisons per family 15     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
Col 1mg vs. Col 1+5F 33.57 No ns  A-B 
Col 1mg vs. Col1+10F 0.4833 No ns  A-C 
Col 1mg vs. Col 2mg 63.95 Yes ****  A-D 
Col 1mg vs. Col 2+5F 37.75 No ns  A-E 
Col 1mg vs. Col2+10F 26.25 No ns  A-F 
Col 1+5F vs. Col1+10F -33.08 No ns  B-C 
Col 1+5F vs. Col 2mg 30.38 No ns  B-D 
Col 1+5F vs. Col 2+5F 4.183 No ns  B-E 
Col 1+5F vs. Col2+10F -7.317 No ns  B-F 
Col1+10F vs. Col 2mg 63.47 Yes ****  C-D 
Col1+10F vs. Col 2+5F 37.27 No ns  C-E 
Col1+10F vs. Col2+10F 25.77 No ns  C-F 
Col 2mg vs. Col 2+5F -26.20 No ns  D-E 
Col 2mg vs. Col2+10F -37.70 No ns  D-F 
Col 2+5F vs. Col2+10F -11.50 No ns  E-F 
Test details Mean rank 1 Mean rank 2 
Mean rank 
diff. n1 n2 
Col 1mg vs. Col 1+5F 117.5 83.93 33.57 30 30 
Col 1mg vs. Col1+10F 117.5 117.0 0.4833 30 30 
Col 1mg vs. Col 2mg 117.5 53.55 63.95 30 30 
Col 1mg vs. Col 2+5F 117.5 79.75 37.75 30 30 
Col 1mg vs. Col2+10F 117.5 91.25 26.25 30 30 
Col 1+5F vs. Col1+10F 83.93 117.0 -33.08 30 30 
Col 1+5F vs. Col 2mg 83.93 53.55 30.38 30 30 
Col 1+5F vs. Col 2+5F 83.93 79.75 4.183 30 30 
Col 1+5F vs. Col2+10F 83.93 91.25 -7.317 30 30 
Col1+10F vs. Col 2mg 117.0 53.55 63.47 30 30 
Col1+10F vs. Col 2+5F 117.0 79.75 37.27 30 30 
Col1+10F vs. Col2+10F 117.0 91.25 25.77 30 30 
Col 2mg vs. Col 2+5F 53.55 79.75 -26.20 30 30 
Col 2mg vs. Col2+10F 53.55 91.25 -37.70 30 30 
Col 2+5F vs. Col2+10F 79.75 91.25 -11.50 30 30 
 
 
HT1080 distance to start 
Table Analyzed d2S HT1080 n1 
Kruskal-Wallis test  
P value 0.0002 
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Exact or approximate P value? Approximate 
P value summary *** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 6 
Kruskal-Wallis statistic 24.67 
Data summary  
Number of treatments (columns) 6 
Number of values (total) 180 
Number of families 1     
Number of comparisons per family 3     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
Col 1mg vs. Col 2mg 40.93 Yes **  A-D 
Col 1+5F vs. Col 2+5F 43.15 Yes **  B-E 
Col1+10F vs. Col2+10F 27.25 No ns  C-F 
Test details Mean rank 1 Mean rank 2 Mean rank diff. n1 n2 
Col 1mg vs. Col 2mg 106.1 65.13 40.93 30 30 
Col 1+5F vs. Col 2+5F 112.2 69.08 43.15 30 30 
Col1+10F vs. Col2+10F 108.9 81.62 27.25 30 30 
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HT1080 speed 
Table Analyzed Speed HT1080 n1 
Kruskal-Wallis test  
P value < 0.0001 
Exact or approximate P value? Approximate 
P value summary **** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 6 
Kruskal-Wallis statistic 53.67 
Data summary  
Number of treatments (columns) 6 
Number of values (total) 180 
Number of families 1     
Number of comparisons per family 7     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
Col 1mg vs. Col 2mg 46.17 Yes **  A-D 
Col 1mg vs. Col 1+5F 0.4333 No ns  A-B 
Col 1+5F vs. Col1+10F -11.17 No ns  B-C 
Col 1+5F vs. Col 2+5F 63.73 Yes ****  B-E 
Col1+10F vs. Col2+10F 55.10 Yes ***  C-F 
Col 2mg vs. Col 2+5F 18.00 No ns  D-E 
Col 2+5F vs. Col2+10F -19.80 No ns  E-F 
Test details Mean rank 1 Mean rank 2 
Mean rank 
diff. n1 n2 
Col 1mg vs. Col 2mg 114.6 68.40 46.17 30 30 
Col 1mg vs. Col 1+5F 114.6 114.1 0.4333 30 30 
Col 1+5F vs. Col1+10F 114.1 125.3 -11.17 30 30 
Col 1+5F vs. Col 2+5F 114.1 50.40 63.73 30 30 
Col1+10F vs. Col2+10F 125.3 70.20 55.10 30 30 
Col 2mg vs. Col 2+5F 68.40 50.40 18.00 30 30 
Col 2+5F vs. Col2+10F 50.40 70.20 -19.80 30 30 
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Distance from start comparison between HT1080 and MDA-MB-231 
Table Analyzed D2S comparison 
Kruskal-Wallis test  
P value < 0.0001 
Exact or approximate P value? Approximate 
P value summary **** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 12 
Kruskal-Wallis statistic 113.5 
Data summary  
Number of treatments (columns) 12 
Number of values (total) 720 
Number of families 1     
Number of comparisons per family 3     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
MDA Col 1mg vs. HT Col 1mg 169.8 Yes ***  A-B 
MDA Col1+5F vs. HT Col 1+5F 80.93 No ns  C-D 
MDA Col1+10F vs. HT Col1+5F 59.69 No ns  E-F 
Test details Mean rank 1 Mean rank 2 Mean rank diff. n1 n2 
MDA Col 1mg vs. HT Col 1mg 495.6 325.7 169.8 90 30 
MDA Col1+5F vs. HT Col 1+5F 431.3 350.4 80.93 90 30 
MDA Col1+10F vs. HT Col1+5F 419.9 360.2 59.69 90 30 
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HT1080 and MDA-MB-231 cells: control group v n1-3 cells on collagen 
Table Analyzed D2S Comparison HT and MDA 
Kruskal-Wallis test  
P value 0.0149 
Exact or approximate P value? Approximate 
P value summary * 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 10.48 
Data summary  
Number of treatments (columns) 4 
Number of values (total) 225 
Number of families 1     
Number of comparisons per family 2     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
HT Control vs. HT N1-3 2.650 No ns  A-B 
MDA Control vs. MDA N1-3 21.60 No ns  C-D 
Test details Mean rank 1 
Mean rank 
2 
Mean rank 
diff. n1 n2 
HT Control vs. HT N1-3 103.5 100.8 2.650 30 90 
MDA Control vs. MDA N1-3 141.6 120.0 21.60 30 75 
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B8. 2D/3D assay 
MDA-MB-231 n1-3 - speed 
Table Analyzed MDA 3 cols     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 7.545 0.9719 ns No  
Cell speed 5.295 0.7765 ns No  
Location 30.10 
< 
0.0001 **** Yes  
ANOVA table SS DF MS F (DFn, DFd) 
P 
value 
Interaction 0.5194 18 0.02886 F (18, 60) = 0.4408 
P = 
0.9719 
Cell speed 0.3645 9 0.04050 F (9, 60) = 0.6186 
P = 
0.7765 
Location 2.072 2 1.036 F (2, 60) = 15.82 
P < 
0.0001 
Residual 3.928 60 0.06547   
Number of missing values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons per 
family 3        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 95% CI of diff. Significant? Summary     
2D vs. Border -0.1253 
-0.2841 to 
0.03348 No ns     
2D vs. 3D 0.2404 
0.08159 to 
0.3991 Yes **     
Border vs. 3D 0.3657 0.2069 to 0.5244 Yes ****     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
2D vs. Border 0.5254 0.6507 -0.1253 0.06607 30 30 2.682 60 
2D vs. 3D 0.5254 0.2851 0.2404 0.06607 30 30 5.145 60 
Border vs. 3D 0.6507 0.2851 0.3657 0.06607 30 30 7.827 60 
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HT1080 2D/3D assay - speed 
Table Analyzed HT 3 cols     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Significant?  
Interaction 10.13 0.7284 ns No  
Cell speed 7.060 0.3984 ns No  
Location 38.80 < 0.0001 **** Yes  
ANOVA table SS DF MS 
F (DFn, 
DFd) P value 
Interaction 0.2651 18 0.01473 
F (18, 60) 
= 0.7668 
P = 
0.7284 
Cell speed 0.1848 9 0.02054 
F (9, 60) = 
1.069 
P = 
0.3984 
Location 1.016 2 0.5078 
F (2, 60) = 
26.44 
P < 
0.0001 
Residual 1.152 60 0.01921   
Number of missing 
values 0     
Compare column means (main column 
effect)         
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
Tukey's multiple comparisons test 
Mean 
Diff. 
95% CI of 
diff. Significant? Summary     
2D vs. Border -0.1380 
-0.2240 to 
-0.05202 Yes ***     
2D vs. 3D 0.1220 
0.03605 to 
0.2080 Yes **     
Border vs. 3D 0.2600 
0.1741 to 
0.3460 Yes ****     
Test details Mean 1 Mean 2 Mean Diff. 
SE of 
diff. N1 N2 q DF 
2D vs. Border 0.2547 0.3927 -0.1380 0.03578 30 30 5.455 60 
2D vs. 3D 0.2547 0.1326 0.1220 0.03578 30 30 4.823 60 
Border vs. 3D 0.3927 0.1326 0.2600 0.03578 30 30 10.28 60 
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Appendix C  
MCF7 and GFP clones comparison 
Table Analyzed Aspect Ratio MCF7     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 23.39 0.4540 ns No  
Cells 6.517 0.5705 ns No  
Cell Type 2.144 0.4752 ns No  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 15.38 27 0.5695 F (27, 80) = 1.020 P = 0.4540 
Cells 4.284 9 0.4760 F (9, 80) = 0.8527 P = 0.5705 
Cell Type 1.409 3 0.4697 F (3, 80) = 0.8415 P = 0.4752 
Residual 44.66 80 0.5582   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 6        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 
95% CI 
of diff. Significant? Summary     
MCF7 3D vs. DPF5 1.661 
-10.19 to 
13.51 No ns     
MCF7 3D vs. D6F2 4.968 
-6.881 to 
16.82 No ns     
MCF7 3D vs. D1B6 -1.681 
-13.53 to 
10.17 No ns     
DPF5 vs. D6F2 3.306 
-8.543 to 
15.16 No ns     
DPF5 vs. D1B6 -3.342 
-15.19 to 
8.506 No ns     
D6F2 vs. D1B6 -6.649 
-18.50 to 
5.200 No ns     
Test details Mean 1 Mean 2 Mean Diff. 
SE of 
diff. N1 N2 q DF 
MCF7 3D vs. DPF5 23.79 22.13 1.661 4.516 30 30 0.5203 80 
MCF7 3D vs. D6F2 23.79 18.82 4.968 4.516 30 30 1.556 80 
MCF7 3D vs. D1B6 23.79 25.47 -1.681 4.516 30 30 0.5265 80 
DPF5 vs. D6F2 22.13 18.82 3.306 4.516 30 30 1.035 80 
DPF5 vs. D1B6 22.13 25.47 -3.342 4.516 30 30 1.047 80 
D6F2 vs. D1B6 18.82 25.47 -6.649 4.516 30 30 2.082 80 
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Table Analyzed 
Distance 
from Start 
MCF7     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value P value summary Significant?  
Interaction 24.69 0.3198 ns No  
Cells 9.195 0.2646 ns No  
Cell TYpe 1.901 0.5034 ns No  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 9408 27 348.5 F (27, 80) = 1.139 P = 0.3198 
Cells 3504 9 389.3 F (9, 80) = 1.273 P = 0.2646 
Cell TYpe 724.3 3 241.4 F (3, 80) = 0.7893 P = 0.5034 
Residual 24471 80 305.9   
Number of missing 
values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 6        
Alpha 0.05        
Tukey's multiple comparisons test 
Mean 
Diff. 
95% CI of 
diff. Significant? Summary     
MCF7 3D vs. DPF5 1.661 
-10.19 to 
13.51 No ns     
MCF7 3D vs. D6F2 4.968 
-6.881 to 
16.82 No ns     
MCF7 3D vs. D1B6 -1.681 
-13.53 to 
10.17 No ns     
DPF5 vs. D6F2 3.306 
-8.543 to 
15.16 No ns     
DPF5 vs. D1B6 -3.342 
-15.19 to 
8.506 No ns     
D6F2 vs. D1B6 -6.649 
-18.50 to 
5.200 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
MCF7 3D vs. DPF5 23.79 22.13 1.661 4.516 30 30 0.5203 80 
MCF7 3D vs. D6F2 23.79 18.82 4.968 4.516 30 30 1.556 80 
MCF7 3D vs. D1B6 23.79 25.47 -1.681 4.516 30 30 0.5265 80 
DPF5 vs. D6F2 22.13 18.82 3.306 4.516 30 30 1.035 80 
DPF5 vs. D1B6 22.13 25.47 -3.342 4.516 30 30 1.047 80 
D6F2 vs. D1B6 18.82 25.47 -6.649 4.516 30 30 2.082 80 
 
  
289 
 
MDA-MB-231 v GFP+ clones 
Table Analyzed Aspect Ratio MDA     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 17.14 0.7805 ns No  
Row Factor 9.563 0.2602 ns No  
Column Factor 6.939 0.0459 * Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 94.00 27 3.482 
F (27, 80) = 
0.7653 P = 0.7805 
Row Factor 52.45 9 5.827 F (9, 80) = 1.281 P = 0.2602 
Column Factor 38.06 3 12.69 F (3, 80) = 2.789 P = 0.0459 
Residual 363.9 80 4.549   
Number of missing values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons per 
family 6        
Alpha 0.05        
Tukey's multiple comparisons 
test Mean Diff. 95% CI of diff. Significant? Summary     
MDA vs. XB5 -1.465 
-2.910 to -
0.02042 Yes *     
MDA vs. YA1 -1.213 -2.658 to 0.2318 No ns     
MDA vs. ZB2 -1.126 -2.571 to 0.3185 No ns     
XB5 vs. YA1 0.2522 -1.193 to 1.697 No ns     
XB5 vs. ZB2 0.3389 -1.106 to 1.784 No ns     
YA1 vs. ZB2 0.08669 -1.358 to 1.532 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
MDA vs. XB5 2.293 3.758 -1.465 0.5507 30 30 3.763 80 
MDA vs. YA1 2.293 3.506 -1.213 0.5507 30 30 3.115 80 
MDA vs. ZB2 2.293 3.420 -1.126 0.5507 30 30 2.893 80 
XB5 vs. YA1 3.758 3.506 0.2522 0.5507 30 30 0.6477 80 
XB5 vs. ZB2 3.758 3.420 0.3389 0.5507 30 30 0.8703 80 
YA1 vs. ZB2 3.506 3.420 0.08669 0.5507 30 30 0.2226 80 
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Table Analyzed 
Distance from Start 
MDA     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 24.07 0.3951 ns No  
Cell distance 2.003 0.9817 ns No  
Cell TYpe 7.245 0.0402 * Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 138680 27 5136 F (27, 80) = 1.070 P = 0.3951 
Cell distance 11537 9 1282 F (9, 80) = 0.2670 P = 0.9817 
Cell TYpe 41736 3 13912 F (3, 80) = 2.897 P = 0.0402 
Residual 384141 80 4802   
Number of missing values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons per 
family 6        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 95% CI of diff. Significant? Summary     
MDA vs. XB5 -7.716 -54.66 to 39.23 No ns     
MDA vs. YA1 38.31 -8.639 to 85.25 No ns     
MDA vs. ZB2 25.52 -21.42 to 72.47 No ns     
XB5 vs. YA1 46.02 
-0.9226 to 
92.97 No ns     
XB5 vs. ZB2 33.24 -13.71 to 80.19 No ns     
YA1 vs. ZB2 -12.78 -59.73 to 34.16 No ns     
         
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
MDA vs. XB5 94.48 102.2 -7.716 17.89 30 30 0.6099 80 
MDA vs. YA1 94.48 56.18 38.31 17.89 30 30 3.028 80 
MDA vs. ZB2 94.48 68.96 25.52 17.89 30 30 2.017 80 
XB5 vs. YA1 102.2 56.18 46.02 17.89 30 30 3.638 80 
XB5 vs. ZB2 102.2 68.96 33.24 17.89 30 30 2.627 80 
YA1 vs. ZB2 56.18 68.96 -12.78 17.89 30 30 1.010 80 
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HT1080 cells v lentiviral GFP+ clones 
Table Analyzed 
Distance from 
start HT1080     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Significant?  
Interaction 14.68 0.9975 ns No  
Row Factor 7.567 0.6281 ns No  
Column Factor 6.806 0.0002 *** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 68377 78 876.6 
F (78, 216) = 
0.5732 P = 0.9975 
Row Factor 35236 26 1355 
F (26, 216) = 
0.8862 P = 0.6281 
Column Factor 31689 3 10563 
F (3, 216) = 
6.907 P = 0.0002 
Residual 330332 216 1529   
Number of missing 
values 0     
Compare column means (main column 
effect)         
Number of families 1        
Number of comparisons per family 6        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. 
Significan
t? 
Summa
ry     
HT1080 vs. A1D9  26.47 
10.56 to 
42.38 Yes ***     
HT1080 vs. B696  19.35 
3.437 to 
35.26 Yes *     
HT1080 vs. ZB5  19.89 
3.977 to 
35.80 Yes **     
A1D9 vs. B696  -7.124 
-23.03 to 
8.786 No ns     
A1D9 vs. ZB5  -6.584 
-22.49 to 
9.326 No ns     
B696 vs. ZB5  0.5401 
-15.37 to 
16.45 No ns     
Test details Mean 1 Mean 2 Mean Diff. 
SE of 
diff. N1 N2 q DF 
HT1080 vs. A1D9  63.33 36.86 26.47 6.145 81 81 6.092 216 
HT1080 vs. B696  63.33 43.99 19.35 6.145 81 81 4.453 216 
HT1080 vs. ZB5  63.33 43.45 19.89 6.145 81 81 4.577 216 
A1D9 vs. B696  36.86 43.99 -7.124 6.145 81 81 1.640 216 
A1D9 vs. ZB5  36.86 43.45 -6.584 6.145 81 81 1.515 216 
B696 vs. ZB5  43.99 43.45 0.5401 6.145 81 81 0.1243 216 
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Table Analyzed Aspect Ratio     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation % of total variation P value 
P value 
summary Significant?  
Interaction 20.66 0.8755 ns No  
Cells 10.88 0.1062 ns No  
Cell type 0.6462 0.3856 ns No  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 341.0 117 2.914 
F (117, 320) = 
0.8331 P = 0.8755 
Cells 179.6 39 4.604 
F (39, 320) = 
1.316 P = 0.1062 
Cell type 10.67 3 3.556 
F (3, 320) = 
1.016 P = 0.3856 
Residual 1119 320 3.498   
Number of missing 
values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per 
family 6        
Alpha 0.05        
Tukey's multiple comparisons 
test Mean Diff. 
95% CI of 
diff. 
Significan
t? Summary     
HT1080 vs. A1D9  0.05334 
-0.5703 to 
0.6769 No ns     
HT1080 vs. B696  -0.1263 
-0.7499 to 
0.4973 No ns     
HT1080 vs. ZB5  0.2853 
-0.3383 to 
0.9089 No ns     
A1D9 vs. B696  -0.1796 
-0.8032 to 
0.4440 No ns     
A1D9 vs. ZB5  0.2319 
-0.3917 to 
0.8555 No ns     
B696 vs. ZB5  0.4115 
-0.2121 to 
1.035 No ns     
Test details Mean 1 Mean 2 
Mean 
Diff. SE of diff. N1 N2 q DF 
HT1080 vs. A1D9  3.940 3.887 0.05334 0.2415 120 120 
0.312
4 320 
HT1080 vs. B696  3.940 4.066 -0.1263 0.2415 120 120 
0.739
5 320 
HT1080 vs. ZB5  3.940 3.655 0.2853 0.2415 120 120 1.671 320 
A1D9 vs. B696  3.887 4.066 -0.1796 0.2415 120 120 1.052 320 
A1D9 vs. ZB5  3.887 3.655 0.2319 0.2415 120 120 1.358 320 
B696 vs. ZB5  4.066 3.655 0.4115 0.2415 120 120 2.410 320 
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Figure C1.  Immuno-staining controls for GFP antibody on CAM.  A CAM section stained 
with DAPI, phalloidin and anti-GFP antibody.  B Secondary antibody only on CAM with 
phalloidin and DAPI stains.  Images taken with a Nikon A1 Plus confocal microscope using NIS 
Elements software.  Scale bars = 25µm.  
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Appendix D 
HT1080 on dCAM – vimentin expression 
Table Analyzed Final Comparison One Control 
Kruskal-Wallis test  
P value < 0.0001 
Exact or approximate P value? Approximate 
P value summary **** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 7 
Kruskal-Wallis statistic 61.58 
Data summary  
Number of treatments (columns) 7 
Number of values (total) 277 
Number of families 1      
Number of comparisons per family 6      
Alpha 0.05      
Dunn's multiple comparisons test Mean rank diff. Significant? Summary  A-?  
2D Control vs. 3D dCAM n1 -12.79 No ns  B 3D dCAM n1 
2D Control vs. 3D dCAM n2 69.47 Yes ***  C 3D dCAM n2 
2D Control vs. 3D dCAM n3 -7.172 No ns  D 3D dCAM n3 
2D Control vs. 3D dCAM n4 19.24 No ns  E 3D dCAM n4 
2D Control vs. dCAM Day1 -88.92 Yes ****  F dCAM Day1 
2D Control vs. dCAM Day3 20.76 No ns  G dCAM Day3 
Test details Mean rank 1 Mean rank 2 
Mean rank 
diff. n1 n2  
2D Control vs. 3D dCAM n1 138.2 151.0 -12.79 95 33  
2D Control vs. 3D dCAM n2 138.2 68.77 69.47 95 26  
2D Control vs. 3D dCAM n3 138.2 145.4 -7.712 95 29  
2D Control vs. 3D dCAM n4 138.2 119.0 19.24 95 31  
2D Control vs. dCAM Day1 138.2 227.2 -88.92 95 30  
2D Control vs. dCAM Day3 138.2 117.5 20.76 95 33  
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Appendix E 
Inverted invasion assay 
Table Analyzed 
MCF7 
Inverted 
Invasion     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Significant?  
Interaction 8.496 > 0.9999 ns No  
nucleus height 10.32 0.6759 ns No  
Treatments 6.655 0.0005 *** Yes  
ANOVA table SS DF MS F (DFn, DFd) P value 
Interaction 182.9 58 3.153 
F (58, 180) = 
0.3537 P > 0.9999 
nucleus height 222.1 29 7.659 
F (29, 180) = 
0.8592 P = 0.6759 
Treatments 143.3 2 71.63 
F (2, 180) = 
8.036 P = 0.0005 
Residual 1605 180 8.914   
Number of missing values 0     
Compare column means (main 
column effect)         
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
Tukey's multiple comparisons test Mean Diff. 
95% CI of 
diff. Significant? Summary     
Control vs. FAK  -1.523 
-2.575 to -
0.4711 Yes **     
Control vs. SRC -1.567 
-2.618 to -
0.5148 Yes **     
FAK vs. SRC -0.04367 
-1.096 to 
1.008 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Control vs. FAK  10.51 12.03 -1.523 0.4451 90 90 4.839 180 
Control vs. SRC 10.51 12.08 -1.567 0.4451 90 90 4.978 180 
FAK vs. SRC 12.03 12.08 -0.04367 0.4451 90 90 0.138 180 
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Table Analyzed 
MDA 
Inverted 
Invasion     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Significant?  
Interaction 18.17 0.8150 ns No  
Nucleus 8.955 0.7524 ns No  
Treatment 4.396 0.0025 ** Yes  
ANOVA table SS DF MS F (DFn, DFd) 
P 
valu
e 
Interaction 1310 62 21.14 
F (62, 192) = 
0.8218 
P = 
0.81
50 
Nucleus 645.8 31 20.83 
F (31, 192) = 
0.8099 
P = 
0.75
24 
Treatment 317.0 2 158.5 
F (2, 192) = 
6.162 
P = 
0.00
25 
Residual 4938 192 25.72   
Number of missing values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons 
per family 3        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 95% CI of diff. Significant? Summary     
Control vs. FAK  -1.165 -2.894 to 0.5644 No ns     
Control vs. SRC -2.566 -4.295 to -0.8372 Yes **     
FAK vs. SRC -1.402 -3.131 to 0.3274 No ns     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Control vs. FAK  7.953 9.117 -1.165 0.7320 96 96 2.250 192 
Control vs. SRC 7.953 10.52 -2.566 0.7320 96 96 4.958 192 
FAK vs. SRC 9.117 10.52 -1.402 0.7320 96 96 2.708 192 
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Table Analyzed 
HT Inverted 
Invasion     
Two-way ANOVA Ordinary     
Alpha 0.05     
Source of Variation 
% of total 
variation P value 
P value 
summary Significant?  
Interaction 15.64 0.9223 ns No  
Nucleus height 11.18 0.4056 ns No  
Treatment 7.163 < 0.0001 **** Yes  
ANOVA table SS DF MS 
F (DFn, 
DFd) P value 
Interaction 2300 62 37.09 
F (62, 192) 
= 0.7335 
P = 
0.9223 
Nucleus height 1643 31 53.01 
F (31, 192) 
= 1.048 
P = 
0.4056 
Treatment 1053 2 526.7 
F (2, 192) = 
10.42 
P < 
0.0001 
Residual 9709 192 50.57   
Number of missing values 0     
Compare column means 
(main column effect)         
Number of families 1        
Number of comparisons per 
family 3        
Alpha 0.05        
Tukey's multiple 
comparisons test Mean Diff. 
95% CI of 
diff. Significant? Summary     
Control vs. FAK  3.588 
1.163 to 
6.012 Yes **     
Control vs. SRC -0.8153 
-3.240 to 
1.609 No ns     
FAK vs. SRC -4.403 
-6.827 to -
1.978 Yes ****     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. N1 N2 q DF 
Control vs. FAK  10.70 7.108 3.588 1.026 96 96 4.943 192 
Control vs. SRC 10.70 11.51 -0.8153 1.026 96 96 1.123 192 
FAK vs. SRC 7.108 11.51 -4.403 1.026 96 96 6.066 192 
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Correlation n1 
Aspect Ratio 
vs. 
Mean Fluorescence 
Pearson r  
r -0.1414 
95% confidence interval -0.4623 to 0.2122 
R squared 0.01999 
P value  
P (two-tailed) 0.4326 
P value summary ns 
Significant? (alpha = 0.05) No 
Number of XY Pairs 33 
Correlation n2 
Aspect Ratio 
vs. 
Mean Fluorescence 
Pearson r  
r -0.007052 
95% confidence interval -0.3664 to 0.3541 
R squared 4.973e-005 
P value  
P (two-tailed) 0.9705 
P value summary ns 
Significant? (alpha = 0.05) No 
Number of XY Pairs 30 
Correlation n3 
Aspect Ratio 
vs. 
Mean Fluorescence 
Pearson r  
r -0.1355 
95% confidence interval -0.4727 to 0.2363 
R squared 0.01836 
P value  
P (two-tailed) 0.4753 
P value summary ns 
Significant? (alpha = 0.05) No 
Number of XY Pairs 30 
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Appendix F 
Figure A.7, Comparison of HT-1080 (HT) and MDA-MB-231 (MDA) migrating on 2mg/ml 
collagen for an 8 hour period from time-lapse images taken at 10 minute intervals.  Control 
groups containing 30 cells from an earlier experiment were compared with grouped cells for 
N1-3 (30 cells in each group).  No significant difference was evident for either cell migration 
distance from start (A) or cell migration speed (B) between control groups and N1-3 cell 
experiments.  A Kruskal-Wallis ANOVA with Dunn’s test for multiple comparisons was used 
to test for significant differences between each control and N1-3 pair. The table for this is 
given on the next page. 
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Table Analyzed 
D2S Comparison HT 
and MDA 
Kruskal-Wallis test  
P value 0.0149 
Exact or approximate P value? Approximate 
P value summary * 
Do the medians vary signif. (P < 
0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 10.48 
Data summary  
Number of treatments (columns) 4 
Number of values (total) 225 
Number of comparisons per family 1     
Alpha 2     
 0.05     
Dunn's multiple comparisons test      
 
Mean 
rank 
diff. Significant? Summary   
HT Control vs. HT N1-3      
MDA Control vs. MDA N1-3 2.650 No ns  A-B 
 21.60 No ns  C-D 
Test details       
 
Mean 
rank 1 Mean rank 2 
Mean rank 
diff. n1 n2 
HT Control vs. HT N1-3      
MDA Control vs. MDA N1-3 103.5 100.8 2.650 30 90 
 141.6 120.0 21.60 30 75 
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Table Analyzed 
Speed Comparison HT 
and MDA 
Kruskal-Wallis test  
P value 0.0011 
Exact or approximate P value? Approximate 
P value summary ** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 16.10 
Data summary  
Number of treatments (columns) 4 
Number of values (total) 225 
Number of families 1     
Number of comparisons per family 2     
Alpha 0.05     
Dunn's multiple comparisons test Mean rank diff. Significant? Summary   
HT Control vs. HT N1-3 8.767 No ns  A-B 
MDA Control vs. MDA N1-3 16.71 No ns  C-D 
Test details Mean rank 1 Mean rank 2 
Mean rank 
diff. n1 n2 
HT Control vs. HT N1-3 104.2 95.47 8.767 30 90 
MDA Control vs. MDA N1-3 142.5 125.8 16.71 30 75 
 
 
 
